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(3R,3'R,6'R)-Lutein (1) and (3R,3'R)-zeaxanthin (5) are dietary carotenoids that 
are found in most fruits and vegetables. Numerous studies have shown that 1 and 5 
play an important role in the prevention of age-related macular degeneration (AMD) 
that is the leading cause of blindness. To date, the metabolic pathways of 1 and 5 in 
ocular tissues of an animal model in relation to AMD have not been explored. This is 
primarily because of the lack of a viable method for the synthesis of 1 and 5 that can 
be labeled with a stable isotope. Among the eight possible stereoisomers of lutein, 
only 1 has been previously prepared by total synthesis in 14 steps in an overall yield 
of 0.5%. 
The total synthesis of lutein, zeaxanthin, and their stereoisomers from (±)-α-
ionone has been accomplished by a C15+C10+C15 coupling strategy. Therefore, 
(3R,3'R,6'R)-lutein (1, 8%), (3R,3'S,6'S)-lutein (2, 7%), (3R,3'S,6'R)-lutein (3, 6%), 
and (3R,3'R,6'S)-lutein (4, 7%) were each prepared in a high optical purity in 7 steps. 
3-Hydroxy-α-ionylideneacetaldehyde served as a common precursor to afford luteins 
1 – 4 by a much shorter synthetic sequence and a higher overall yield than that of a 
published method for 1. The other four stereoisomers of lutein can be similarly 
prepared.  
(3R,3'R)-Zeaxanthin (5, 12%) and (3S,3'S)-zeaxanthin (6, 11%) were prepared in 
8 steps from (±)-α-ionone via 3-hydroxy-α-ionone which was transformed into 3-
hydroxy-β-ionone (3R-42, 22%) and its enantiomer (3S-42, 21%), respectively. The 
key intermediates, 3R-42 and 3S-42 were converted into the corresponding C15-Wittig 
salts 3R-16 and 3S-16 that were used in a double Wittig reaction with the C10-
dialdehyde 17 to afford 5 (98% ee) and 6 (98% ee). 
Utilizing Wittig salts 3R-16 and 3S-16, (3R)-β-cryptoxanthin (135, 8%) and (3S)-
β-cryptoxanthin (136, 9%) were each prepared in optical purity of 98%. 
The most important feature of the strategies presented here is its application to 
the total synthesis of isotopically labeled and optically pure lutein, zeaxanthin, and 
their stereoisomers for metabolic studies. This synthesis also provides access to the 
C15-precursors of optically active carotenoids with 3-hydroxy-ε- and 3-hydroxy-β-end 
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(3R,3'R,6'R)-Lutein and (3R,3'R)-zeaxanthin are dietary carotenoids that are 
present in commonly consumed fruits and vegetables.1,2 These carotenoids 
accumulate in the human plasma, major organs, and ocular tissues [macula, retinal 
pigment epithelium (RPE), ciliary body, iris, lens] and have been implicated in the 
prevention of age-related macular degeneration (AMD).3,4  
Lutein contains 3 stereogenic centers at C3, C3', and C6' positions that can result 
in 8 possible stereoisomers. The chemical structures of 4 of these stereoisomers are 
shown in Figure 1. The other 4 stereoisomers of lutein (structures not shown), are 
those in which the configuration at C3 is S while the stereochemistry at C3' and C6' 
remains the same as those lutein isomers shown in Figure 1. Among these 8 





























Figure 1. The chemical structure of dietary (3R,3'R,6'R)-lutein (1) and three of its 
stereoisomers. 
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Unlike lutein, zeaxanthin has a symmetrical structure and possesses two chiral 






















Figure 2. The chemical structures of zeaxanthin stereoisomers. 
 
In the past decade, numerous epidemiological and experimental studies have 
shown that (3R,3'R,6'R)-lutein (1) and (3R,3'R)-zeaxanthin (5) play an important role 
in the prevention of AMD that is the leading cause of blindness in the U.S. and 
Western World.5,6 Statistics from the Eye Disease Prevalence Research Group 
estimates that 1.8 million U.S. residents are legally blind, and another 7.3 million are 
at risk for vision loss from AMD.7 The US National Eye Institute is currently 
conducting a multi-center, randomized clinical trial known as: “The Age-Related Eye 
Disease Study 2 (AREDS2)” to assess the effects of oral supplementation of 
(3R,3'R,6'R)-lutein (1) and (3R,3'R)-zeaxanthin (5) and/or long-chain omega-3 fatty 
acids (docosahexaenoic acid) [DHA] and eicosapentaenoic acid [EPA] on the 
progression to advanced AMD (http://www.areds2.org). 
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Macula is anatomically defined as an exact center of the retina and has a 
diameter of approximately 5.5 mm (Figure 3). 
 
 
Figure 3. Anatomy of the human eye. (Source: www.macugen.com/whatisamd.asp) 
 
Macula is consisted of cone photoreceptors and the initial process of vision 
occurs in the outer segment of these photoreceptors that provide good visual acuity 
(20/20). Human rod outer segment (ROS) within the macula is the region of the retina 
most exposed to oxidation with aging because of its relatively high oxygen tension 
and high concentration of long-chain polyunsaturated fatty acids (Figure 4).7  
 
 
Figure 4. Three dimensional representation of a portion of human retina.  
(source: http://webvision.med.utah.edu/imageswv/3dlabel.jpeg) 
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In 1945, Wald tentatively identified the yellow pigment in the human macula as a 
carotenoid belonging to the xanthophyll families in green leaves.6  In 1985, Bone et al. 
presented preliminary evidence that the human macular pigment is a mixture of 1 and 
5.8 Subsequently, in 1993 Bone et al. established the complete identification and 
stereochemistry of the human macular pigment as (3R,3'R,6'R)-lutein [(3R,3'R,6'R)-
β,ε-carotene-3,3'-diol] (1), (3R,3'R)-zeaxanthin [(3R,3'R)-β,β-carotene- 3,3'-diol] (5), 
and (3R,3'S;meso)-zeaxanthin [(3R,3'S;meso)-β,β-carotene-3,3'-diol] (7).9 It has been 
hypothesized that 1 and 5 protect the macula against photooxidative damage and 
prevent the onset of AMD that is the leading cause of blindness in persons aged 60 
years or older. 
Two mechanisms for the protective role of 1 and 5 against AMD have been 
proposed: 1) functioning as antioxidants and/or 2) as optical filters.10,11 In 1994, an 
epidemiological study concluded that persons consuming green leafy vegetables, 
specifically rich in 1 and 5 (ca. 6 mg/day), had 43% lower risk of AMD.12 One of the 
underlying hypotheses for the protective role of carotenoids in AMD and cataract has 
been based on the ability of these carotenoids to act as antioxidants that can protect 
the human retina from photooxidation. For a review of the protective role of 
carotenoids against AMD, see the publication by Schalch13 and Snodderly.14   
Macular carotenoids are thought to function as an optical filter by absorbing 
short-wavelength visible light and reducing chromatic aberration.13 This may also 
prevent photochemical damage to cones and retinal pigment epithelium (RPE) in the 
fovea which is a small depression in the center of macula.6, 13-14 Fovea has the highest 
density of photoreceptors and also the highest concentration of 1 and 5. Another 
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mechanism by which macular carotenoids provide protection against AMD involves 
their antioxidant function.13, 15-19 
However, carotenoids are highly concentrated in the plexiform layers of the 
fovea where an antioxidant mechanism of action would not be expected. Rapp et al. 
have provided the "missing link" in this theory by detecting lutein 1 and zeaxanthin 5 
in the photoreceptor rod outer segment (ROS) membranes of the human retina.20 This 
region of the retina has the highest concentration of long-chain polyunsaturated fatty 
acids that exist in high oxygen tension and therefore most susceptible to oxidative 
insult.21,22 These findings provide further support for the critical role of 1 and 5 in 
protecting the eye from light-induced oxidative damage.  
In 1997, Khachik et al. provided preliminary evidence for the possible 
antioxidant role of 1 and 5 in the retina by identifying and quantifying 1, 5, and 
several of their oxidative metabolites in human and monkey retinas.23 These 
metabolites were: (3R,3'S,6'R)-lutein (3'-epilutein) (3), 3-hydroxy-β,ε-caroten-3'-one 
(3'-oxolutein), 3'-hydroxy-ε,ε-caroten-3-one, ε,ε-carotene-3,3'-dione, and 
(3R,3'S;meso)-zeaxanthin (7). To account for the presence of these non-dietary 
carotenoids, Khachik et al. proposed possible metabolic transformations for dietary 
lutein 1 and zeaxanthin 5 in human retina as shown in Scheme 1. The authors 
postulated that non-dietary 3'-epilutein (3) and 3'-oxolutein in human ocular tissues 
may be formed from 1 and/or 5 as a result of a series of oxidation-reduction and 
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Scheme 1. Proposed metabolic transformations of dietary lutein and zeaxanthin in 
human retina.23 
According to these proposed metabolic transformations, allylic oxidation of 1 
can result in the formation of 3'-oxolutein that may subsequently undergo 
stereoselective reduction to 3. Alternatively, double bond isomerization of 5 can also 
result in the formation of 3. The formation of 3'-hydroxy-ε,ε-caroten-3-one was 
explained by double bond isomerization of 3'-oxolutein. Similarly, double bond 
isomerization of 3 followed by allylic oxidation to ε,ε-carotene-3,3'-dione was 
proposed. With the exception of (3R,3'S;meso)-zeaxanthin (7), all of the other 
metabolites shown in Scheme 1 are also present in human plasma, tissues and organs 
at low concentrations. Therefore, the presence of these metabolites in ocular tissue 
can be attributed to their transport through the circulatory system or these carotenoids 
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may be formed locally in the eye by an independent process.23,24,28,33-35,37 In a more 
recent study by Khachik et al., (3R,3'S; meso)-zeaxanthin (7) has been shown to be 
absent in foods, human serum and liver while relatively high concentrations of this 
carotenoid metabolite were found in human ocular tissues [retina, macula, retinal 
pigment epithelium (RPE)/choroid, ciliary body, iris, lens].24 The presence of 
(3R,3'S;meso)-zeaxanthin (7) in human ocular tissue was explained by in vivo double 
bond isomerization of dietary (3R,3'R,6'R)-lutein (1).3,4  
In 2005, Johnson et al. proved that (3R,3'S;meso)-zeaxanthin (7) was formed 
from dietary (3R,3'R,6'R)-lutein (1) and not from dietary (3R,3'R)-zeaxanthin (5) in a  
supplementation study involving xanthophyll-free monkeys.25 In this study, the 
authors raised Rhesus monkeys on a diet that was free from xanthophylls 
[(3R,3'R,6'R)-lutein (1) and dietary (3R,3'R)-zeaxanthin (5)] and then fed these 
animals with either 1 or 5 supplements. (3R,3'S;meso)-Zeaxanthin (7) was only 
detected in the retinas of the lutein-fed monkeys after 6-8 month while this 
carotenoids was absent in the retinas of zeaxanthin-fed monkeys. In 2006, this was 
also confirmed in a study by Khachik et al. in which the authors demonstrated that 
(3R,3'S;meso)-zeaxanthin levels in the retinas, ciliary body, and lens of Rhesus 
Macaques is substantially increased with high dose (10 mg per kg body weight/day) 
supplementation with 1 after 1 year.4  
While the experimental evidence to date unequivocally supports the conversion 
of dietary lutein 1 to meso-zeaxanthin (7) in the human ocular tissues, the origin of the 
other metabolites is not known at present. It is quite likely that dietary lutein 1 and 
zeaxanthin 5 in the eye undergo oxidation, reduction and double bond isomerization 
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reactions by photo-induced and/or enzymatic transformation to their metabolites. 
However, the nature of these reactions and the enzymes that may be involved remains 
unclear. 
The proposed metabolic transformation of 1 and 5 shown in Scheme 1 can be 
best compared to the ocular metabolism of retinol that also involves oxidation-
reduction and isomerization reactions. For example, if 1 and 5 act as antioxidants to 
protect the macula from oxidative injury, it would be reasonable to assume that at the 
early stage of AMD, the normal metabolic cycle of these carotenoids would be 
adversely affected. These metabolic transformations are most likely to involve certain 
proteins and enzymes. In such a case, characterization of the enzymes and proteins 
whose improper function may be responsible for the defective metabolism of 1 and 5 
at the onset of AMD is essential. Unlike the metabolic cycle of vitamin A in the eye 
that has been well established, enzymes and proteins that may be involved in the 
metabolic transformations of 1 and 5 in the eye are yet to be identified. The 
characterization of these enzymes and proteins and understanding of their function in 
the human eye could provide a significant breakthrough in preventing AMD. However, 
prior to isolation and characterization of the enzymes and proteins that may be 
involved, the metabolic cycle of 1 and 5 needs to be fully established. For example, 
allylic oxidation of 1 at C3' that results in the formation of 3'-oxolutein may involve 
an oxido-reductase enzyme similar to the allylic oxidation of retinol to retinaldehyde 
(retinal) and the reverse reduction by retinol dehydrogenase.  
Due to the invasive nature, metabolic studies that investigate such transformation 
would have to be conducted in an appropriate animal model. Rhesus Masques have 
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been shown to serve as the ideal animal model in supplementation studies with 1 and 
5.26 Japanese quail (Cotornix japonica) have also been identified as a suitable non-
primate animal model due to the distribution of carotenoids and their metabolites in 
their retinas that is similar to that of humans.27 
Regardless of the selection of the animal model, the proposed metabolic 
pathways shown in Scheme 1 need to be investigated in supplementation studies with 
isotopically labeled 1 and 5. In exploring biochemical and metabolic transformations, 
radiolabeled compounds (3H, 14C) are normally employed. However, in the case of 
carotenoids, the total synthesis of these compounds involves numerous steps and 
would require large amounts of radioactive water or carbon-14 source that present 
serious hazards with respect to handling and waste disposal. Consequently, stable 
isotopes of lutein 1 and zeaxanthin 5 would be ideal for metabolic studies with these 
compounds. In selection of the stable isotope (13C or 2H), two major factors need to be 
considered, these are: 1) no scrambling or exchange of the label with other positions 
in the molecule should occur, and 2) no isotope dilution as a result of exchange of 
label with solvent and/or reagents should take place.  
Several carotenoids specifically labeled with deuterium have been synthesized 
and used in the study of their fragmentation patterns in mass spectrometry (MS).28-30 
Comparison of the fragmentation patterns of 2H- and 13C-labeled carotenoids, 
however, has shown that 13C-labeled carotenoids are the material of choice since no 
scrambling or the exchange of label is observed during their fragmentation.31 
Consequently, MS fragmentation patterns and mechanisms can be elucidated 
unambiguously. In metabolic studies with 1 and 5, where certain transformations such 
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as oxidation-reduction and double bond isomerization reactions (Scheme 1) are of 
particular interest, the location of the 13C-label is not crucial. This is because the 
general skeleton of these carotenoids remains unchanged throughout these metabolic 
reactions.3,27,32-35 However, in metabolic studies with (3R,3'R,6'R)-lutein (1) and 
(3R,3'R)-zeaxanthin (5), it is imperative that at least four carbons in the molecules of 
these carotenoids are labeled. This is based on the fact that the metabolites of 1 and 5 
are either isomeric to these carotenoids or are only two mass units lower than their 
parent compounds (Scheme 1). Therefore by increasing the molecular weight in the 
labeled compound by four mass units, one can readily distinguish the metabolites of 1 
and 5 from their unlabelled counterparts.  
With the wealth of information on the distribution of ocular carotenoids and their 
metabolites in humans, monkeys, and quail, metabolic studies with carotenoids 
labeled with C-13 would be expected to be relatively straightforward. However, to 
date the metabolism of 1 and 5 in the ocular tissues of an appropriate animal model in 
relation to AMD has not been explored. This is primarily because of the lack of an 
efficient and economically viable method for the synthesis of 1 and 5 that can be 
labeled with a stable isotope. The major difficulty with the total synthesis of 
(3R,3'R,6'R)-lutein (1) is due to the presence of 3 stereogenic centers mentioned at the 
beginning of this dissertation that can result in 8 possible stereoisomers (Figure 1).  
At present, it is not known whether the other lutein stereoisomers could be 
formed in humans as a consequence of metabolic transformation of 1. Therefore, the 
fate and biological activity of other lutein stereoisomers in humans remains 
unexplored due to the lack of availability of these carotenoids. While 5 has been 
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commercially available by total synthesis for more than two decades, the industrial 
production of 1 and its stereoisomers by chemical synthesis has not yet materialized. 
Consequently, 1 is commercially produced from saponified extracts of marigold 
flowers.36 The total synthesis of (3R,3'R,6'R)-lutein (1) has been reported by Mayer 
and Rüttimann in 1980 who employed C15+C10+C15 double Wittig coupling strategy to 
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Scheme 2. Total synthesis of (3R,3'R,6'R)-lutein (1) according to Mayer and 
Rüttimann.37 
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Reaction of 8 with mesyl chloride gave the corresponding mesylate which, on 
treatment with tetrabutylammonium acetate, was converted into the acetoxyketone 9 
with complete inversion of configuration. The introduction of the second chiral center 
was achieved by epoxidation of the protected hydroxyketone 10 with dimethyl 
sulphonium methylylide that led to the isolation of epoxide 11. The product of the 
reaction of the EtMgBr with acetone was then allowed to catalyze stereoselective ring 
opening reaction of epoxide 11 to yield the protected hydroxyl-α-cyclocitral 12. The 
authors did not provide any rationale for the stereoselectivity in this reaction and the 
possible formation of the other stereoisomers of 12 was not discussed. Subsequent 
chain lengthening by Wadsworth-Horner-Emmons (WHE) reaction gave a nitrile, 
which on treatment with MeLi, was converted into C13-hydroxyketone 13. Vinylation 
of 13 gave a mixture of epimeric vinyl carbinols 14 which were treated with PPh3 and 
aqueous HBr to yield the corresponding C15-phosphonium bromide salt. Since the 
bromide salt was not stable, it was converted to the chloride salt with aqueous NaCl to 
afford 15. 
The Wittig reaction of 16 that was previously prepared by the authors for the 
synthesis of (3R,3'R)-zeaxanthin (5) with commercially available 2,6-dimethyl-octa- 
2,4,6-triene-1,8-dial (C10-dialdehyde 17)38 gave the C25-hydroxyaldehyde 18 (Scheme 
2). The final step of the synthesis of 1 involved the Wittig reaction of aldehyde 18 
with Wittig salt 15. The key starting material for this synthesis, synthon 8, had to be 
prepared from 6-oxoisophorone in 3 steps in an overall yield of 25% (Scheme 3).39 
Therefore, the overall yield of the total synthesis of 1 according to Mayer and 



































Scheme 3. Preparation of the hydroxylketone 8 from 6-oxoisophorone (19).39 
 
The chiral ketone 8 was synthesized in three steps starting from the enantiomeric 
fermentative reduction of 6-oxoisophorone (19) using Baker’s yeast to yield the 
saturated chiral diketone 20. Reduction of this chiral diketone by hydrogenation over 
Raney Ni followed by diastereomeric separation afforded the chiral hydroxyketone 22. 
After protection of the hydroxyl group, this chiral hydroxyketone was brominated 
under acidic condition to yield 23 which was dehydrobrominated to 8. Consequently, 
this synthetic approach to (3R,3'R,6'R)-lutein (1) from 6-oxoisophorone (19) did not 
provide an efficient and economically viable route for industrial production of this 
carotenoid. To date, this remains as the only reported synthesis of 1 and no attempt 
has been made to prepare the other stereoisomers of this carotenoids by total synthesis. 
However, it should be noted that Khachik has reported the partial synthesis of 3'-
epilutein (3) from 1.40 Thus, the main objective of the research presented in this 
dissertation was to develop viable processes that could be applied to the synthesis of 
isotopically labeled lutein, zeaxanthin, and their stereoisomers.  
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Unlike 1, zeaxanthin (5) has a symmetrical structure and possesses two chiral 
centers resulting in 3 possible stereoisomers and is much easier to synthesize. The 
first total synthesis of optically inactive (±)-zeaxanthin was reported in 1957 by Isler 
et al. employing C19+C2+C19 Grignard coupling strategy (Scheme 4).41 
6-Oxoisophorone (19) was reduced chemically under acidic condition to racemic 
saturated diketone 20. Unlike the stereoselective reduction of 6-oxoisophorone (19) 
discussed earlier, optically pure isomers of diketone 20 was not needed for this 
synthesis.  The less sterically hindered keto group in 20 was selectively protected and 
4-ethylenedioxy-2,2,6-trimethylcyclohexanone (24) was then coupled with the C5-
acetylenic synthon 25 to give 26 (Scheme 4). The triple bond of 26 was reduced with 
LAH to 27 and the ketal 27 was simultaneously deprotected and dehydrated to C14-
aldehyde 28 under acidic condition. This aldehyde was then further transformed into 
29 by the following sequence of reactions: selective protection of the aldehyde group, 
LAH reduction of the ketone functionality, acetylation of the resulting hydroxyl group, 
and deprotection of the aldehyde group. Isomerization of 29 to 31 was accomplished 
via the corresponding enol acetate 30. In the following step, 31 was transformed into 
C19-aldehyde 33 via 32 by two consecutive enol ether condensations. 
The final coupling of two of this C19-synthon with acetylene dimagnesium 
bromide gave 3,3'-diacetoxy-β-C40-diol (34) (Scheme 4). Dehydration of (34) with 
hydrochloric acid gave 15,15'-dehydrozeaxanthin (35) which upon hydrogenation 
with Lindlar catalyst afforded the desired (±)-zeaxanthin. However, the overall yield 













































































Scheme 4. Synthesis of (±)-zeaxanthin by Isler et al.41 
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In 1971, a more practical total synthesis of (±)-zeaxanthin was reported by 
Loeber et al. by implementing a C15+C10+C15 Wittig coupling reaction as shown in 

























































Scheme 5. The total synthesis of (±)-zeaxanthin according to the method of Loeber et 
al.42 
The key intermediate for this synthesis was (±)-3-hydroxy-(β-ionylideneethyl)- 
triphenylphosphonium bromide (44) that was coupled with the commercially 
available C10-dialdehyde 17 in a double Wittig reaction to yield a racemic mixture of 
zeaxanthin. This (±)-C15-Wittig salt 44 was prepared in 8 steps from protected ketone 
(24) that was sequentially converted to 3-hydroxy-vinyl-α-ionol (43) in 6.6% yield. 
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The reaction of ketone 24, prepared from 6-oxoisophorone (19), with the 
Grignard reagent prepared from but-3-yn-2-ol (36) afforded glycol 37 that was 
deprotected to dihydroxyketone 38. In the following step, 38 was reduced with 
NaBH4 and the resulting triol was protected to 39 which was dehydrated with 
phosphorus oxychloride to yield enyne 40. Partial reduction of the acetylenic bond in 
40 with LiAlH4 in THF gave 3-hydroxy-β-ionol (41); this was subsequently oxidized 
with MnO2 to 3-hydroxy-β-ionone (42). Reaction of this β-ionol 42 with vinyl 
magnesium bromide led to vinyl alcohol 43 that was transformed into the racemic 
Wittig salt 44. The final coupling of the Wittig salt 44 with the C10-dialdehyde 17 
gave (±)-zeaxanthin in an overall yield of 4.1%. 
The first total synthesis of optically active (3R)-3-hydroxy-(β-ionylideneethyl)- 
triphenylphosphonium chloride [(3R)-16] and its (3S)-isomer [(3S)-16] was reported 
in 1980 by Rüttimann and Mayer (Scheme 6).43 The key starting materials in this 
synthesis were the chiral aldehydes, (3R)-3-hydroxy-β-cyclogeranial [(3R)-48] and 
(3S)-3-hydroxy- β-cyclogeranial [(3S)-48], that were each prepared in 5 steps from 



















































Scheme 6. Synthesis of (3R)-3-hydroxy-(β-ionylideneethyl)triphenylphosphonium 
chloride and its (3S)-isomer reported by Rüttimann and Mayer.43 
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The aldehyde 45 was first reduced with DIBAL-H and was subsequently 
protected as isopropenyl methyl ether to give the protected safranal (46). In the 
following step, 46 was seperately hydroborated with (+)-diisopinocampheylborane 
[(+)-(IPC)2BH] and (–)-diisopinocampheylborane [(–)-(IPC)2BH] to yield chiral diols 
(3R)-47 and (3S)-47, respectively. These alcohols were separately oxidized to their 
corresponding chiral aldehydes (3R)-48 and (3S)-48 which were elongated to (3R)-3-
hydroxy-β-ionone [(3R)-42] and its 3S-enantiomer [(3S)-42] by aldol condensation 
with acetone, respectively. 
The method of Loeber et al. that was described earlier in Scheme 5 was 
employed to transform hydroxyionones (3R)-42 and (3S)-42 into their corresponding 
C15-Wittig salts (3R)-16 and (3S)-16, respectively.42 These optically active Wittig salts 
were then transformed into (3R,3'R)-zeaxanthin (5), (3S,3'S)-zeaxanthin (6), and 























Scheme 7. Transformation of (3R)-16 and (3S)-16 into zeaxanthin 5, 6, and 7. 
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In 1990, two additional processes for the technical synthesis of (3R,3'R)-
zeaxanthin via Wittig salt (3R)-16 were also reported by Widmer et al.44 and Soukup 
et al.45 These processes did not involve 3-hydroxy-β-ionone as an intermediate but 
started from the readily available, optically active (4R)-4-hydroxy-2,2,6-
trimethylcyclohexanone (22) which had been previously prepared from 6-
oxoisophorone (19) in 62% yield by Mayer and Rüttimann for the synthesis of lutein 
(1). In the first process, the C15-Wittig salt, (3R)-3-hydroxy-(β-
ionylideneethyl)triphenylphosphonium chloride [(3R)-16] was synthesized from 22 
by a C9+C6 coupling strategy as shown in Scheme 8. 
The hydroxyl group of 22 was first protected with isopropenyl methyl ether and 
the resulting ketone was then coupled with C6-synthon, (E)-3-methylpent-2-en-4-yn-
1-ol (49); after acidic work-up, triol 50 was obtained in 95% yield. The dehydration of 
50 was carried out with aqueous HCl in 1,2-dichloroethane in two phase to give diol 
51 which was converted to the acetylenic Wittig salt 52. After partial hydrogenation of 
52 with Lindlar catalyst or Raney Ni, Wittig salt (3R)-16 was obtained in an overall 
yield of 30% from 19. In the final coupling step, Widmer et al. employed C15+C10+C15 
strategy that had been previously developed by Loeber et al. to prepare (3R,3′R)-

















































Scheme 8. The technical synthesis of (3R,3′R)-zeaxanthin (5) by Widmer et al.44 
  
In the second technical synthesis of optically active (3R,3′R)-zeaxanthin, Soukup 
et al. employed a different synthetic strategy to improve the over yield from 27% to 
39% (Scheme 9).45 The hydroxyl group of 22 was first protected and the resulting 
ketone was allowed to react with Li-acetylide to yield diol 53. After acetylation with 
Ac2O, the monoacetate 54 was dehydrated with CuSO4 in refluxing o-xylene to 55; 






























































Scheme 9. The technical synthesis of (3R,3′R)-zeaxanthin (5) by Soukup et al.45 
 
The acetylenic alcohol 56 was first protected as isopropenyl ether and was 
subsequently elongated with methyl vinyl keone to protected vinyl-β-ionol 57 via a 
three-step sequence carried out as a one-pot procedure. β-Ionol 57 was then 
transformed into Wittig salt (3R)-16. Therefore, the technical synthesis of zeaxanthin 
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5 was accomplished in 11 steps in an overall yield of 39% and is currently used in 
industrial production. 
In summary, since 1971 numerous reports have clearly demonstrated that the 
synthesis of (±)-zeaxanthin and its three stereoisomers can be readily accomplished 
from the Wittig reaction of the racemic or optically active C15-Wittig salt (3R)-16 and 
(3S)-16 with C10-dialdehyde by a C15+C10+C15 coupling strategy. Furthermore, in the 
synthetic strategies developed by Loeber et al. as well as Rüttimann and Mayer, 3-
hydroxy-β-ionone (42) has been shown to serve as the key starting material for the 
total synthesis of zeaxanthin. However, the synthesis of optically active (3R)-42 and 
its (3S)-isomer by a relatively straightforward process is lacking and the development 
of such a process can considerably simplify the total synthesis of zeaxanthin and their 
stereoisomers.  
According to the synthetic strategies described here, it is apparent that while 
zeaxanthin can be prepared in a good overall yield, the total synthesis of lutein is 
much more challenging. Therefore the objectives of the research presented here were: 
1) to employ a convergent synthetic strategy to prepare the end-groups of luteins 1 – 4 
and zeaxanthins 5 – 7 with appropriate stereochemistry from a commercially available 
and inexpensive achiral precursor and 2) to employ these end-groups to develop 
efficient total syntheses of unlabeled optically active 1 – 7 that can be applied to the 
synthesis of carotenoids labeled with carbon-13 for future metabolic studies. 
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NOMENCLATURE 
Carotenoid numbering system has been used for compounds 73 – 84 to allow 
comparison of their stereochemical transformations to compounds 1 – 4 and 64 – 71. 
The correct systematic names of these carotenoid precursors followed by their 
common names are shown in brackets as follows: 73 – 76, (2E,4E)-3-methyl-5-(2,6,6-
trimethyl-4-hydroxy-2-cyclohexen-1-yl)penta-2,4-dienal [(7E,9E)-3-hydroxy-α-ionyl-
ideneacetaldehyde]; 77 – 80, (2E,4E)-3-methyl-5-(2,6,6-trimethyl-4-hydroxy-2-
cyclohexen-1-yl)penta-2,4-dienenitrile [(7E,9E)-3-hydroxy-α-ionylideneacetonitrile]; 
81: (2E,4E)-, 82: (2Z,4E)-3-methyl-5-(2,6,6-trimethyl-4-oxo-2-cyclohexen-1-
yl)penta-2,4-dienenitrile, [81: (7E,9E)-, 82: (7E,9Z)-3-keto-α-ionylideneacetonitrile]; 
83: (2E,4E)-, 84: (2Z,4E)-3-methyl-5-(2,6,6-trimethyl-2-cyclohexen-1-yl)penta-2,4-
dienenitrile, [83: (7E,9E)-, 84: (7E,9Z)-α-ionylideneacetonitrile]. 
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RESULTS AND DISCUSSION  
The chemical structure of carotenoids is consisted of a central polyene chain that 
is attached to two end groups on each side. One of the most challenging tasks in the 
total synthesis of carotenoids is to construct the polyene chain of these molecules with 
an (all-E)-stereochemistry. This is because the all-E-isomers of carotenoids are 
crystalline whereas their Z-stereoisomers are difficult to crystallize. In an 
unsymmetrical molecule such as (3R,3'R,6'R)-lutein (1) numerous mono-Z and di-Z-
isomers are possible. However, 7Z, 7'Z, 11Z, and 11'Z-bonds are sterically hindered 















unstable 15Z isomerβ-End group




























The 15Z-isomers of carotenoids have been shown to be thermodynamically 
unstable and can be isomerized thermally or catalytically to their all-E isomers.46 The 
occurrences of di-Z-stereoisomers of carotenoids in natural products are very rare. 
Therefore, the possible mono Z-isomers for lutein are 9Z, 9'Z, 13Z, and 13'Z. 
The most common methodology for construction of carotenoid molecule is the 
Wittig reaction, employing C15+C10+C15 coupling strategy as shown in Scheme 10 for 
the synthesis of α-carotene.38 This is because the C15-end groups 58 and 59 and C10-
dialdehyde 17 can be synthesized with an all-E stereochemistry and the 11Z isomer 


























Scheme 10. C15+C10+C15 coupling strategy for the synthesis of α-carotene.38 
 
 The C10-dialdehyde 17 has been prepared by many different routes. Among 
these, the synthesis of 17 by enol ether condensation is the most convenient and is 
used in industrial production (Scheme 11).38 Therefore, the possible formation of Z-



















Scheme 11. One of the industrial routes to (all-E)-2,7-dimethylocta-2,4,6-triene- 1,8-
dial (C10-dialdehyde, 17).38 
 
The synthesis of the (7E,9E)-C15-end groups are more challenging due to the fact 
that the 9Z-isomers of carotenoids are quite stable. For example, in the total synthesis 
of lutein 1 reported by Mayer and Rüttimann, the Wittig salts 15 and 16 were prepared 
as a mixture of (9E)- and (9Z)-isomers from which the all-E isomer was crystallized 
in low yield (Scheme 12).37 Another drawback with the synthesis of lutein is the fact 
that the Wittig salt 15 which was used in the final coupling step, was prepared in a 



























Scheme 12. The final step of the total synthesis of (3R,3′R,6′R)-lutein (1) reported by 
Mayer and Rüttimann.37  
 28
Retrosynthetic Analysis of Luteins 1 – 4 
Although the C15+C10+C15 coupling strategy has been shown to be the method of 
choice for the synthesis of C40-carotenoids, this approach has not been successfully 
applied to the synthesis of (3R,3′R,6′R)-lutein (1) by Mayer and Rüttimann.37 
Therefore, to accomplish the synthesis 1, two retrosynthetic strategies were explored; 
the first strategy described in Scheme 13 is based on the C15+C10+C15 coupling 
strategy. In contrast to the reported synthesis of lutein, different building blocks were 
used, these were: 3-hydroxy-α-ionylideneacetaldehydes (C15-aldehydes 73 – 76), C10-
Wittig aldehydes 72 and C15-Wittig salt 16. It was anticipated that the final step of our 
synthesis could be readily accomplished by elongation of the optically pure C25-
hydroxyaldehydes 64 – 67 with the Wittig salt 16 that could be readily prepared 
according to the known processes.44,45 In the latter part of this thesis, a novel route for 
the synthesis of Wittg salt 16 from (±)-α-ionone that has been developed in our 
laboratory will be described. We rationalized that the optically pure 3-hydroxy-12'-
apo-ε-caroten-12'-al (C25-hydroxyaldehydes 64 – 67) could be prepared from 
deprotection of their corresponding dimethylacetals 68 – 71 under mild acidic 
conditions without epimerization of their allylic hydroxyl groups at C3. Each of these 
optically pure acetals could in turn be prepared from the reaction of protected C10-
Wittig salt 72 with the optically pure C15-hydroxyaldehydes 73 – 76 with the required 
stereochemistry at C3 and C6. The protected C10-Wittig salt 72 was readily accessible 
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Scheme 13. Retrosynthetic strategy 1 for total synthesis of luteins 1 – 4 using 
C15+C10+C15 building blocks. 
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The application of this Wittig salt 72 in the synthesis of unsymmetrical 
carotenoids with sensitive end-groups has been well documented in the literature.48-51 
However, this building block has not been employed in the synthesis of lutein or its 
precursors. The C15-hydroxynitriles 77 – 80 as a racemic mixture or with the 
appropriate stereochemistry at C3 and C6 could serve as the precursors to C15-
hydroxyaldehydes 73 – 76. (7E,9E)-3-Keto-α-ionylideneacetonitrile (81) and its 
(7E,9Z)-isomer (82), prepared from allylic oxidation of nitriles 83 and 84, could be 
transformed into C15-hydroxynitriles 77 – 80. We envisioned that either the 
diastereomeric hydroxynitriles or hydroxyaldehydes could be first separated from 
their respective racemic mixtures into two pairs of enantiomers by chromatography 
and each pair could then be resolved by enzyme-mediated acylation. However the 
(7E,9E)-isomer (81) would be preferable since this would avoid the difficulties 
associated with the separation of optically active 9E/9Z-isomers throughout our entire 
synthetic strategy. The commercially available and inexpensive (±)-α-ionone was 
selected as the starting material for the synthesis of ketonitriles 81 and 82. Ketonitriles 
81 and 82 have been previously synthesized as a mixture of E/Z-isomers from (±)-α-
ionone via (±)-3-keto-α-ionone (85) by Wadsworth-Horner-Emmons (WHE) 
olefination.52 Therefore, we had to develop a methodology that could provide 83 as a 
single isomer and transform this nitrile into 81 without stereoisomerization. Other 
challenges with our synthetic approach were separation of C15-hydroxyaldehydes 73 – 
76 or their precursors, C15-hydroxyanitriles 77 – 80, in high optical purity and 
maintaining their stereochemical integrity throughout the synthesis of luteins 1 – 4.  
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Another possible route for the synthesis of carotenoids is by employing a 
C20+C20 coupling strategy. As mentioned earlier, any amount of 15Z-isomer that is 
formed as a result of this coupling can be transformed into the thermodynamically 
more stable all-E-isomer, simply by refluxing in an organic solvent at high 
temperatures. An example of this is the total synthesis of β-carotene (60) by Wittig 
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X= Cl or HSO4
 
Scheme 14. Synthesis of (all-E)-β-carotene (60) by C20+C20 coupling strategy.53-55 
 
Thus, our second strategy focused on the reaction of C20-Wittig salt 88 and C20-
3-hydroxy-α-retinals (C20-hydroxyaldehydes 89 – 92) in a final step to arrive at 
luteins 1 – 4 (Scheme 15).  
 32
Lutein
1: (3R,3'R,6'R), 2: (3R,3'S,6'S)






















89: (3R,6R), 90: (3S,6S)















77: (3R,6R), 78: (3S,6S)
79: (3S,6R), 80: (3R,6S)
73: (3R,6R), 74: (3S,6S)
75: (3S,6R), 76: (3R,6S)
97
11
81: (7E,9E), 82: (7E,9Z)
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Scheme 15. Retrosynthetic strategy 2 for total synthesis of luteins 1 – 4 using C20+C20 
building blocks. 
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The selection of the C20-Wittig salt 88 and the C20-hydroxyaldehydes 89 – 92 
was based on the position of the hydroxyl groups in the end-groups of these 
precursors. The C20-hydroxyaldehydes 89 – 92 have allylic hydroxyl groups that are 
sensitive to acids. Therefore, it was anticipated that the preparation of the 
corresponding Wittig salts from these end-group would be problematic and 
accompanied by elimination of water. On the contrary, the preparation of the C20-
Wittig salt 88 with a β-end-group in which the hydroxy group is not allylic was not 
expected to present this problem. As described earlier in Scheme 14, C20-Wittig salt 
86, which has been used in the synthesis of β-carotene, has been successfully 
prepared. However, it was unclear to us whether the presence of the non-allylic 
hydroxyl group could interfere with the preparation of this Wittig salt. It was 
envisioned that both of these C20-end groups 88 and 89 – 92, could be prepared from a 
non-chiral and commercially available common precursor such as (±)-α-ionone by 
convergent synthesis. 
 As illustrated in Scheme 15, racemic mixture or optically pure hydroxynitriles 
77 – 80 could serve as the key intermediates for synthesis of both C20-Wittig salt 88 
and C20-hydroxyaldehydes 89 – 92. These C20-hydroxyaldehydes 89 – 92 could be 
prepared from the reduction of their corresponding C20-hydroxynitriles 93 – 96. These 
nitriles 93 – 96 would be accessible from WHE olefination of C15-hydroxyaldehydes 
73 – 76 with the C5-synthon, 4-(diethylphosphono)-3-methyl- 2-butenenitrile (97). As 
described earlier (see Scheme 13), (±)-α-ionone could serve as the starting material 
for the synthesis of C15-hydroxyaldehydes 73 – 76. The separation of the optically 
pure hydroxyaldehydes 73 – 76 or their nitrile precursors 77 – 80 could be 
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accomplished by combination of chromatography and enzyme-mediated acylation as 
described earlier.   
We planned to prepare the C20-Wittig salt 88 from 3-hydroxy-retinol (98) 
according to known procedures. This precursor could be readily obtained from 
reduction of hydroxyester 99. The optical resolution of nitriles 102 and 103 would be 
achieved and nitrile 102 coule serve as the precursor to 101. We rationalized that since 
the H-6 hydrogen in hydroxynitriles 77 – 80 are fairly acidic, the optically pure or 
racemic mixture of these nitriles could readily undergo base-catalyzed isomerization 
to nitriles 102 and 103.  
We could also arrive at the C20-hydroxyaldehydes 89 – 92 from their 
corresponding diols 104 – 107 (Scheme 16). These diols would be readily accessible 
from ketoester 112 via hydroxyesters 108 – 111. The Wittig reaction of Wittig salt 114 
with ethyl-3-formyl-2-butenoate 113 would provide the ketoester 112. The Wittig salt 
114 has been previously prepared from (±)-α-ionone via 3-keto-vinyl-α-ionol (115).37 
According to this route, enzymatic acylation of hydroxyesters 108 – 111 in 
combination with chromatography could be employed to separate these esters and 












89: (3R,6R), 90: (3S,6S)





















104: (3R,6R), 105: (3S,6S)







108: (3R,6R), 109: (3S,6S)








Scheme 16. Alternative route to the synthesis C20-3-hydroxy-α-retinals (C20-
hydroxyaldehydes, 89 – 92). 
 
Synthesis of Lutein and its Stereoisomers According to Strategy 1 Employing 
C15+C10+C15 Coupling Reaction  
The initial challenge for the synthesis of luteins 1 – 4 was to develop a 
methodology that could provide (7E,9E)-3-keto-α-ionylideneacetonitrile (81) as 
single isomer. This is because when this (7E,9E)-isomer 81 is reduced in the 
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following step, a new stereogenic center at C3 is generated that results in the 















Figure 6. Structures of ketonitriles 81 and 82 and their reduction products. 
 
Consequently, the reduction of a mixture of (7E,9E)–81 and (7E,9Z)–82 could 
afford as many as 8 stereoisomeric hydroxynitriles which would be difficult to 
separate in high optically purity. Therefore, the initial goal was to explore the possible 
routes by which (±)-α-ionone could be transformed mainly into (7E,9E)-ketonitrile 
81. For this purpose, we first investigated the reported transformation of (±)-α-ionone 


















   
Scheme 17. Synthesis of 3-ketonitrile 81 and 82 by Imai et al.52  
These authors obtained ketonitriles 81 and 82 via 3-keto-α-ionone (85) in 81% 
yield as an oil; however the isomeric ratio of 81/82 was not reported. Therefore, we 
investigated this reaction to determine the isomeric ratio of these ketonitriles.  
There are several published methodologies for oxidation of (±)-α-ionone to 3-
keto-α-ionone (85). The first was reported by Prelog and Osgan in 1952 that involved 
using tert-butyl chromate to oxidize(±)-α-ionone to 85 in 14% isolated yield.56 
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Widmer et al. employed Ac2Co.4H2O/NH4Br/O2 to improve the yield of this reaction 
to 31%.44 More recently, another procedure for allylic oxidation of ionone-like dienes 
with TBHP catalyzed by CaCl2 and MgCl2.6H2O at 60°C has also been reported that 
can afford 85 in 67% isolated yield.57 Imai et al. used the method of Prelog and Osgan 
to prepare 85.52 However, since this method only gave 14% yield of ketoionone, we 
first investigated this reaction employing 3 different oxidizing reagents and the results 
are shown in Table 1.  
 

















Pd/C, 5.5 M TBHP in decane, K2CO3, CH2Cl2, 0˚C to R.T., 36 h 
Rh2(cap)4a, 5.5 M TBHP in decane, K2CO3, CH2Cl2, R.T., 22 h 




a Rh2(cap)4 = Dirhodium (II) caprolactamate 
 
We first tried the oxidation method of α-ionone similar to the Pd(II)-mediated 
allylic oxidation of cyclic alkenes developed by Yu and Corey (Table 1, entry 1).58 
Under this condition, (±)-α-ionone was oxidized to 3-keto-α-ionone (85) in 53% 
isolated yield. We were also able to prepare 85 in 63% yields by catalytic oxidation 
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with dirhodium(II) caprolactamate that has been recently developed by Catino et al. 
for allylic oxidation of olefins (Table 1, entry 2).59 While both of these methodologies 
provided 85 in moderate yields, their main drawback was the use of dry and 
concentrated TBHP (5.5M in decane) that could be difficult to handle on a large 
industrial scale.  
Recently, a water-based oxidation system, using household laundry bleach and 
aqueous TBHP (70% in water), has been shown to convert steroidal olefins to α,β-
enones in an economical and environmentally friendly manner.60 Employing this 
bleach oxidation, we prepared crystalline 85 from (±)-α-ionone in 64% isolated yield 
(Table 1, entry 3). The proposed mechanisms of these allylic oxidation reactions with 
Pd/C/TBHP and bleach/TBHP will be discussed later.  
Next, we investigated the WHE reaction of (±)-3-keto-α-ionone (85) with diethyl 
cyanomethylphosphonate in THF according to the method of Imai et al.52 and 
obtained a mixture of 81: 82 = 3:1 in 81% yield after purification by chromatography 
(Scheme 17). The isomeric ketonitriles 81 and 82 were subjected to low temperature 
crystallization (–15oC) in ethanol that afforded 81 as white crystals in 40% isolated 
yield. 
 To increase the E/Z ratio, we attempted the WHE reaction of 85 with  
diisopropyl cyanomethylphosphonate because this bulky phosphonate has been used 
in the WHE reaction with β-ionone to significantly increase the E/Z ratio of the 
product.60 In our case, this phosphonate only marginally improved the E/Z ratio to 4/1.  
Due to the fact that considerable amounts of (7E,9Z)-isomer of ketonitriles 82 
was present in the product, the crystallization of the (7E,9E)-isomer 81 could only be 
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accomplished after 2 weeks at –15oC. In addition, when this reaction was scaled up, 
the yield of isomeric mixture of 81 and 82 after chromatography dropped to 40%. 
To overcome these problems, we decided to first convert α-ionone to α-
ionylideneacetonitriles (83 and 84) and then performed the allylic oxidation to obtain 
ketonitriles 81 and 82 (Scheme 18). α-Ionone was transformed to nitriles 83 and 84 
under two different sets of reaction conditions. 









(7E,9E)-83 : (7E,9Z)-84 = 3 : 1













83 : 84 = 12 : 1 81 : 82 = 12 : 1  
Scheme 18. Synthesis of (7E,9E)-3-keto-α-ionylideneacetonitriles (81) from (±)-α-
ionone. a) (EtO)2P(O)CH2CN or (i-PrO)2P(O)CH2CN/NaH, TBME or THF or 
NaOMe/MeOH; b) CH2(CN)CO2H, cyclohexylamine, 80-85°C, 3.5 h. c) Pd/C, 
TBHP, K2CO3; d) Rh2(cap)4, TBHP, K2CO3; e) Household bleach (5.25% NaOCl), 
70% TBHP, K2CO3.  
The WHE reaction of (±)-α-ionone with diethyl cyanomethylphosphonate in 
TBME using NaH as base gave nitriles 83 : 84 = 3 : 1 in 74% isolated yield after 
distillation (Scheme 18, route A). Further, the use of diisopropyl 
cyanomethylphosphonate did not improve the E/Z ratio.61 Therefore, in an attempt to 
increase the E/Z ratio of nitriles 83/84, we examined the Knoevenagel reaction of (±)-
α-ionone with cyanoacetic acid (Scheme 18, route B). In 1944, Young et al. prepared 
α-ionylideneacetonitrile from condensation of α-ionone with cyanoacetic acid using a 
 40
mixture of acetamide and ammonium acetate as catalyst.62 However, due to the old 
nature of this publication and lack of sophisticated analytical methods at that time, the 
E/Z-ratio of these nitriles could not be determined. More recently, Knoevenagel 
condensation of β-ionone with cyanoacetic acid in boiling pyridine and catalytic 
amounts of piperidinium acetate has been shown to afford β-ionylideneacetonitrile in 
high yield, predominantly as the (7E,9E)-isomer.63 When we applied these conditions 
to the condensation of (±)-α-ionone with cyanoacetic acid, no reaction was observed. 
After examining this reaction with a number of organic amines, we discovered that 
cyclohexylamine could promote this reaction under mild conditions to give a 75% 
yield of 83 : 84 = 12 : 1 as a colorless oil after distillation (Scheme 18, route B). With 
these nitriles in hand, we explored the oxidation reaction of nitriles 83 and 84 with 
three oxidizing reagents (Table 2).   























Pd/C, 5.5M TBHP in decane, K2CO3, CH2Cl2, 0˚C to R.T., 3 days 
Rh2(cap)4, 5.5M TBHP in decane, K2CO3, CH2Cl2, R.T., 24 h 
Household bleach (5.25% NaOCl), 70% TBHP in H2O, K2CO3,  






Ketonitriles 81 and 82 were prepared in 12 to 1 ratio in 53% yield by palladium-
mediated oxidation of nitriles 83 and 84 with TBHP in CH2Cl2 at 0°C by applying the 
method developed by Yu and Corey as described before (Table 2, entry 1).58 The 
mechanism of this palladium-catalyzed allylic oxidation modified for our substrate is 
shown in Scheme 19. According to the authors, this oxidation involves the formation 









81 : 82 = 12 : 1
83 : 84 = 12 : 1
Pd(OOt-Bu)2/C t-BuOO
 
Scheme 19. The mechanism of Pd-mediated oxidation of nitriles 83 and 84 using 
method of Yu and Corey.58 
 
The catalytic oxidation of nitriles 83/84 with Rh2(cap)4/TBHP according to the 
method of Catino et al. was unsuccessful (Table 2, entry 2).59 Fortunately, the bleach 
oxidation of a mixture of nitriles 83 and 84 with tert-BuOOH (TBHP, 70% in water), 
household bleach (5.25% NaOCl), and catalytic amounts of K2CO3 in CH3CN at -5 to 
0°C afforded 81 : 82 = 12 : 1 (Table 2, entry 3).60 After purification by 
chromatography, a mixture of these ketonitriles was obtained in 57% yield. This 
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mixture was crystallized from ethanol at -15 °C to give the 81 as white crystals free 
from 82 in 37% isolated yield. The proposed mechanism of bleach oxidation for 
nitriles 83/84 is shown in Scheme 20 and involves generation of tert-butylperoxide 
radical which initiates the formation of the allylic radical of the substrate. The 
reaction of hypochlorite with TBHP is highly exothermic and generates considerable 
amount of oxygen in situ and as a result, the temperature of this reaction should be 
preferably kept below 5oC. The authors have demonstrated that at higher temperature, 
the yield of this oxidation is substantially decreased.  
 
NaOCl + H2O                  HOCl + NaOH
t-BuOOH + HOCl                    t-BuOH + O2 + HCl
2 t-BuOOH + 2HOCl                     2 t-BuO + 2 H2O + O2 +Cl2























81 : 82 = 12 : 1
83 : 84 = 12 : 1
 
Scheme 20. The mechanism of bleach oxidation of nitriles 83 and 84.60 
 
These oxidation reactions clearly revealed that upon oxidation of nitriles 83/84 to 
81/82, the E/Z isomeric ratio remained unchanged. It should be noted that the direct 
oxidation of nitriles 83/84 to 81/82 has not been previously reported. While the 
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overall yield of ketonitriles 81 and 82 by routes A and B discussed above were 
comparable, route B proved to be easier to scale up and due to the high E-
stereoselectivity of the Knoevenagel condensation, 81 could be crystallized from the 
isomeric mixture more expeditiously. 
The reduction of (7E,9E)-ketonitrile 81 that gave four stereoisomeric 
hydroxynitriles 77 – 80 was explored with a number of reagents and the results are 
shown in Table 3. Because (3R,6R)-hydroxynitrile 77 with a trans relationship 
between the OH at C3 and C6-dienenitrile side chain is the precursor of the naturally 
occurring (3R,3'R,6'R)-lutein (1), it was desirable to increase the composition of the 



































1 NaBH4, EtOH, H2O, 0oC to R.T., 24 h 1.0 : 1.0 97 c 
2 Triisobutylaluminum (TIBA), Toluene, -40oC to R.T., 1 h 2.0 : 3.0 95 
3 NaBH4/d-Tartaric acid (3/1), EtOH, -10 to -15oC, 2 h 3.0 : 1.0 94 
4 NaBH4/l-Tartaric acid (3/1), EtOH, - 10 to -15oC, 2 h 3.0 : 1.0 94 
5 NaBH4/Dibenzoyl-d-tartaric acid (3/1),  
EtOH, - 10 to -15oC, 2 h 3.0 : 1.0 96 
6 NaBH4/dl-Tartaric acid (3/1), EtOH, -10 to -15oC, 2 h 3.0 : 1.0 94 
7 Sodium bis(2-methoxyethoxy)aluminum hydride, 
NaAlH2(OCH2CH2OMe)2 = (Red-Al™), TBME, -5 to 0 oC, 1 h 1.3 : 1.0 95 
8 Lithium tri-sec-butylborohydride, LiB[CHMeCH2CH3]3H 
(L-Selectride™), TBME, -30oC, 0.5 h  1.2 : 1.0 93 
9 Sodium tri-sec-butylborohydride, NaB[CHMeCH2CH3]3H 
(N-Selectride™), TBME, -30oC, 0.5 h 2.5 : 1.0 92 
10 Potassium trisiamylborohydride, KB[CHMeCHMe2]3H 
(KS-Selectride™), TBME, -30 to 0oC, 2 h  2.2 : 1.0 91 
11 Potassium tri-sec-butylborohydride, KB[CHMeCH2CH3]3H
(K-Selectride™), TBME, -30oC, 0.5 h  6.0 : 1.0 96c 
12 BH3/(R)-2-methyl-CBS-oxazaborolidine, TBME, 0oC, 1.5 h 1.0 : 6.0  90c 
13 BH3/ (S)-2-methyl-CBS-oxazaborolidine, TBME, 0oC, 1.5 h 1.0 : 3.0 93 
a Ratios were determined by HPLC on a silica-based nitrile bonded column and a chiral 
column (Eluent A and Eluent C, see Appendix I). b Conversion to product was determined 
by HPLC (Eluent A). c Isolated yield after chromatography. 
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Reduction of the ketonitrile 81 with NaBH4 was sluggish and gave trans-
hydroxynitriles (77+78) and cis-hydroxynitriles (79+80) in nearly equal amounts and 
was not stereoselective (Table 3, entry 1). The ratio of 77+78 to 79+80 was 
determined by HPLC analysis of the products employing a silica-based nitrile bonded 
column that readily separated the trans-hydroxynitriles (77+78) from the cis-
hydroxynitriles (79+80) (Eluent A, Appendix I). While the reduction with TIBA was 
quite efficient even at low temperature (-40°C), the relative composition of trans-
hydroxynitriles (77+78) to cis-hydroxynitriles (79+80) was not dramatically affected 
(Table 3, entry 2).  
There are several literature report on the use of the combination of NaBH4 and 
chiral tartaric acid and its derivatives in the reduction of ketones but none of these 
examples involve the reduction of cyclic α,β-enones.64-67 For example, l-tartaric acid 
has been successfully applied to the reduction of cyclic ketones affording equatorial 
alcohols as the major product and the axial alcohol as the minor product.67 It has been 
proposed that the resulting complex from NaBH4 and carboxylic acid,  
acyloxyborohydride, acts as an axial hydride donor in order to produce the equatorial 











Scheme 21. Reduction of 4-tert-butylcyclohexanone with NaBH4/l-tartaric acid.67 
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When we employed a combination of d-tartaric acid and NaBH4, we were 
pleasantly surprised to obtain trans-hydroxynitriles (77+78) : cis-hydroxynitriles 
(79+80) = 3 : 1. Interestingly we obtained exactly the same product ratio with l-
tartaric acid and NaBH4; this finding prompted us to investigate the reduction of 
ketonitriles 81 with the inexpensive dl-tartaric acid.  
Ironically, this reagent was found to be as efficient as enantiomerically pure d- or 
l-tartaric acid (Table 3, entries 3-6). Consequently in our case, the stereochemistry of 
the reducing agent does not seem to influence the stereoselectivity of this reduction. 
Therefore, NaBH4/tartaric acid complex may add the hydride preferably to the 
pseudoaxial position of the nitrile 81 to afford a greater proportion of trans-































Scheme 22. Proposed mechanism for the reduction of 81 using NaBH4/tartaric acid.  
 
Red-Al™ [sodium bis(2-methoxyethoxy)aluminum hydride] is a common and 
convenient reducing agent that is highly efficient in the reduction of ketones. 
However, as expected, the reduction of 81 with Red-Al™ did not show a significant 
preference for the formation of trans-hydroxynitriles (77+78) (Table 3, entry 7).  
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Bulky trialkylborohydrides (Selectrides™) have been shown to be promising 
reagents for stereoselective reduction of rigid cyclic enones and yield the 
thermodynamically more stable pseudoequatorial alcohol as the major product.69-72 
Encouraged by these literature reports, we surveyed four different Selectrides, these 
were: L-Selectride™, N-Selectride™, K-Selectride™ and KS-Selectride™. The 
reduction of 81 with lithium tri-sec-butylborohydride (L-Selectride™) did not show a 
significant preference for the formation of trans-hydroxynitriles (77+78) (Table 3, 
entry 8). When sodium tri-sec-butylborohydride (N-Selectride™) or potassium 
trisiamylborohydride (KS-Selectride™) were employed as the reducing agents, the 
relative composition of trans-hydroxynitriles (77+78) to cis-hydroxynitriles (79+80) 
was 2.5 : 1 and 2.2 : 1, respectively (Table 3, entries 9 and 10). Surprisingly, the best 
stereoselectivity was achieved when 81 was reduced with potassium tri-sec-
butylborohydride (K-Selectride™) which gave trans-hydroxynitriles as the major 
product and the cis-hydroxynitriles as the minor product (77+78/79+80 = 6/1) (Table 
3, entry 11). Since N-Selectride™, L-Selectride™, and K-Selectride™ bear the same 
tri-alkyl groups; our observed stereoselectivity with the latter Selectride is probably 
due to the size of the metal ion (Scheme 23). The large size of potassium relative to 
lithium and sodium may be responsible for the formation of the borohydride complex 











Scheme 23. Formation of the complex between ketone 81 and K-Selectride™. 
  
Contrary to the results obtained with K-Selectride™, the reduction of ketonitrile 
81 with BH3/(R)-2-methyl-CBS-oxazaborolidine according to the method of Corey et 
al.73-74 gave trans-hydroxynitriles (77+78) as the minor product and the cis-
hydroxynitriles (79+80) as the major product in 1:6 ratio (Table 3, entry 12). When 
BH3/(S)-2-methyl-CBS-oxazaborolidine was used as the reducing agent, the cis-
hydroxynitriles (79+80) were still obtained as the major products but the 
stereoselectivity was not as high as that obtained with the R-isomer of CBS-
oxazaborolidine (Table 3, entry 13). These contradictory results are not clearly 
understood at this time.   
To summarize the outcome of the reduction reactions described in Table 3, we 
were able to develop methods for the reduction of 81 to trans-hydroxynitriles (77+78) 
and cis-hydroxynitriles (79+80) in ratios ranging from 6:1 and 1:6.  
 
Enzyme-Mediated Separation of Hydroxynitriles 77 – 80 
As described in the retrosynthetic analysis described in Scheme 13, we 
anticipated that trans-hydroxynitriles 77+78 could first be separated from their 
diastereomers, cis-hydroxynitriles 79+80 by column chromatography; subsequently 
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each pair of enantiomer would be subjected to enzyme-mediated acylation to resolve 
these nitriles. This idea was inspired from a literature report that has clearly 
demonstrated that 3′-epilutein [(3R,3′S,6′R)-lutein (3)] can be separated from 
(3R,3′R,6′R)-lutein (1) by enzyme-mediated acylation with lipase AK (Pseudomonas 
fluorescens) in 90% de.40 It should be noted that this literature report is the only 
example for separation of diastereomeric carotenoids by enzymatic acylation and to 
our knowledge, there is no literature report on separation of enantiomeric carotenoids 
or their C15-precursors. However, there are numerous literature reports on resolution 
of cyclic alcohols by enzyme mediated acylation.40,75,76 The separation of trans-
hydroxynitriles 77+78 from cis-hydroxynitriles 79+80 by column chromatography 
proved to be challenging and this could only be accomplished by subjecting these 
nitriles to several column chromatographic separations. In addition, attempts to 
resolve the (±)-hydroxynitriles 77+78 or 79+80 by enzyme-mediated acylation with 
lipase AK (Pseudomonas fluorescens) or lipase PS (Pseudomonas cepacia) resulted in 
poor ee for these nitriles. Discouraged by these findings, other enzymes were not 
investigated and the separation of these hydroxynitriles was postponed until after 
reduction to their corresponding hydroxyaldehydes 73 – 76. 
 
One-Pot Reduction of Ketonitrile 81 to Hydroxyaldehydes 73 – 76 via 
Hydroxynitriles 77 – 80   
The reduction of hydroxynitriles 77 – 80 with DIBAL-H in dichloromethane 
afforded a mixture of the four hydroxyaldehydes 73 – 76 in 70% isolated yield after 
chromatography (Scheme 24). In the following step, a mixture of trans-C15-
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hydroxyaldehydes 73+74 was readily separated from a mixture cis-C15-
hydroxyaldehydes 75+76 by column chromatography. Hydroxyaldehydes 73 – 76 
could also be prepared in an efficient one-pot reaction using K-Selectride™ followed 
by reduction with DIBAL-H to yield 73+74 and 75+76 in the ratio of 6:1 in 83% 










73: (3R,6R), 74: (3S,6S)
77: (3R,6R), 78: (3S,6S)
79: (3S,6R),
75: (3S,6R), 76: (3R,6S)
80: (3R,6S)
K-SelectrideTM









1) K-SelectrideTM, TBME, -30oC to 0oC
2) DIBAL-H, -30oC to 0oC    83%
(73+74) : (75+76) = 6 : 1
96% 70%
Scheme 24. Reduction of ketonitrile 81 to aldehydes 73 – 76 via nitriles 77 – 80. 
 
The ratio of trans-C15-hydroxyaldehydes 73+74 to cis-C15-hydroxyaldehydes 
75+76 was determined by HPLC analysis of the products employing a silica-based 




Figure 7. The HPLC profile of a racemic mixture of hydroxyaldehydes 73 – 76. 
HPLC conditions (Eluent A) is described in Appendix I.  
 
Enzyme-Mediated Separation of Hydroxyaldehydes 73 – 76 
The racemic mixture of trans-hydroxyaldehydes 73+74 were separated by 
enzyme-mediated acylation with lipase AK (Pseudomonas fluorescens) in refluxing 
pentane in the presence of vinyl acetate within 48 h (Scheme 25). Similarly, the cis-











































KOH/MeOH, 0oC KOH/MeOH, 0oC







Scheme 25. Separation of optically pure C15-hydroxyaldehydes 73 – 76 by enzyme-
mediated acylation. 
While hydroxyaldehyde 74 was acylated to acetoxyaldehyde 117, 
hydroxyaldehyde 73 remained unreacted. Due to the large difference in their 
solubility properties, 117 and 73 were readily separated by column chromatography 
and the latter was obtained in 94% ee. Acetoxyaldehyde 117 was nearly quantitatively 
hydrolyzed with KOH/MeOH at 0°C to hydroxyaldehyde 74 (93% ee). Similarly, cis-
hydroxyaldehydes 75 and 76 were resolved by enzyme-mediated acylation with 
immobilized lipase AK (Pseudomonas fluorescens) in refluxing pentane in the 
presence of vinyl acetate in 50 h. Hydroxyaldehyde 75 underwent acylation to 
acetoxyaldehyde 118 while hydroxyaldehyde 76 remained unreacted (Scheme 25). 
Separation of 118 and 76 was readily accomplished by column chromatography. This 
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afforded (3R,6S)-3-hydroxy-α-ionylideneacetaldehyde (76) in 92% ee. Alkaline 
hydrolysis of 118 with KOH/MeOH at 0°C, provided (3S,6R)-3-hydroxy-α- 
ionylideneacetaldehyde (75) in 91% ee. 
The course of these enzymatic acylation reactions were monitored by chiral HPLC 
(Eluent D, Appendix I) that allowed the separation of each enantiomeric pair (Figure 
8). It should be pointed out that enantiomeric aldehydes 75 (HPLC peak 1) and 76 
(HPLC peak 3) were well separated by chiral HPLC and this was also the case with 
aldehydes 73 (HPLC peak 2) and 74 (HPLC peak 4) (Figure 8). However, attempt to 
simultaneously separate these aldehydes resulted in partial separation between 
diastereomeric aldehydes. 
Figure 8. HPLC separation of hydroxyaldehydes 73 – 76 on a Chiralpak AD column 






Therefore, all four hydroxyaldehydes 73 – 76 became accessible in optical purities 
ranging from 91-94%. Before using these hydroxyaldehydes in the synthesis of the 
stereoisomeric luteins 1 – 4, the absolute configuration of these aldehydes had to be 
established. 
 
Determination of Absolute Configuration of Hydroxyaldehydes 73 – 76 
Hydroxyldehydes 73 – 76 were fully characterized from their 1H- and 13C-NMR 
as well as MS and UV spectra. The relative stereochemistry of these aldehydes at C-3 
and C-6 was established from comparison of the proton NMR chemical shifts of H-6 
with published values for (3R,3'R,6'R)-lutein (1) and (3R,3'S,6'R)-lutein (3) (Figure 
9).77-80 It has been well documented that when H-6 and the hydroxyl group at C-3 are 
in a cis-geometry, the chemical shift of H-6 is shifted downfield by 0.25 ppm in 
comparison with the chemical shift of this proton when it is in a trans-geometry with 
OH at C-3.  
HO
H (δ = 2.50 ppm)
HO
H (δ = 2.25 ppm)
ε-end group of 
(3R,3'R,6'R)-Lutein (1)
ε-end group of 
(3R,3'S,6'R)-Lutein (3'-Epilutein) (3)
63 63









(δ = 2.50 ppm) (δ = 2.25 ppm)
Figure 9. H-6' chemical shift in (3R,3'R,6'R)-lutein (1), (3R,3'S, 6'R)-lutein (3) and 
aldehydes 73 and 75.  
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The chemical shift of H-6 proton in trans-aldehydes (73 and 74) in which this 
proton is in a cis-geometry with the hydroxyl group at C-3 appeared at δ = 2.50 ppm 
while this chemical shift in cis-aldehydes (75 and 76) (H-6 & OH in trans-geometry) 
moved upfield to δ = 2.25 ppm. Therefore, the relative stereochemistry of 
hydroxyldehydes 73 – 76 was assigned on this basis. However, the absolute 
configuration of these aldehydes could only be unequivocally determined with 
comparison of the circular dichroism (CD) data with a model compound in which the 
stereochemistry at C3 and C6 was known. We prepared this model compound by 
oxidative cleavage of the polyene chain of naturally occurring (3R,3'R,6'R)-lutein (1) 
in which the stereochemistry in the ε-end group of this carotenoid at C3' and C6' is 
























Scheme 26. Oxidative degradation of (3R,3′R,6′R)-lutein (1). (a) Ac2O, pyridine, THF, 
50 °C, 98%; (b) TBHP, bleach (5.25% NaOCl), EtOAc, 0 °C to R.T., 3 h, 20%; (c) 
KOH:MeOH (10%, wt:v), CH2Cl2, R.T., 2 h, 98%; (d) column chromatography  
(hexane:acetone, from 98:2 to 95:5) followed by semipreparative normal phase HPLC 
(Eluent E, Appendix). 
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Prior to oxidative cleavage of 1, the hydroxyl groups were protected by acylation 
with Ac2O-pyridine and the resulting (3R,3'R,6'R)-lutein diacetate was then 
oxidatized with TBHP/bleach. After saponification and column chromatography, 
HPLC analysis of the crude product showed the presence of unreacted 1 (80%) and a 
number of oxidation products. Among these, (3R,6R)-3-hydroxy-13-apo-ε- caroten-
13-one (119) with an ε-end group and (3R)-3-hydroxy-β-ionone (3R)-42 with a β-end 
group were the only major stable products (119: (3R)-42 = 3:1). These were separated 
by semipreparative normal phase HPLC and were fully characterized from their NMR, 
MS, UV-Vis, and CD spectra.  
The CD spectra of trans-aldehydes (3R,6R)-73 [281 nm (+18 mdeg), 242 nm (-1.3 
mdeg)] and (3S,6S)-74 [281 nm (-13 mdeg), 242 nm (+1.0 mdeg)] in 
hexane:ether:methanol (10:3:1) with strong opposite Cotton effects clearly indicated 
that these aldehydes were enantiomeric. The absolute configuration of 73 was 
assigned as (3R,6R) by comparison of its CD spectrum with that of hydroxyketone 
(3R,6R)-119 [320 nm (+10.6 mdeg)] that similar to this aldehyde showed a positive 




Figure 10. Circular dichroism (CD) spectra of C18-ketone 119, C15-hydroxyaldehydes 
73 and 74 in hexane:ether:MeOH = 10:3:1. 
 
To establish the absolute configuration of 75 and 76, aldehydes 73 and 75 were 
separately epimerized in dilute aqueous HCl similar to the previously reported 
epimerization of 1 to 3 (3'-epilutein).40 Under identical reaction conditions, the HPLC 
analysis of the crude product revealed that hydroxyaldehydes 73 (36%) and 75 (64%) 






























































Scheme 27. Epimerization reactions of hydroxyaldehydes 73 and 75 under acidic 
conditions. 
The products of these reactions were then separated by semipreparative normal 
phase HPLC (Eluent A, Appendix I) and their absolute configurations were 
determined by NMR and CD. The H-6 chemical shift of the epimer of 73 appeared at 
δ = 2.25 ppm indicating a trans-geometry between H-6 and OH and on this basis, this 
epimer was identified as (3S,6R)-75. The CD spectrum of the epimer of 73 was also 
identical to the synthetic sample resolved by enzymatic acylation. In addition, the 
epimer of 75 was shown by NMR and CD to be identical to 73. Because the CD 
spectra of (3S,6R)-75 and 76 indicated that these aldehydes were enantiomeric, the 




Figure 11. Circular dichroism (CD) spectra of C15-hydroxyaldehydes 75 and 76 in 
hexane:ether:MeOH = 10:3:1. 
 
Synthesis of Luteins 1 – 4 via C25-Hydroxy-Apocarotenals 64 – 67  
The C15-hydroxyaldehydes 73 – 76 prepared in optical purities ranging from 91-
94% were each first elongated to their corresponding protected C25-aldehydes 68 – 71 
by olefination with the protected Wittig salt 72 in the presence of NaOMe/MeOH at 
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73: (3R,6R), 94% ee; 74: (3S,6S),  93% ee;




64: (3R,6R), 94% ee; 65: (3S,6S), 93% ee;  
66: (3S,6R), 91% ee; 67: (3R,6S), 92% ee  
Scheme 28. Synthesis of C25-hydroxyaldehyde 64 – 67 from C15-hydroxyaldehydes 
73 – 76. (a) NaOMe, MeOH, R.T., 4 h, 90% conversion by HPLC; (b) 0.3 N HCl, 
R.T., 1 h; (c) Pd(OAc)2, EtOAc, reflux, 2h; (d) chromatography (hexane:EtOAc, 95:5 
to 80:20), 53-85% isolated yield after chromatography. 
After solvent evaporation and without isolation of the products, acetals 68 – 71 
that were obtained as a mixture of all-E and 11Z were deprotected in dilute aqueous 
HCl (0.3 N) in acetone to give C25-aldehydes 64 – 67 as a mixture of all-E and 11Z. 
Thus, prior to purification, the crude mixture of all-E and 11Z isomers of C25-
aldehydes 64 – 67 were catalytically isomerized to their corresponding all-E-isomers 
in the presence of palladium (II) acetate in refluxing ethyl acetate within 2 h. In the 
following step, the individual aldehydes were purified by column chromatography to 
afford 64 – 67 in isolated yields ranging from 53-85%. 
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Under the conditions employed for the deprotection of acetals 68 – 71, the 
hydroxyl group at C3 did not undergo epimerization under acidic condition and the 
optical purities of the resulting C25-aldehydes 64 – 67 were not compromised. This 
was confirmed by chiral HPLC (Eluent D, Appendix I) of the individually synthesized 
C25-aldehydes (Figure 12). 
 
 
Figure 12. HPLC separation of 3-hydroxy-12'-apo-ε-caroten-12'-al (64 – 67) on a 
Chiralpak AD column (Eluent D, Appendix I). 
It should be noted that enantiomeric C25-aldehydes 65 (HPLC peak 1) and 64 
(HPLC peak 4) were well separated by chiral HPLC and this was also the case with 
aldehydes 67 (HPLC peak 2) and 66 (HPLC peak 3) (Figure 13). However, attempt to 
simultaneously separate these aldehydes resulted in partial separation between 
diastereomeric aldehydes.  
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The CD spectra of 64 and 65 showed an opposite Cotton effect indicating that 
these aldehydes were enantiomeric. This was also the case with the CD spectra of 66 















Figure 13. CD spectra of C25-hydroxyaldehydes 64 – 67 in hexane:ether:MeOH = 
10:3:1. 
As described earlier, C25-hydroxyaldehydes were initially obtained as a mixture of 
all-E and 11Z isomers. Although the 11Z-isomers were readily transformed into their 

















































isomerization of the 11Z and 11'Z-bonds that are formed by Wittig coupling reactions 
could be postponed until after luteins 1 – 4 were prepared.   
In the final step of the synthesis of luteins 1 – 4, each of the C25-hydroxyaldehydes 
64 – 67 (all-E + 11Z or pure all-E) were allowed to react with the Wittig salt 16 44-45 





















KOH, H2O, CH2Cl2, 
-5oC to R.T., 3 h
(all-E)-Luteins
1: (3R,3'R,6'R), 98% ee; 2: (3R,3'S,6'S), 98% ee
3: (3R,3'S,6'R), 91% ee;  4: (3R,3'R,6'S), 94% ee
 
Scheme 29. Final steps of the synthesis of luteins 1 – 4 via C25-hydroxyaldehydes 
64 – 67. 
The individually prepared E/Z-luteins 1 – 4 were then catalytically isomerized to 
their corresponding all-E isomers with Pd(OAc)2 in a refluxing solution of ethyl 
acetate within 4 h. The isolated yields of all-E-luteins 1 – 4 after column 
chromatography and crystallization from hexane:acetone = 4:1 were in the range of 
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53-85% (91-98% de). It is interesting to note that the HPLC separation of 
diastereomeric (3R,3'R,6'R)-lutein (1) and (3R,3'S,6'S)-lutein (2) could not be 
achieved on a regular nitrile bonded column. This was presumably because of the 
remote position of the (3R)-hydroxyl group at C3 of these carotenoids that resulted in 
almost identical chromatographic properties for these luteins as though these were 
enantiomeric. This was also the case with diastereomeric (3R,3'S,6'R)-lutein (3) and 
(3R,3'R,6'S)-lutein (4). Therefore, luteins 1 – 4 had to be separated by chiral HPLC 
under two different sets of conditions to determine their diastereomeric excess. The 
HPLC separation of synthetic standards of luteins 1 and 2 is shown in Figure 14a 
(Eluent G) and that of standards of luteins 3 and 4 is shown in Figure 14b (Eluent H). 
The CD spectra of optically pure luteins 1 – 4 are shown in Figure 15.  
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Figure 14. Chiral HPLC separation of luteins 1 – 4. a) HPLC separation of standards 
of luteins 1 and 2 (Eluent G), b) HPLC separation of standards of luteins 3 and 4 









Figure 15. CD spectra (hexane:ether:MeOH = 10:3:1) of luteins  1 – 4. a) 






































































The overall yield of luteins 1 – 4 according to our synthetic strategy can be 
determined based on the stereochemistry of the targeted lutein. For example, if the 
synthesis of (3R,3'R,6'R)-lutein (1) and (3R,3'S,6'S)-lutein (2) is of particular interest, 
the one-pot reduction of ketonitrile 81 with potassium tri-sec-butylborohydride (K-
Selectride®) followed by DIBAL-H would be the preferred route. This is because this 
reduction predominantly provides the trans-hydroxyaldehydes 73 and 74 that are 
precursors to the ε-end group of luteins 1 and 2, respectively. Using this approach, the 
overall yields for luteins 1 and 2 from ketonitrile 81 were determined as follows: 81 
→ (73 + 74), 71% → 73 (30%) and 74 (31%) → 64 (26%) and 65 (28%) → 1 (18%) 
and 2 (20%). Because the isolated yield of ketonitrile 81 from (±)-α-ionone was 28% 
after crystallization, the overall yields of luteins 1 and 2 from (±)-α-ionone were 5% 
and 6%, respectively.  
Similarly, if luteins 3 and 4 are the target carotenoids, the reduction of 81 with 
(R)-2-methyl-CBS-oxazaborolidine is preferred since this reagent provides the cis-
hydroxyaldehydes 75 and 76 as the major products. According to this route, the 
overall yields of luteins 3 and 4 based on ketonitrile 81 were 17% and 19%, 
respectively. However, the calculated yields of 3 (5%) and 4 (6%) based on (±)-α-
ionone were significantly lower.   
While 81 served as the key starting material in our synthesis, the preparation and 
crystallization of this (7E,9E)-isomer from (±)-α-ionone in a low yield (28%) 




Investigating an Alternative Route to C15-Hydroxyaldehydes from (±)-α-Ionone 
In the interest of atom economy, we decided to investigate an alternative 
apporoach to optically pure C15-hydroxyaldehydes 73 – 76. This involved synthesis of 
optically pure 3-hydroxy-α-ionones (120 – 123) prior to elongation to C15-










73: (3R,6R), 74: (3S,6S)
75: (3S,6R), 76: (3R,6S) 120: (3R,6R), 121: (3S,6S)










Scheme 30. An alternative retrosynthetic route to C15-hydroxyaldehydes 73 – 76. 
 
This idea was appealing because the stereochemistry of the precursor to 73 – 76 
could be fixed at an earlier stage of the lutein synthesis. We rationalized that the 
optically pure 3-hydroxy-α-ionones (120 – 123) could be obtained by a similar 
strategy used previously for separating the optical isomers of C15-ahydroxyaldehydes 
73 – 76. 3-Hydroxy-α-ionone (124) could be prepared in 4 convenient steps from the 
commercially available and inexpensive (±)-α-ionone via 3-keto-α-ionone ketal 
(124), and α-ionone ketal (125).  
 69
(±)-α-Ionone ketal (125) has been previously prepared from (±)-α-ionone by 
Pommer in 1958.85 Following the Pommer’s procedure, the carbonyl group of (±)-α-
ionone was protected with ethylene glycol in the presence of trimethylorthoformate 
and catalytic amount of p-TsOH to afford (±)-α-ionone ketal (125) in nearly 
quantitative yield; this was used in the following step without purification (Scheme 
31). Utilizing the bleach oxidation method described earlier (detailed mechanism is 
described in Scheme 20), 3-keto-α-ionone ketal (124) was obtained in 86% isolated 








OBleach, Aq. TBHP, K2CO3







Scheme 31. Preparation of 3-keto-α-ionone ketal (124) from (±)-α-ionone. 
  
It should be pointed out that such a direct and efficient synthesis of keto ketal 
124 has not been reported previously. However, this compound has been obtained as a 
side product in the synthesis of 3-(3,3-ethylenedioxy)-β-ionone (127) from 3-keto-α-



















0.5 mL 2N HCl
MeOH/H2O, R.T., 4h, 95%
(127)
Scheme 32. Preparation of ketoketal 127 from 3-keto-α-ionone (85) according to the 
method of Ellis et al.86 
 
The reduction of 3-keto-α-ionone ketal (124) to 3-hydroxy-α-ionones (120 – 
123) was carried out with a number of reducing agents to investigate the 
stereoselectivity of this reaction. These reduction reactions followed by deprotection 
gave two major products that were separated by column chromatography and fully 
characterized as (±)-trans-3-hydroxy-α-ionones (120 and 121) and (±)-cis-3-hydroxy-
α-ionones (122 and 123). The results of these reactions are summarized in Table 4. 
The trans and cis isomers refer to the stereochemical relationship between the OH at 
C-3 and the enone side chain at C-6. Unfortunately, no significant stereoselectivity 





































1  NaBH4, EtOH 1.0 : 1.0  58 
2  NaBH4/dl-Tartaric acid (3/1), EtOH 1.0 : 1.0 77 
3  NaBH4-CeCl3 1.0 : 1.9 40 
4  9-Borabicyclo[3.3.1]nonane (9-BBN), THF 1.0 : 1.4 20 
5  Red-Al™ = NaAlH2(OCH2CH2OMe)2, TBME 1.0 : 1.0 57 
6  DIBAL-H, CH2Cl2 1.0 : 1.9 90 
7  N-Selectride™ = NaB[CHMeCH2CH3]3H, TBME 1.0 : 1.4 80 
8  K-Selectride™ = KB[CHMeCH2CH3]3H, TBME 1.2 : 1.0 85 
a Indicates the stereochemical relationship between the hydroxyl group at C3 and the enone 
side chain at C6. bRatios were determined by HPLC (Elent A, Appendix I) 
 
Enzyme-Mediated Separation of (±)-3-Hydroxy-α-Ionone (120 – 123) 
Initially we examined lipase AK since we had successfully employed this 
enzyme in separation of enantiomeric aldehydes 73 and 74 as well as 75 and 76. In 
the following step, the purified racemic mixture of trans-hydroxy-α-ionones 120+121 
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was subjected to enzyme-mediated acylation using vinyl acetate as an acyl donor. The 
course of enzymatic acylation of ionones 122+123 was followed by chiral HPLC 
(Eluent I, Appendix I). After 42h, the acylation became sluggish and HPLC analysis 
revealed that the unesterified ionones were present in a ratio of 10/1. The major 
unesterified product was tentatively identified as (3R,6R)-120 and the structure of the 
acylated ionone was assigned as (3S,6S)-acetoxyionone 128 (Scheme 33). This 
assignment was based on our previous experience with the enzymatic separation of 


















1) Lipase AK, 














(3S,6S)-121, 49%  
Scheme 33. Enzyme-mediated acylation of racemic mixture of trans-hydroxyionones 
120 and 121. 
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Acetoxyionone 128 was readily separated from hydroxyionones 120 by column 
chromatography. Ionone 120 was shown by chiral HPLC to have an ee of 82%. Upon 
soaponification of 3-acetoxy-α-ionone (128) at room temperature, in addition to 
ionone 121 (49%), another product was formed which was separated by 
semipreparative HPLC (Eluent E, Appendix I) and fully characterized as 3-hydroxy-
β-ionone (51%, 42). This finding was interesting to us since 42 is an important 
precursor to Wittig salt 16 and has been employed in the synthesis of zeaxanthin.42,43  
To avoid the formation of 3-hydroxy-β-ionone (42), the soaponification of 3-
acetoxy-α-ionone (128) was carried out at 0oC to afford 3-hydroxy-α-ionone (121) 
quantitatively. Chiral HPLC revealed an ee of 28% for this ionone (Eluent I, 
Appendix I). These results indicated that lipase AK exhibits poor enantioselectivity 
towards ionones 120 and 121. Therefore, we examined other commercially available 
enzymes such as lipase PS, lipase A, and lipase AY in an attempt to resolve (3R,6R)-
120 and (3S,6S)-121; the results of these enzymatic acylation are compared with 
lipase AK in Table 5.  
 
Table 5. Enzyme-mediated acylation of a racemic mixture of trans-hydroxyionones 







1  Lipase AK, Vinyl acetate, EtOAc, 44oC, 42 h 82 28 
2  Lipase PS (immobilized), Vinyl acetate, EtOAc, 50oC, 24 h 86 86 
3  Lipase A (immobilized), Vinyl acetate, EtOAc, R.T to 50oC, 68 h No Reaction 
4  Lipase AY (immobilized), Vinyl acetate, EtOAc, R.T to 50oC, 68 h No Reaction 
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The reaction with lipase PS was extremely slow and only 5% of 121 underwent 
acylation after 24 hours and addition of more enzyme did not alter the course of this 
reaction. To increase the rate of this enzymatic acylation, the separation of 120 and 
121 was examined with immobilized lipase PS. With this enzyme, (3R,6R)-120 (86% 
ee) and (3S,6S)-121 (86% ee) were separated in moderate ee. The acylation with 
immobilized lipase A and lipase AY did not give any acylated product even after 68 
hours.  
We then turned our attention to the enzyme-mediated separation of cis-
hydroxyionones 122 and 123. Unfortunately, we could not observe any acylation of 
these ionones with lipase AK, PS, A and AY under various experimental conditions. 
Because of theses disappointing results, the enzymatic separation of hydroxyionones 
was abandoned.  
Despite the fact that the separation of these ionones by enzymatic acylation were 
unsuccessful, they lead us to a very intriguing observation that trans-acetoxyionone 
128 can be isomerized to 3-hydroxy-β-ionone (42) under mild basic conditions. While 
the trans-hydroxyionones 120 and 121 underwent partial double bond isomerization 
during soaponification, it was unclear to us whether the cis-hydroxyionones 122 and 
123 could do the same.  
In such a case, all four stereoisomers of 3-hydroxy-α-ionones (120 – 123) could 
be transformed into a racemic mixture of 3-hydroxy-β-ionones with only one 
stereogenic center. Although we were unable to separate racemic mixture of 3-
hydroxy-α-ionone by enzyme-mediated acylation, we rationalized that this approach 
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could be more successful with the separation of racemic mixture of 3-hydroxy-β-
ionone.  
Therefore, the base-catalyzed double bond isomerization of 3-hydroxy-α-ionones 
(120 – 123) was further explored at elevated temperature to force the double bond 
isomerization of 3-hydroxy-α-ionones (120 – 123) to completion. After tuning the 
condition of this reaction, hydroxy-α-ionones 120 – 123 were converted to (±)-3-
hydroxy-β-ionone (42) with KOH/MeOH (10%, wt/v) at 50 oC after 1 hour in THF. 
After purification by column chromatography, 42 was obtained in 65% isolated yield 
(Scheme 34).  
 
10%KOH/MeOH







Scheme 34. Double bond isomerization of 3-hydroxy-α-ionones 120 – 123 to (±)-3-
hydroxy-β-ionone (42). 
 
Enzyme-Mediated Acylation of (±)-3-Hydroxy-β-Ionone. 
The racemic mixture of 3-hydroxy-β-ionone was resolved by enzyme-mediated 
acylation with immobilized lipase PS (pseudomonas cepacia) in EtOAc in the 
presence of vinyl acetate within 20 h at R.T (Scehem 35). 
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Scheme 35. Enzymatic acylation of (±)-3-Hydroxy-β-ionone (42).  
 
While (3R)-3-hydroxy-β-ionone (3R)-42 was acylated to (3R)-3-acetoxy-β- 
ionone (129), (3S)-3-hydroxy-β-ionone (3S)-42 remained unreacted. Due to the large 
difference in their solubility properties, 129 and (3S)-42 were readily separated by 
column chromatography. Acetoxyionone 129 was nearly quantitatively soaponified to 
hydroxyionone (3R)-42 with KOH/MeOH at room temperature. According to chiral 
HPLC, (3R)-3-hydroxy-β-ionone [(3R)-42] and its (3S)-isomer [(3S)-42] were each 
obtained in 96% enantiomeric excess (ee). This was confirmed from the chiral HPLC 
profiles (Eluent J, Appendix I) of the individually separated enantiomers (Figure 16).  
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Figure 16. Chiral HPLC separation (Eluent J, Appedix I) of a racemic mixture of 
(3R)-3-hydroxy-β-ionone [(3R)-42] and (3S)-3-hydroxy-β-ionone [(3S)-42]. 
 
Similar results were also obtained by employing immobilized lipase AK 
(pseudomonas fluorescens). The absolute configuration of hydroxyionones (3R)-42 
and (3S)-42 was determined by comparison of their CD spectra (Figure 17b) with a 
standard sample of (3R)-3-hydroxy-β-ionone (Figure 17a) as described earlier. This 
(3R)-42 was obtained from oxidative cleavage of naturally occurring (3R,3'R,6'R)-
lutein (1) (Scheme 26). CD spectra of (3R)-42 and (3S)-42 showed opposite Cotton 




Figure 17. CD spectra (hexane:ether:methanol = 10:3:1) of 3-hydroxy-β-ionone, a) 
(3R)-3-hydroxy-β-ionone [(3R)-42] from oxidative degradation of (3R,3'R,6'R)-lutein 
(1) and b) (3R)-3-hydroxy-β-ionone [(3R)-42] and its (3S)-isomer [(3S)-42] separated 
by enzymatic acylation.  
  
As described earlier in the introduction section (page 17-19), the synthesis of 3-
hydroxy-β-ionone (42) has been reported as a racemic mixture by Loeber et al.42 and 
as single enantiomers [(3R)-42 and (3S)-42] by Rüttimann and Mayer43. Both of these 















































Standard sample of (3R)-42 
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above. In 1992, Broom et al. also reported on the synthesis of 3-hydroxy-β-ionone 






























Scheme 36. Synthesis of 3-hydroxy-β-ionone according to the method of Broom et 
al.87 
 The key starting material for this synthesis was 3,4-dehydro-β-ionone (130) 
that was prepared from β-ionone according to a published procedure.88 The ketone 
130 was then protected as a 1,3-dioxolane to yield 3,4-dehydro-β-ionone ketal (131) 
that was hydroborated with borane-dimethyl sulfide to afford (±)-3-hydroxy-β-ionone 
ketal (132, 75%) and (±)-4-hydroxy-β-ionone ketal (133, 25%). Ketal 133 was isolatd 
from the mixture in 32% yield and was subsequently deprotected with oxalic acid to 






Transformation of (3R)-3-Hydroxy-β-Ionone [(3R)-42] and its 3S-Isomer [(3S)-
42] to (3R,3'R)-Zeaxanthin (5) and (3S,3'S)-Zeaxanthin (6) 
We used the reported procedure by Rüttimann and Mayer to separately transform 
(3R)-3-hydroxy-β-ionone [(3R)-42] and its 3S-isomer [(3S)-42] to the Wittig salts 3-
hydroxy-(β-ionylideneethyl)triphenylphosphonium chlorides (3R)-16 and (3S)-16 via 
vinyl-α-ionols (3R)-43 and (3S)-43, respectively. (Scheme 37).43  
 



































Scheme 37. Transformation of (3R)-3-hydroxy-β-ionone [(3R)-42] and its 3S-isomer 
[(3S)-42] to Wittig salts (3R)-16 and (3S)-16 according to the method of Mayer and 
Rüttimann.43 
The crude ionols (3R)-43 and (3S)-43 were directly converted to Wittig salts 
(3R)-16 and (3S)-16 without purification. After work-up, the crude Wittig salts (3R)-
16 was crystallized from 1,2-dichloroethane and ethyl acetate at -20°C to afford (3R)-
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16 in 60% yield as a grayish powder. Similarly, (3S)-16 was crystallized using the 
same solvent system to afford this Wittig salt in 55% yield. The absolute 
configuration of the Wittig salts (3R)-16 and (3S)-16 was confirmed by comparison of 
their CD spectra with a standard sample of Wittig salt (3R)-16 obtained from DSM 
Nutritional Products (Basel, Switzerland) (Figure 18). 
 
Figure 18. CD spectra (hexane:ether:methanol = 10:3:1) of Wittig salt 16, a) a 
standard sample of (3R)-3-hydroxy-(β-ionylideneethyl)triphenylphosphonium 
chloride obtained from DSM Nutritional Products (Basel, Switzerland) and (b) 












































Standard sample from DSM 
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The final step of the synthesis of (3R,3'R)-zeaxanthin (5) and (3S,3'S)-zeaxanthin 
(6) was accomplished according to the method of Widmer et al.44 These were each 
prepared in 98% ee by double Wittig condensation of C10-dialdehyde 17 with Wittig 
salts (3R)-16 and (3S)-16 in 51% and 43% isolated yields after column 
chromatography and low temperature crystallization, respectively (Scheme 38). 1,2-
Epoxybutane in these reactions served as acid scavenger. The 1H and 13C NMR 
chemical shifts of (3R,3'R)-zeaxanthin (5) and (3S,3'S)-zeaxanthin (6) were in 



































Scheme 38. Synthesis of (3R,3'R)- zeaxanthin (5) and (3S,3'S)-zeaxanthin (6) from 
Wittig salts (3R)-16 and (3S)-16, respectively. 
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These reactions were carried out on several hundred milligrams scale and our 
yields were significantly lower than the reported 90% yield by Widmer et al. who 
performed this coupling reaction on kilogram scale. This may be due to the fact that 
Widmer et al. used only 300 mL of EtOH per 1 Kg of the Wittig salt to prevent E/Z 
isomerization of all-E-zeaxanthin. When we carried out this reaction on a small scale, 
we had to use relatively large volume of solvent to be able to control the temperature. 
Consequently, at reflux temperature of EtOH, E/Z isomerization could have been 
responsible for our lower yield since Z-carotenoids do not crystallize well in 
comparison with their all-E counterparts.  
The optical purity of 5 and 6 was determined by chiral HPLC (Eluent L, 
Appendix I) that not only allowed the separation of these optical isomers but it also 
separated the optically inactive (3R,3'S;meso)-zeaxanthin (7) (Figure 19). As shown 
in the CD spectra of (3R,3'R)-zeaxanthin (5) and (3S,3'S)-zeaxanthin (6) in Figure 20, 
these enantiomeric carotenoids exhibited opposite Cotton effect. The absolute 
configuration of (3R,3'R)-zeaxanthin was assigned by comparison of its CD spectrum 






Figure 19. Chiral HPLC (Eluent L, Appendix I) separation of a mixture of (3R,3'R)-
zeaxanthin (5), (3S,3'S)-zeaxanthin (6), and (3R,3'S;meso)-zeaxanthin (7). 
 
Figure 20. CD spectra (hexane:ether:methanol = 10:3:1) of zeaxanthins, a) a standard 
sample of (3R,3'R)-zeaxanthin (5) from DSM Nutritional Products (Basel, 










































The overall yields for zeaxanthins 5 and 6 from (±)-α-ionone were determined as 
follows: (±)-α-ionone → 125 (96%) → 124 (83%) → 120 – 123 (74%) → [(3R)-42 + 
(3S)-42] (48%) → (3R)-42 (22%) and (3S)-42 (21%) → (3R)-16 (12%) and (3S)-16 
(13%) → 5 (6%) and 6 (5%). It should be noted that the yield for the final Wittig 
coupling step can be probably improved if this reaction is scaled up. Therefore, if we 
could duplicate the reported yield of the final coupling step of Widmer et al., our 
yields of 5 and 6 would improve to 12% and 11%, respectively. The overall yields for 
all the reported total synthesis of zeaxanthin to date are compared with our overall 
yields of 5 and 6 in Table 6. 
 
Table 6. Summary of the yield of the reported synthesis of zeaxanthin. 
Yields, number of steps 
Reported Synthesis 





Loeber et al.42, 1971. 







Rüttimann and Mayer.43, 







Widmer et al.44, 1990.  







Soukup et al.45, 1990 















*Yields of 5 and 6 could be improved on scale-up to 12% and 11%, respectively. 
With Wittig salts (3R)-16 and (3S)-16 at hand, we became interested in the 
synthesis of other carotenoids with 3-hydroxy-β-end group. One of the most 
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important dietary carotenoids with vitamin A activity is β-cryptoxanthin that 
possesses a (3R)-3-hydroxyl-β-end group. Therefore, we decided to investigate the 
application of these Wittig salts in the synthesis of (3R)-β-cryptoxanthin and its (3S)-
enantiomer. 
 
Synthesis of (3R)-β-Cryptoxanthin and (3S)-β-Cryptoxanthin  
(3R)-β-Cryptoxanthin and its (3S)-enantiomer were prepared by condensation of 
β-apo-12'-carotenal (134) with Wittig salts (3R)-16 and (3S)-16, respectively (Scheme 
39). β-Apo-12'-carotenal (134) was synthesized from β-ionone according to the 
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Scheme 39. Synthesis of (3R)-β-cryptoxanthin (135) and its (3S)-enantiomer (136) 
from β-apo-12'-carotenal (134) and Wittig salts (3R)-16 and (3S)-16. 
The crude product of each reaction was directly subjected to low temperature 
crystallization from CH2Cl2 and hexane to afford (3R)-β-cryptoxanthin (135) and its 
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(3S)-enantiomer (134) in 70% isolated yield. Unfortunately, attempts to resolve 
enantiomeric cryptoxanthins 135 and 136 by chiral HPLC (Eluent M, Appendix I) 
was not successful and resulted in partial separation of these carotenoids (Figure 21). 
Therefore, the optical purity of 135 and 136 was assumed to be identical to that of 
Wittig salts (3R)-16 (98% ee) and (3S)-16 (98% ee). The overall yields for making 
Wittig salts (3R)-16 and (3S)-16 were 12% and 13% and as a result, the overall yield 
of (3R)-β-cryptoxanthin (135) and its (3S)-enantiomer (134) from (±)-α-ionone were 
8% and 9%, respectively. 
 
 
Figure 21. Chiral HPLC separation (Eluent M, Appendix I) of (3R)-β-cryptoxanthin 
(135) and (3S)-β-cryptoxanthin (136). 
The CD spectra of (3R)-β-cryptoxanthin (135) and (3S)-β-cryptoxanthin (136) 
were in agreement with those of (3R,3'R)-zeaxanthin (5) and (3S,3'S)-zeaxanthin (6) 
that we had prepared earlier (Figure 22). 
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Figure 22. CD spectra of (3R)-β-cryptoxanthin (135) and (3S)-β-cryptoxanthin (136) 
in hexane:ether:methanol = 10:3:1. 
 
Total Synthesis of Luteins 1 – 4 Using C20+C20 Coupling Strategy 
As described earlier, an alternative approach to the synthesis of luteins 1 – 4 is by 
employing C20-aldehyde + C20-Wittig salt building blocks that can be joined by a 
Wittig coupling reaction to form this C40-carotenoid and its stereoisomers (Scheme 
40). This strategy takes advantage of the fact that any amount of 15Z-isomer of lutein 
that is formed as a result of this coupling can be transformed into the 
thermodynamically more stable all-E-isomer. We investigated two routes for the 
synthesis of C20-aldehydes, 3-hydroxy-α-retinals (89 – 92). The first route involved 
elongation of C15-hydroxyaldehydes 73 – 76 that we had prepared previously. The 
second route was inspired by the relative ease with which the Wittig salt 114 had been 
synthesized from (±)-α-ionone via (±)-3-keto-vinyl-α-ionol (115) by Widmer et al. 
The C20-Wittig salt (88) could be obtained from the double bond isomerization of C15-
hydroxynitriles 77 – 80 followed by reduction with DIBAL-H and elongation to C20-



















 (3R)-β-Cryptoxanthin (135) 
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Scheme 40. Retrosynthetic summary of the synthesis of lutein employing C20+C20 
coupling strategy. 
 
Synthesis of C20-3-Hydroxy-α-retinals (89 – 92) from Hydroxyaldehydes 73 – 76 
To arrive at the optically pure C20-hydroxyaldehydes 89 – 92, we planned to 
employ enzyme-mediated acylation of 89 – 92 or its precursors, hydroxyaldehydes 
73 – 76. While hydroxyaldehydes 73 – 76 were available in high optical purity from 
our previous synthesis, we decided to use the racemic mixture of trans-C15-
hydroxyaldehydes 73 and 74 to first examine the efficacy of this C20+C20 coupling 
strategy. The racemic mixture of C15-hydroxyaldehydes 73 and 74 was elongated with 
C5 synthon 97 to afford (±)-C20-hydroxynitriles 93 and 94 in 83% isolated yield after 
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column chromatography (Scheme 41). DIBAL-H reduction of these hydroxynitriles 



















89: (3R,6R), 90: (3S,6S)
97
73: (3R,6R), 74: (3S,6S) 93: (3R,6R), 94: (3S,6S)
 
Scheme 41. The synthesis of (±)-C20-hydroxyaldehydes 89 and 90 from (±)-C15-
hydroxyaldehydes 73 and 74. 
 
Synthesis of C20-3-Hydroxy-α-Retinals (89 – 92) from (±)-α-Ionone via (±)-3-
Keto-Vinyl-α-Ionol (115) 
The key starting material for the synthesis of C20-hydroxyaldehydes 89 – 92 by 
this alternative route was Wittig salt 114 that has been previously prepared by Widmer 























Scheme 42. Synthesis of Wittig salt 114 according to the method of Widmer et al.90  
We prepared the ketoionol 115 by vinylation of α-ionone with vinylmagnesium 
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bromide according to a published procedure37 in 86% isolated yield followed by 


















Scheme 43. Preparation of (±)-3-keto-α-ionol (115). Conditions are described in 
Table 7. 
In the following step, 116 was converted to 115 by bleach oxidation in 79% 
isolated yield after chromatography.59 Ketone 115 was also prepared from allylic 
oxidation of 116 in 60% yield using dirhodium(II) caprolactamate as catalyst.58 This 
oxidation could also be accomplished in 45% yield by the method of Yu and Corey 














Household bleach (5.25% NaOCl), 70% TBHP in H2O, K2CO3,  
EtOAc, -2 to 5˚C, 17 h 
Rh2(cap)4, 5.5M TBHP in decane, K2CO3, CH2Cl2, R.T., 50 h 






Using conditions developed by Widmer et al.90, we transformed ketone 115 into 
the C15-Wittig salt 114. C15-Wittig salts of carotenoids are usually crystallized to 
remove the 9Z-isomers that are not crystallized well. However, we were unable to 
crystallize 114 and this Wittig salt was directly used in the following step as a mixture 
of all-E and 9Z isomers. Elongation of 114 with (E)-ethyl-3-formyl-2-butenoate (113) 
afforded the C20-ketoester 112 as a mixture of all-E, 9Z and 11Z-isomers in 65% 






















2) Pd(OAc)2, hexane, reflux
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Scheme 44. Preparation of C20-3-ketoester 112 from 115. 
 
It should be noted that aldehyde 113 was prepared as an all-E isomer according 
to a known method.91 Fortunately, the 11Z isomers of carotenoids are sterically 
hindered and are readily converted to their all-E isomers.46 Thus the 11Z bond in 
ketoester 112 was isomerized with Pd(OAc)2 in refluxing hexane to yield a mixture of 
all-E (86%) and 9Z (14%) isomers of 112. A small sample of this isomeric mixture 
was separated by semipreparative HPLC and the individual isomers were fully 
characterized. Although 112 appears to be a useful precursor for the synthesis of C40 
carotenoids, the preparation of this ketoester has not been previously reported. 
Reduction of 112 (all-E+9Z) with NaAlH2(OCH2CH2OMe)2 (Red-Al) gave C20-
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hydroxyesters 108 – 111 (all-E+9Z) in nearly quantitative yield which was then 
further reduced with LAH to afford C20-diol 104 – 107 as a mixture of all-E+9Z in 
75% yield (Scheme 45). Due to the unstable nature of this compound, the diol 104 – 
107 was immediately used in the following step. The oxidation of diol 104 – 107 with 




























Scheme 45. Preparation of C20-hydroxyaldehyde 89 – 92 from C20-ketoester 112. 
In summary, two routes were developed for the synthesis of C20-















75: (3S,6R) + 76: (3R,6S)
3-Keto-vinyl-α-ionol (115)
63
30% overall yield (Route A)
(rac)-C20-Hydrpxyaldehydes
91: (3S,6R) + 92: (3R,6S)
(rac)-α-ionone
 
Scheme 46. The overall yield summary for the preparation of C20-hydroxyaldehydes 
89 – 92 according to routes A and B. 
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According to the first route (Route A), the (cis)-C20-hydroxyaldehydes 91 and 92 
were obtained in 51% from (cis)-C15-hydroxyaldehydes 75 and 76. As described 
earlier in the synthesis of luteins 1 – 4, aldehydes 75 and 76 were prepared from (±)-
α-ionone in 61% yield. Therefore, the overall yield for preparing the racemic mixture 
of 91 and 92 according to route A was 30%. In the second route (Route B), the 
racemic mixture of C20-hydroxyaldehydes 89 – 92 were obtained in 25% overall yield 
from (±)-α-ionone via 3-keto-vinyl-α-ionol (115); details of this synthesis was 
described earlier in Scheme 43. Although the overall yield of (±)-C20-
hydroxyaldehydes by routes A and B were comparable, route A was more appealing 
because we had previously prepared the four optical isomers of C15-hydroxyaldehydes 
73 – 76 in a high ee. However, with Route B, it was not clear to us whether the 
separation of various stereoisomers of (±)-C20-hydroxyaldehydes 89 – 92 could be 
accomplished.  
 
Synthesis of C20-Wittig Salt 88 
Based on our previous experience with the double bond isomerization of 3-
hydroxy-α-ionone (120 – 123) to 3-hydroxy-β-ionone (42), we explored the base-
promoted double bond isomrization of 3-hydroxy-α-ionylideneacetonitrile (77 – 80) 
to 3-hydroxy-β-ionylideneacetonitrile (102 – 103) (Table 8). This is because nitriles 
77 – 80 were readily available from (±)-α-ionone from our earlier synthesis of luteins 
and 102 and 103 could serve as precursors to C20-Wittig Salt 88 as shown in Scheme 
40. Initially, we examined this reaction with a racemic mixture of hydroxynitriles 77 – 
80 employing KOH or KF-alumina as base. 
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Table 8. Base-promoted double bond isomerization of hydroxynitriles 77 – 80 to 































KOH (0.7 eq), EtOH, reflux, 24 h 
KOH (0.7 eq), n-PrOH, 90 °C, 15 h 
KOH (17 eq), MeOCH2CH2OH, 120 °C, 24 h 





 100, 1.0 : 1.0  
  90, 1.0 : 1.6 
  35, 1.0 : 3.0 





KF-Alumina (40% by wt, 2.3 eq), DMF,  
120 °C, 29 h 
KF-Alumina (40% by wt, 1.4 eq), 






  36, 1.0 : 4.4 
 
  50, 1.0 : 2.2 
*Ratios were determined by HPLC (Eluent A, Appendix I). N.R. = No reaction. 
The reactions with KOH in different alcohols revealed that trans-hydroxynitriles 
77+78 began to slowly isomerize to the desired product 102+103 at about 120 °C. 
Meanwhile, the double bond isomerization of the cis-hydroxynitriles 79+80 was 
considerably slower at this temperature. Despite the fact that the reaction with KOH 
was allowed to proceed for extended periods of time, no greater than 64% of 77 – 80 
could be converted to 102+103. Unfortunately, prolonged heating at high temperature 
in the presence of KOH resulted in considerable degradation of product and gave a 
poor yield of about 30%.  
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Following these disappointing results, we decided to promote this isomerization 
with a milder base such as KF-alumina to avoid the degradation of product. The 
utility of alumina coated with KF as a versatile solid-supported base for double bond 
isomerization of olefins to the thermodynamically more stable form has been 
previously documented.92 This reagent has also been used in Aldol condensation93, 
and Michael addition reaction of chalcones and malononitriles.94 The isomerization of 
hydroxynitriles 77 – 80 with KF-alumina in DMF after 29 h at 120 °C resulted in 64% 
conversion of these nitriles and afforded 102+103 in 40% yield. In addition, only 6% 
of trans-hydroxynitriles 77+78 and 30% of cis-hydroxynitriles 79+80 remained 
unreacted. 
To better understand the reason for the much slower conversion of cis-
hydroxynitriles 79+80 to 102+103 in comparison with trans-hydroxynitriles 77+78, 
conformational analyses of these hydroxynitriles was carried out using the Spartan 
MMFF method. As shown in Figure 23, the cis-hydroxynitriles 79+80 can exist in two 
half-chair conformations A and B with the calculated energies of 28.37 and 25.04 
Kcal/mol, respectively. On the contrary, the preferred half-chair conformation of 
trans-hydroxynitriles 77+78 has the energy of 27.43 Kcal/mol. While the higher 
energy of trans-hydroxynitriles (77+78, 27.43 Kcal/mol) relative to the energy of 
conformation B of the cis-hydroxynitriles (79+80, 25.04 Kcal/mol) is unexpected, it 





Figure 23. The half-chair conformations of cis-hydroxynitriles 79+80 and trans-
hydroxynitriles 77+78 and their corresponding energies calculated by Spartan MMFF 
method. 
 
Aside from the relatively low yields, the major drawback with the base-promoted 
double bond isomerization reactions of hydroxynitriles 77 – 80 was separation of the 
unreacted nitriles from hydroxynitriles 102+103 that could only be accomplished by 
repeated column chromatography. Therefore, in order to continue with the synthesis 
of C20-Wittig salt 88, the Wittig salt (3R)-16 that we had previously prepared from 3-
hydroxy-β-ionone (see Scheme 37) was elongated with C5-synthon 137 to afford C20-








A: 28.37 kcal/mol 
B: 25.04 kcal/mol 
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Scheme 47. Synthesis of C20-Wittig salt 88. DIPEA = N,N-diisopopylethylamine. 
 
After protection of the C20-diol 98 with acetyl chloride, the diacetate 138 was 
treated with Ph3P and H2SO4 to form 3-hydroxy-retinaltriphenylphosphonium sulfate 
(88). However, this reaction did not produce any Witig salt and the diacetate 138 was 
partially degraded. As mentioned earlier in Scheme 14, retinaltriphenylphosphonium 
salts 8652-54 have been successfully prepared for the synthesis of β,β-carotene but the 
acylated or hydroxylated derivatives of this Wittig salt 88 have not been reported to 
date. We also tried to prepare the chloride salt but this reaction also failed to produce 
any product.  
In conclusion, our feasibility studies for construction of the optically inactive 
luteins by a C20+C20 Wittig coupling strategy indicated that the C20-3-hydroxy-α-
retinals (89 – 92) could be prepared by two different routes in overall yields of 25% 
and 30%. However, the preparation of the C20-Wittig salt proved to be problematic 
and it is unclear to us whether conditions for making this salt can be worked out. 
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Considering that the overall yield for the synthesis of the diacetate 138 from (±)-α-
ionone via-3-hydroxy-β-ionone was about 11%, any procedure that could provide the 
Wittig salt 88 would have to be highly efficient for this C20+C20 synthetic strategy to 
be viable. Therefore at present, the C15+C10+C15 coupling strategy for the synthesis of 




We have developed methodologies for the synthesis of lutein, zeaxanthin, β-
cryptoxanthin, and their stereoisomers from (±)-α-ionone employing a C15+C10+C15 
coupling strategy. Dietary (3R,3'R,6'R)-lutein (1, 5%, 98% ee) and three of its 
stereoisomers (3R,3'S,6'S)-lutein (2, 6%, 98% ee), (3R,3'S,6'R)-lutein (3, 5%, 91% ee), 
and (3R,3'R,6'S)-lutein (4, 6%, 94% ee) were each prepared from (±)-α-ionone via 
optically pure C15-hydroxyaldehydes 73 – 76 that served as key intermediates in this 
synthesis. This methodology can also be applied to the synthesis of the other four 
stereoisomers of luteins in which the configuration at C3 position is S while the 
stereochemistry at C3' and C6' remains the same as luteins 1 – 4. 
Employing a similar coupling strategy, the synthesis of (3R,3'R)-zeaxanthin (5, 
6%, 98% ee), (3S,3'S)-zeaxanthin (6, 5%, 98% ee), (3R)-β-cryptoxanthin (135, 8%, 
99% ee), and (3S)-β-cryptoxanthin (136, 9%, 99% ee) was accomplished from C15-
Wittig salt 16. This Wittig salt was prepared as 3R and 3S isomers in high 
enantiomeric purity from (±)-α-ionone via (3R)- and (3S)-3-hydroxy-β-ionone (42). 
As mentioned earlier, the main objective of the research described in this 
dissertation was to develop methodologies that could be applied to the synthesis of 
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13C-labeled lutein and its stereoisomers for metabolic studies. This can now be 
accomplished since the C15-hydroxyaldehydes 73 – 76 and the C15-Wittig salts (3R)-
16 and (3S)-16 that are the required end-groups for the synthesis of lutein and its 
stereoisomers have been prepared in high optical purity. However, because of the 
lengthy nature of the synthetic steps and the low overall yields of these end-groups, 
the 13C-labels will have to be incorporated into the protected C10-Wittig salt 72. 
This approach has been successfully applied to the synthesis of 13C4-(3R,3'R)-


































































Scheme 48. Synthesis of 13C4-(3R,3’R)-zeaxanthin (5) by Khachik et al.95 
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all-E-2,7-Dimethylocta-2,4,6-triene-1,8-dial (C10-dialdehyde, 17) labeled with 
four 13C was synthesized from commercially available 13C2-triethyl phophonoacetate 
139 and fumarylaldehyde dimethylacetal in six steps in an overall yield of 43-46%. As 
mentioned earlier, C10-dialdehyde 17 is a common building block for the central 
polyene chain of many carotenoids and has been used in the commercial synthesis of 
zeaxanthin.38 13C2-Triethyl 2-phosphonopropionate 141 was prepared from 139 by 
alkylation with methyl iodide that also afforded 140 (18%) as a side product. 
According to this procedure, the unreacted 139 was recovered in the purification 
process. The use of inexpensive 13C-labelled methyl iodide in alkylation step could 
also allow the introduction of two additional 13C labels into the molecule. Because of 
the polymerization nature of fumarylaldehyde, fumarylaldehyde dimethylacetal was 
catalytically hydrolyzed to fumarylaldehyde monomethylacetal (142); the WHE 
reaction between 141 and this monoacetal resulted in the formation of 13C2-6,6-
dimethoxy-2-methyl-E,E-2,4-hexadienoate (143). Compound 143 was then 
deprotected to 144 and elongated with 141 to yield 13C4- (all-E)-2,7-dimethylocta-
2,4,6-triene-1,8-diacid ethylester 145. Reduction of 145 by LAH followed by 
oxidation of the resulting diol 146 with MnO2 resulted the formation of the desired 
13C4-C10-dialdehyde 17. In the final step of the synthesis, 13C4-(3R,3’R)-zeaxanthin (5) 
was then obtained by double Wittig coupling of 13C4-C10-dialdehyde 17 and the Wittig 
salt (3R)-16 to afforded 13C4- (3R,3’R)-zeaxanthin (5) in 90% yield. Therefore, 
employing this strategy, Khachik et al. incorporated four 13C-labels into (3R,3'R)-
zeaxanthin at positions 12, 13, 12′, and 13′. 
The protected C10-Wittig salt 72 that was used in our synthesis of luteins 1 – 4 
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has been previously prepared from C10-dialdehyde 17 by Bernhard et al.47 Therefore, 
13C4-C10-dialdehyde 17 can be prepared by the method of Khachik et al. and 
subsequently transformed into the protected C10-Wittig salt 72 by the method of 
Bernhard et al. (Scheme 49). 




























Scheme 49. Synthesis of protected C10-Wittig salt 72 according to the method of 
Bernhard et al.47 
 
Considering that C10-dialdehyde 17 labeled with 4 to 6 carbon-13 can be 
prepared in gram quantities from 13C2-triethyl phophonoacetate 139 and 13CH3I, the 
synthesis of 13C-labeled lutein and its stereoisomers can be accomplished in relatively 
large quantities for metabolic studies. 
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EXPERIMENTAL SECTION 
All experiments were carried out in an anhydrous nitrogen atmosphere; reaction 
vessels were dried in the oven prior to use. All solvents were dried over molecular 
sieves (4 Å) or directly used from an unopened bottle. Saturated solutions of NaHCO3 
and NH4Cl refer to saturated solutions of the salt in water. Brine refers to a saturated 
solution of NaCl in water. 
Reactions were monitored by using thin-layer chromatography (TLC) on Merck 
silica-coated glass plates treated with UV-active binder, with compounds being 
identified in one or more of the following methods: UV (254 nm) or phosphomolybic 
acid indicator.  
Reactions were also monitored by HPLC employing normal phase, reversed phase, 
and chiral-columns under various conditions as described below. The analyses were 
performed on an HPLC system (model 1100; Agilent Technology, CA) equipped with 
a quaternary solvent delivery system (model G1311A), an autosampler (model 
G1313A), a thermostat-controlled column compartment (model G1316A), and a 
photodiode array detector (model G1315B). The data were stored and processed by a 
computer (Dell with Windows 2000 using HP Chem-Station software. 
Normal phase HPLC separations were carried on a silica-based nitrile bonded 
column (25 cm length x 4.6 mm i.d.; 5-µm spherical particle; part # PSS830915 
Waters Corporation, MA. The column flow rate was 0.7 mL/min. 
C18-reversed phase HPLC separations were carried out on a C18-Microsorb 
column (25 cm length x 4.6 mm i.d.; 5-µm spherical particle; Varian Instrument Co., 
MA). Pump A pumped a mixture of acetonitrile (90%) and methanol (10%) and pump 
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B pumped a mixture of hexane (45%), methylene chloride (45%), methanol (10%). 
The column flow rate was 0.7 mL/min  
All semipreparative normal phase HPLC separations were carried out on a silica-
based nitrile bonded column (25 cm length x 10 mm i.d.; 10-µm spherical particle; 
Waters Corporation, MA). Various mobile phases were used with this column at a 
flow rate of 3mL/min. 
All chiral HPLC separations were carried out on an amylose tris-(3,5-
dimethylphenylcarbamate) chiral analytical column (Chiralpak AD, 25 cm length x 
4.6 mm i.d.), protected with a silica gel guard cartridge (3 cm length x 4.6 mm i.d.; 5-
µm particle); flow rate = 0.7 mL/min. 
All operations and HPLC analyses were conducted under yellow laboratory light 
to prevent photo-isomerization and degradation of carotenoids and their precursors. 
1H NMR spectra were recorded on a Bruker DRX-400 MHz spectrometer with CDCl3 
(7.27 ppm) as internal standard. 1H noise-decoupled 13C spectra were recorded on a 
Bruker DRX-400 MHz at 100 MHz with chloroform (77.0 ppm) as an internal 
standard. Low resolution (LRMS) and high resolution (HRMS) mass spectra were 
obtained on a JEOL AccuTOF CS mass spectrometer (ion source: ESI, EI, CI or DEI; 
needle voltage:  2300 v; flow rate: 50 µl/min; desolvation chamber temperature = 
250˚C; data acquisition time:  2 min). Circular dichroism (CD) was carried out on a 
JASCO (Model J810) instrument. A mixture of hexane, ether, and methanol (10:3:1) 
was used as the background solvent. All compounds were determined to be >95% 
pure by 1H NMR or HPLC analysis, unless otherwise noted. All new compounds were 
fully characterized using 1H NMR, 13C NMR, UV/Vis, CD, and low resolution and 
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high resolution mass spectrometry. 
 
Palladium(II)-Mediated Oxidation of (±)-α-Ionone to (±)-3-Keto-α-Ionone (85) 
(Table 1, Entry 1). Freshly distilled (±)-α-ionone (1.00 g, 5.20 mmol) in 
dichloromethane (10 mL) was cooled down in an ice-salt bath to 0°C under N2 and 
was treated with K2CO3 (0.180 g, 1.30 mmol) and Pd/C (10 wt.% on C, 0.150 g ∼ 15 
mg Pd, 0.14 mmol). A 5.5 M anhydrous solution of TBHP in decane (5.0 mL, 28 
mmol) was added to the mixture at 0°C. The mixture was stirred for 24 h at 0°C and 
12 h at room temperature (R.T.) under N2. The solids were removed by filtration 
through celite and the filtrate was washed with water (3 X 20 mL), brine, and dried 
over Na2SO4. The solvent was removed under reduced pressure to give 1.3 g of a 
yellow oil. The crude product was purified by column chromatography (silica gel, 
hexane:acetone, from 98:2 to 92:8, Rf = 0.53 in hexane:acetone = 7:3) followed by 
crystallization from ether:hexane (1.4:1) to yield (±)-3-keto-α-ionone (85) as a white 
solid: 0.57 g, 2.8 mmol, 53%, mp 75-76°C. 1H NMR (400MHz, CDCl3) δ 0.88 (s, 3H), 
0.95 (s, 3H), 1.78 (s, 3H), 2.00 (d, J = 16.8, 1H), 2.15 (s, 3H), 2.24 (d, J = 16.8, 1H) 
2.61 (d, J = 9.5, 1H),  5.83 (s, 1H), 6.06 (d, J = 15.8, 1H), 6.57 (dd, J = 9.5, 15.8, 1H); 
13C NMR (100 MHz, CDCl3) δ 23.3, 27.1, 27.4, 27.7, 36.5, 47.1, 55.2,126.7, 133.6, 
143.4, 159.0, 197.4, 198.1. MS (ESI+) calculated for C13H18O2 [M+H]+ 207.1385, 
found 207.1232. 
 
Rh2(cap)4 Catalyzed Oxidation of (±)-α-Ionone to (±)-3-Keto-α-Ionone (85) 
(Table 1, Entry 2). To a solution of (±)-α-ionone (1 g, 5.2 mmol) in 10 mL of CH2Cl2 
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was added K2CO3 (0.36 g, 2.6 mmol), and dirhodium(II) caprolactamate [Rh2(cap)4] 
(2.1 mg, 0.005 mmol), followed by 6.3 M tert-butylhydroperoxide (4.1 mL, 26 mmol). 
The reaction mixture was stirred at R.T. for 22 h and then filtered through celite. The 
product was washed with H2O (2 × 100 mL), the organic layer was dried over Na2SO4, 
and concentrated in vacuo to give a pale yellow oil. Purification by column 
chromatography (silica gel, hexane:acetone, from 98:2 to 92:8) afforded 0.8 g of a 
colorless oil which was subjected to crystallization (ether:hexane=1.4:1) to obtain 
white solids of (±)-3-keto-α-ionone (85) (0.61 g, 63%). The NMR data were shown to 
be identical with 85 reported previously.   
 
Bleach Oxidation of (±)-α-Ionone to (±)-3-Keto-α-Ionone (85) (Table 1, Entry 
3). Freshly distilled (±)-α-ionone (20 g, 0.10 mol) was transferred into a 500 mL 
three-necked flask using EtOAc (103 mL, 92.1 g, 1.05 mol). K2CO3 (1.44 g, 10.4 
mmol) was added and the mixture was cooled down in an ice-salt bath to 0°C under 
N2. A 70% solution of TBHP in water (89 mL, 70% of 80 g ≈ 56 g, 0.62 mol) was 
added dropwise to the mixture under N2 at 0°C in 30 min. Household bleach 
containing 5.25% NaOCl (295 g, 15.5 g NaOCl, 0.208 mol) was then added over a 
period of 5 h at -5 to 0°C. After the addition was completed, the reaction mixture was 
stirred at 0°C for an additional hour. The organic layer was removed and the water 
layer was washed with EtOAc (2 X 100 mL). The combined organic layer was 
washed with water (2 X 150 mL), dried over Na2SO4, and evaporated to give 26.8 g 
of a yellow oil. The crude product was purified by column chromatography (silica gel, 
hexane:acetone, from 98:2 to 92:8) followed by crystallization (ether:hexane=1.4:1) 
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to yield (±)-3-keto-α-ionone (85) (13.7 g, 66.4 mmol, 64%) as a white solid. The 
NMR data of this white solid were shown to be identical with 85 reported previously.   
 
Synthesis of (7E,9E)-3-Keto-α-Ionylideneacetonitrile (81) and (7E,9Z)-3-Keto-
α-Ionylideneacetonitrile (82)  from (±)-3-Keto-α-Ionone (85). Sodium hydride 
(0.43 g of 60% suspension in oil ≈ 0.26 g, 10 mmol) was placed in a three-necked 
flask equipped with a nitrogen inlet and a thermometer and washed with hexane (2 X 
10 mL). TBME (30 ml) was added and the mixture was cooled to 0°C. Diethyl 
cyanomethylphosphonate (0.96 g of 98% pure, 0.95 g, 5.3 mmol) in 10 mL TBME 
was added to the suspension at 5-10˚C under N2 and the mixture was allowed to stir at 
R.T. for 1 h. The reaction mixture was cooled down in an ice bath and (±)-3-keto-
ionone (1.0 g, 4.9 mmol) in 10 mL TBME was added dropwise in 30 min at 0-5°C. 
After stirring for 6 hours at R.T., the reaction was quenched with water and the 
organic layer was removed. The aqueous layer was extracted with TBME (2 X 20 
mL). The combined organic layer was washed with water, dried over Na2SO4, and 
evaporated to dryness. The crude product (1.1 g) was purified by column 
chromatography (hexane:acetone, from 98:2 to 95:5) to yield a mixture of 81 and 82 
(0.9 g, 4 mmol, 81%) as a pale yellow oil. The product was shown by analytical 
normal phase HPLC (Eluent A, Appendix I) as well as 1H- and 13C-NMR to consist of 
81 (75%) and 82 (25%) [ratio of isomeric mixture: 7E,9E:7E,9Z = 3:1]. 
Crystallization from ethanol at -20°C gave the (7E,9E)-isomer (81) as a white crystal 
(0.45 g, 1.9 mmol, 40%), mp 93-95°C. Analytically pure samples of 82 were purified 
from a mixture of 81 and 82 by semipreparative normal phase HPLC (Eluent A, 
 108
Appendix I).     
81: 1H NMR (400 MHz, CDCl3) δ 0.97 (s, 3H), 1.06 (s, 3H), 1.89 (d, J = 1.2 Hz, 
3H), 2.13 (d, J = 16.8 Hz, 1H), 2.16 (d, J = 1.0 Hz, 3H), 2.33 (d, J = 16.8 Hz, 1H), 
2.66 (d, J = 9.4 Hz, 1H), 5.23 (s, 1H), 5.95 (s, 1H), 5.98 (dd, J = 15.5, 9.4 Hz, 1H), 
6.25 (d, J = 15.5 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 16.8, 23.5, 27.3, 27.9, 36.7, 
47.3, 55.9, 98.4, 117.2, 126.5, 133.7, 135.2, 155.8, 160.0, 198.5. UV λmax = 260 nm 
(hexane). MS (ESI+) calcd for C15H19NO [M + H]+ 230.1545, found 230.1332. 
82: 1H NMR (400 MHz, CDCl3) δ 0.98 (s, 3H), 1.08 (s, 3H), 1.92 (d, J = 1.3, 3H), 
2.02 (d, J = 1.5, 3H), 2.17 (d, J = 17.1, 1H), 2.36 (d, J = 17.1, 1H), 2.73 (d, J = 9.9, 
1H), 5.21 (s, 1H), 5.95 (s, 1H), 5.98 (dd, J = 15.3, 9.9, 1H), 6.80 (d, J = 15.3, 1H). 13C 
NMR (100 MHz, CDCl3) δ 19.6, 23.5, 27.4, 27.8, 36.5, 47.5, 56.3, 97.0, 116.6, 126.3, 
131.3, 136.1, 155.3, 160.3, 198.5. UV λmax = 260 nm (hexane). 
 
Preparation of (7E,9E)-α-Ionylideneacetonitriles (83) and (7E,9Z)-α-
Ionylideneacetonitriles (84) from (±)-α-Ionone by WHE Coupling (route A, 
Scheme 18). To a freshly prepared solution of NaOMe, prepared from Na (5.47 mol) 
and MeOH (70 mL), was added a solution of diisopropyl cyanomethylphosphonate 
(47 g of 95% pure ≈ 44.65 g, 0.218 mol) in TBME (20 mL) at 0-5°C in 20 min under 
N2. After stirring at room temperature for 1 h, the mixture was cooled down in an ice 
bath and freshly distilled (±)-α-ionone (38 g, 0.20 mol) in TBME (20 mL) was added 
in 45 min at 0-5°C. The mixture was stirred at room temperature for 4 h and the 
product was quenched with water, diluted with TBME, washed with brine, and dried 
over Na2SO4. After solvent evaporated under reduced pressure, 45 g of a pale yellow 
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oil was obtained. The crude product was purified by fractional distillation to yield a 
mixture of (7E,9E)-83 and (7E,9Z)-84 (b.p. = 107-110°C at 10 mm) as a colorless oil 
(31.6 g, 0.147 mol, 74%); 83:84 = 3:1 (determined by analytical normal phase HPLC, 
Eluent A, See Appendix I). Analytically pure samples of 83 and 84 were separated by 
semipreparative normal phase HPLC (Eluent B, Appendix I).    
83: 1H NMR (400 MHz, CDCl3) δ 0.81 (s, 3H), 0.91 (s, 3H), 1.20 (m, 1H), 1.46 (m, 
1H), 1.55 (d, J = 2.0 Hz, 3H), 2.02 (m, 2H), 2.13 (d, J = 1.0 Hz, 3H), 2.22 (d, J = 9.8 
Hz, 1H), 5.15 (s, 1H), 5.46 (m, 1H), 5.94 (dd, J = 15.5, 9.4 Hz, 1H), 6.12 (d, J = 15.5 
Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 156.9, 140.5, 135.6, 132.7, 131.5, 122.1, 
96.3, 54.6, 32.5, 31.3, 27.7, 26.8, 23.0, 22.8, 16.8. UV λmax = 260 nm (hexane); MS 
(DEI+) calcd for C15H21N [M + H]+ 216.1752, found 216.1831. 
84: 1H NMR (400 MHz, CDCl3) δ 0.83 (s, 3H), 0.92 (s, 3H), 1.20 (m, 1H), 1.46 (m, 
1H), 1.57 (d, J = 2.0 Hz, 3H), 2.02 (m, 2H), 2.14 (d, J = 1.0 Hz, 3H), 2.30 (d, J = 10 
Hz, 1H), 5.08 (s, 1H), 5.46 (m, 1H), 5.96 (dd, J = 15.6, 9.6 Hz, 1H), 6.65 (d, J = 15.6 
Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 156.5, 141.3, 136.1, 132.8, 128.9, 121.9, 
94.9, 54.8, 32.4, 31.5, 27.8, 26.8, 23.0, 22.8, 16.5. UV λmax = 258 nm (hexane); MS 
(DEI+) calcd for C15H21N 215.1674, found 215.2000. 
 
Synthesis of (7E,9E)-α-Ionylideneacetonitriles (83) and (7E,9Z)-α-
Ionylideneacetonitriles (84) from (±)-α-Ionone and Cyanoacetic Acid (route B, 
Scheme 18). Freshly distilled (±)-α-ionone (32.0 g, 0.166 mol) was transferred into a 
250 mL three necked flask using cyclohexylamine (55 mL, 48 g, 0.48 mol). 
Cyanoacetic acid (18 g, 0.21 mol) was added and the mixture was heated at 80-85°C 
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under N2. After 3.5 h, the mixture was allowed to cool down to room temperature and 
the product was partitioned between hexane (150 mL) and water (150 mL). The 
organic layer was removed and the aqueous layer was extracted with hexane (50 mL). 
The combined organic layer was washed with water (3 X 200 mL), dried over Na2SO4, 
and evaporated to dryness to give 34 g of a pale yellow oil. The crude product was 
purified by fractional distillation to yield a mixture of 83 and 84 (b.p. = 105-110°C at 
10 mm) as a colorless oil (26.7 g, 0.124 mol, 75%) that was shown by 1H-NMR as 
well as analytical normal phase HPLC (Eluent A, Appendix I) to consist of 83 (92%) 
and 84 (8%) [ratio of isomeric mixture: 83: (7E,9E) / 84: (7E,9Z) = 12/1]. The NMR 
data were shown to be identical with 83/84 characterized earlier.   
 
Palladium(II)-Mediated Oxidation of (±)-α-Ionylideneacetonitrile (83:84 = 12:1) 
to (7E,9E)-3-Keto-α-Ionylideneacetonitrile (81) (Table 2, Entry 1). A solution of 
(±)-α-ionylideneacetonitrile 83/84 (19.6 g, 91.0 mmol, 83:84 = 12:1) in 
dichloromethane (150 mL) was cooled down in an ice-salt bath to 0°C under N2 and 
was treated with K2CO3 (8.4 g, 61 mmol) and Pd/C (10 wt.% on C, 7.5 g ∼ 0.75 g Pd, 
7.1 mmol). A 5.5 M anhydrous solution of TBHP in decane (100 mL, 0.550 mol) was 
added to the mixture dropwise while maintaining the temperature at 0°C. The mixture 
was stirred for 36 h at 0°C and 50 h at R.T. under N2. The solids were removed by 
filtration through celite and the filtrate was washed with water (3 X 150 mL), brine, 
and dried over Na2SO4. The solvent was removed under reduced pressure to give 24 g 
of a yellow oil. The crude product was purified by column chromatography 
(hexane:ethyl acetate, from 98:2 to 92:8) to yield a mixture of 81 and 82 (11 g, 48  
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mmol, 53%) as a yellow oil. The product was shown by analytical normal phase 
HPLC (Eluent A, Appendix I) to consist of an isomeric mixture of 81:82 = 12:1. 
Crystallization from ethanol at -20°C gave the (7E,9E)-isomer (81) as a white crystal 
(6.0 g, 26 mmol, 29%). The NMR data were shown to be identical with that of 81 
characterized previously. 
 
Bleach Oxidation of (±)-α-Ionylideneacetonitrile (83:84 = 12:1) to (7E,9E)-3-
Keto-α-Ionylideneacetonitrile (81) (Table 2, entry 3). (±)-α-Ionylideneacetonitriles 
(83/84) (27 g, 0.12 mol; 83:84 = 12:1) was transferred into a 1 L three-necked flask 
using acetonitrile (103 mL, 81.0 g, 197 mmol). K2CO3 (1.71 g, 12.4 mmol) was added 
and the mixture was cooled down in an ice-salt bath to 0°C under N2. A 70% solution 
of TBHP in water (124 mL, 112 g, 70% ≈ 78.1 g, 867 mmol) was added dropwise to 
the mixture under N2 at 0 °C in 30 min. Household bleach containing 5.25% NaOCl 
(386 g, 20.3 g NaOCl, 272 mmol) was then added over a period of 8 h at -5 to 0°C. 
After the addition was completed, the reaction mixture was stirred at 0°C for an 
additional hour. The product was extracted with hexane (200 mL) and the organic 
layer was separated. The water layer was washed with hexane (2 X 100 mL) and the 
combined organic layer was washed with water (3 X 200 mL), dried over Na2SO4, 
and evaporated to give 36.7 g of a yellow oil. The crude product was purified by 
column chromatography (hexane:ethyl acetate, from 98:2 to 92:8) to yield a mixture 
of (7E,9E)-3-keto-α-ionylideneacetonitrile (81) and (7E,9Z)-3-keto-α-
ionylideneacetonitrile (82) (15.1 g, 65.6 mmol, 53%) as a yellow oil. The product was 
shown by analytical normal phase HPLC (Eluent A, Appendix I) and 1H NMR to 
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consist of 81 (92%) and 82 (8%) [81: (7E,9E) / 82: (7E,9Z) = 12:1]. Crystallization 
from ethanol at -15°C gave 81 as a white crystal (10.5 g, 45.79 mmol, 37%). The 1H-
NMR spectrum of this white solid was identical with that of 81 characterized earlier. 
 
Reduction of (7E,9E)-3-Keto-α-Ionylideneacetonitrile (81) to (7E,9E)-3-
Hydroxy-α-Ionylideneacetonitriles (77 – 80) with NaBH4 (Table 3, Entry 1). To a 
solution of (7E,9E)-3-keto-α-ionylideneacetonitrile (81) (2.0 g, 8.7 mmol) in 20 mL 
ethanol and 15 mL water was added NaBH4 (0.7 g, 17 mmol) at 0°C. The mixture was 
allowed to warm up to room temperature, stirred for 24 h, and the product was treated 
with 10 mL of 0.3 N HCl and extracted with ethyl acetate (50 mL). The organic layer 
was removed and the aqueous layer was extracted with 30 mL of ethyl acetate. The 
combined organic layer was washed with 5% NaHCO3, water, and dried over Na2SO4. 
After solvent evaporation, the crude product was purified by column chromatography 
(hexane:acetone = 97:3) to afford 3-hydroxy-α-ionylidene-acetonitriles 77 – 80 (1.95 
g, 8.43 mmol, 97%) as a colorless oil. A mixture of 77+78 was separated from 79+80 
by semipreparative HPLC and was fully characterized by 1H and 13C NMR as well as 
mass spectrometry and UV-visible spectrophotometry. The isomeric ratio of 
(77+78):(79+80) = 1:1 was established by normal phase HPLC (Eluent A, Appendix 
I) of the mixture. Hydroxynitriles 77+78 and 79+80 were each shown by chiral HPLC 
(Eluent C, Appendix I) to consist of an approximately 1:1 mixture of enantiomers. 
(7E,9E)-(3,6-trans)-3-Hydroxy-α-ionylideneacetonitriles (77+78): 1H NMR (400 
MHz, CDCl3) δ  0.84 (s, 3H), 0.99 (s, 3H), 1.37 (dd, J = 13.3, 6.4, 1H), 1.59 (s, 3H), 
1.81 (dd, J = 13.3, 6.4, 1H), 2.13 (s, 1H), 2.44 (d, J = 10.0, 1H), 4.25 (m, 1H), 5.17 (s, 
 113
1H), 5.58 (s, 1H), 5.85 (dd, J = 15.4, 10.0, 1H), 6.15 (d, J = 15.4, 1H). 13C NMR (100 
MHz, CDCl3) δ 16.8, 22.7, 24.3, 29.3, 34.0, 44.1, 54.7, 65.4, 96.9, 117.6, 125.5, 133.0, 
135.9, 138.5, 156.4. UV λmax = 260 nm (hexane). MS (FAB+) calculated for 
C15H21NO [M+H]+ 232.1701, found 232.2000. 
(7E,9E)-(3,6-cis)-3-Hydroxy-α-ionylideneacetonitriles (79+80): 1H NMR (400 
MHz, CDCl3) δ  0.83 (s, 3H), 0.94 (s, 3H), 1.35 (dd, J = 12.9, 9.8, 1H), 1.60 (t, J = 
1.5, 3H), 1.64 (dd, J = 12.9, 6.5, 1H), 2.12 (d, J = 1.0, 3H), 2.19 (d, J = 9.3, 1H), 4.23 
(m, 1H), 5.17 (s, 1H), 5.53 (s, 1H), 5.95 (dd, J = 15.3, 9.3, 1H), 6.14 (d, J = 15.3, 1H). 
13C NMR (100 MHz, CDCl3) δ 16.8, 22.4, 26.9, 29.1, 34.9, 40.5, 54.6, 66.3, 96.8, 
117.6, 125.8, 131.9, 136.0, 139.2, 156.7. UV λmax = 260 nm (hexane). MS (FAB+) 
calculated for C15H21NO [M+H]+ 232.1701, found 232.2000. 
 
Reduction of (7E,9E)-3-Keto-α-Ionylideneacetonitrile (81) to (7E,9E)-3-
Hydroxy-α-Ionylideneacetonitriles (77 – 80) with Triisobutylaluminum (TIBA) 
(Table 3, Entry 2). A solution of (7E,9E)-3-keto-α-ionylideneacetonitrile (81) (0.15 g, 
0.65 mmol) in toluene (10 mL) was cooled down to -40°C under N2 and a solution of 
triisobutylaluminum (3 mL of 1M in toluene, 3 mmol) was added. The course of the 
reaction was monitored by HPLC. The mixture was allowed to warm up to R.T. and 
stirred for 1 h. The reaction was quenched by adding a dilute aqueous solution of HCl 
(0.5 mL, 5% v/v) followed by water (10 mL). The product was diluted with TBME 
(10 mL) and washed sequentially with brine and water. The organic layer was dried 
over Na2SO4 and evaporated to dryness. The product (0.14 g, 0.62 mmol, 95%) was 
shown by HPLC to consist of two fractions which were separated by semipreparative 
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HPLC (Eluent A, Appendix I) and identified in the order of chromatographic elution 
as (7E,9E)-3-hydroxy-α-ionylideneacetonitriles 77+78 (40%) and (7E,9E)-3-hydroxy-
α-ionylideneacetonitriles 79+80 (60%). The identification was accomplished by 
comparison of the 1H-NMR spectra and the HPLC retention times of the 
hydroxynitriles with those of authentic samples characterized earlier. Hydroxynitriles 
77+78 and 79+80 were each shown by chiral HPLC (Eluent C, Appendix I) to consist 
of an approximately 1:1 mixture of enantiomers. 
 
Reduction of (7E,9E)-3-Keto-α-Ionylideneacetonitrile (81) to (7E,9E)-3-
Hydroxy-α-Ionylideneacetonitriles (77 – 80) with Sodium Borohydride/dl-Tartaric 
acid (Table 3, Entry 6). A solution of dl-tartaric acid (46 mg, 0.31 mmol) in EtOH (4 
mL) was cooled down to 0°C and was treated with NaBH4 (12 mg, 0.32 mmol). After 
the evolution of H2 subsided, the mixture was stirred at R.T. for 1 h and was then 
cooled down to -15°C and treated with a solution of (7E,9E)-3-keto-α-
ionylideneacetonitrile (81) (72 mg, 0.31 mmol) in EtOH (3 mL). NaBH4 (24 mg, 0.63 
mmol) in EtOH (3 mL) was added to the suspension at -15°C and the course of the 
reaction was followed by HPLC (Eluent A, Appendix I). After 2h, the product was 
partitioned between water (10 mL) and ethyl acetate (15 mL). The organic layer was 
removed and the aqueous layer was extracted with ethyl acetate (10 mL). The 
combined organic layer was washed with water (2 X 10 mL), dried over Na2SO4, and 
evaporated to dryness. The crude product (68 mg, 0.29 mmol, 94%) was shown by 
HPLC to consist of two major fractions which were separated by semipreparative 
HPLC and identified in the order of chromatographic elution as (7E,9E)-3-hydroxy-α-
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ionylideneacetonitriles 77+78 (70%) and (7E,9E)-3-hydroxy-α-ionylidene-
acetonitriles 79+80 (30%). The 1H-NMR and the HPLC retention times of the 
hydroxynitriles were identical with those of authentic samples of these compounds 
characterized earlier. Hydroxynitriles 77+78 and 79+80 were each shown by chiral 
HPLC (Eluent C, Appendix I) to consist of an approximately 1:1 mixture of 
enantiomers. 
Reduction of 81 to 77 – 80 with sodium borohydride/2,3-dibenzoyl-d-tartaric acid, 
sodium borohydride/d-tartaric acid,  sodium borohydride/l-tartaric acid were carried 
out employing the same experimental procedure and produced similar results (Table 3, 
Entry 3-5). 
 
Reduction of (7E,9E)-3-Keto-α-Ionylideneacetonitrile (81) to Hydroxynitrile 
77 – 80 with Sodium bis(2-methoxyethoxy)aluminum Hydride (Red-Al™) (Table 
3, Entry 7). A solution of (7E,9E)-3-keto-α-ionylideneacetonitrile (81) (0.12 g, 0.52 
mmol) in TBME (5 mL) was cooled down to -5°C under N2, a solution of Red-Al™ 
(0.18 mL of 0.65 wt.% in toluene, 0.12 g, 0.59 mmol) in TBME (1 mL) was added, 
and the mixture stirred for 1 h at this temperature. The reaction was quenched by 
adding water (10 mL) and the product was extracted with TBME (10 mL) and washed 
sequentially with brine and water. The organic layer was dried over Na2SO4 and 
evaporated to dryness. The product (0.12 g, 0.50 mmol, 95%) was shown by HPLC to 
consist of (7E,9E)-3-hydroxy-α-ionylideneacetonitriles 77+78 (57%) and (7E,9E)-3-
hydroxy-α-ionylideneacetonitriles 79+80 (43%). The identification was accomplished 
by comparison of the HPLC retention times and UV spectra of the hydroxynitriles 
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obtained by a photodiode array detector with those of authentic samples characterized 
earlier. Hydroxynitriles 77+78 and 79+80 were each shown by chiral HPLC (Eluent C, 
Appendix I) to consist of an approximately 1:1 mixture of enantiomers. 
 
General Procedure for Reduction of 81 to 77 – 80 with Selectrides (Table 3, 
Entry 8 – 11). 
Reduction of (7E,9E)-3-Keto-α-Ionylideneacetonitrile (81) to Hydroxynitriles 
77 – 80 with Potassium tri-sec-Butylborohydride (K-Selectride™) (Table 3, 
Entry 11). A solution of (7E,9E)-3-keto-α-ionylideneacetonitrile (81) (3.0 g, 13  
mmol) in TBME (25 mL) was cooled down to -30°C under N2, a solution of K-
Selectride™ (20 mL of 1 M in THF, 20 mmol) in TBME (10 mL) was added 
dropwise in 40 min and the mixture was stirred at this temperature for 4 h. The 
reaction mixture was treated with 15 mL of 3 N NaOH followed by 15 mL of 30% 
H2O2 and stirred at R.T. for 30 min. The product was extracted with TBME (10 mL) 
and washed sequentially with brine and water, dried over Na2SO4, and evaporated to 
dryness to give a colorless oil. The product (2.9 g, 12 mmol, 96%) after column 
chromatography (hexane:acetone = 97:3) was shown by HPLC to consist of a mixture 
of (7E,9E)-3-hydroxy-α-ionylideneacetonitriles 77+78 (86%) and (7E,9E)-3-hydroxy-
α-ionylideneacetonitriles 79+80 (14%). These were identified by comparison of their 
HPLC retention times and UV spectra obtained by a photodiode array detector with 
those of authentic samples of these hydroxynitriles characterized earlier. 
Hydroxynitriles 77+78 and 79+80 were each shown by chiral HPLC (Eluent C) to 
consist of an approximately 1:1 mixture of enantiomers. 
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Reduction of 81 with Lithium tri-sec-Butylborohydride (L-Selectride™) (Table 
3, Entry 8). Ketonitrile 81 was reduced using the same general experimental 
procedure as described above. The product (94 mg, 0.41 mmol, 93%) was worked up 
as described earlier and was shown by HPLC to consist of (7E,9E)-3-hydroxy-α-
ionylideneacetonitriles 77+78 (55%) and (7E,9E)-3-hydroxy-α-
ionylideneacetonitriles 79+80 (45%). Hydroxynitriles 77+78 and 79+80 were each 
shown by chiral HPLC to consist of an approximately 1:1 mixture of enantiomers. 
 
Reduction of 81 with Sodium tri-sec-Butylborohydride (N-Selectride™) (Table 
3, Entry 9). The reaction was carried out and worked up as described in the general 
procedure to give a mixture of (7E,9E)-3-hydroxy-α-ionylideneacetonitriles 77+78 
(71%) and (7E,9E)-3-hydroxy-α-ionylidene-acetonitriles 79+80 (29%) [(94 mg, 0.41 
mmol, 92%)]. Hydroxynitriles 77+78 and 79+80 were each shown by chiral HPLC to 
consist of an approximately 1:1 mixture of enantiomers.    
 
Reduction of 81 with Potassium Trisiamylborohydride (KS-Selectride™) 
(Table 3, Entry 10). The reaction was carried out and worked up as described in the 
general procedure to give a mixture of (7E,9E)-3-hydroxy-α-ionylideneacetonitriles 
77+78 (69%) and (7E,9E)-3-hydroxy-α-ionylidene-acetonitriles 79+80 (31%) [(90 
mg, 0.39 mmol, 91%)]. Hydroxynitriles 77+78 and 79+80 were each shown by chiral 




Reduction of (7E,9E)-3-Keto-α-Ionylideneacetonitrile (81) to Hydroxynitriles 
(77 – 80) with (R)-2-Methyl-CBS-Oxazaborolidine (Table 3, Entry 12). To a 
solution of (R)-2-methyl-CBS-oxazaborolidine (0.3 mL 1M in toluene, 0.3 mmol) in 
TBME (4 mL) was added BH3.THF (0.3 mL 1M in THF, 0.3 mmol) at R.T. under N2. 
The mixture was stirred at R.T. for 20 min and was then cooled down to 0°C and 
treated with a solution of (7E,9E)-3-keto-α-ionylideneacetonitrile (81) (69 mg, 0.30 
mmol) in TBME (3 mL). After stirring the reaction mixture for 1.5 h at 0°C, HPLC 
(Eluent A, Appendix I) showed the complete reduction of 81. The reaction was 
quenched by slow addition of methanol (1 mL) and the product was diluted with 
TBME, washed with a saturated solution of NH4Cl, followed by 5% NaHCO3, and 
then brine. The organic layer was washed with water (10 mL), dried over Na2SO4, and 
evaporated to dryness. After purification by column chromatography purification 
(hexane:acetone = 97:3), the product (62 mg, 0.27 mmol, 90%) was shown by HPLC 
to consist of a mixture of (7E,9E)-3-hydroxy-α-ionylideneacetonitriles 77+78 (14%) 
and (7E,9E)-3-hydroxy-α-ionylideneacetonitriles 79+80 (86%). The hydroxynitriles 
77+78 and 79+80 were each shown by chiral HPLC to consist of an approximately 
1:1 mixture of enantiomers. 
 
Reduction 81 to 77 – 80 with (S)-2-Methyl-CBS-Oxazaborolidine (Table 3, 
Entry 13). The reduction was carried out using the same procedure described above. 
After work up, a colorless oil (65 mg, 0.28 mmol, 93%) was obtained that was shown 
by HPLC to consist of a mixture of (7E,9E)-3-hydroxy-α-ionylideneacetonitriles 
77+78 (25%) and (7E,9E)-3-hydroxy-α-ionylideneacetonitriles 79+80 (75%). The 
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hydroxynitriles 77+78 and 79+80 were each shown by chiral HPLC to consist of an 
approximately 1:1 mixture of enantiomers. 
 
Reduction of (7E,9E)-3-Hydroxy-α-Ionylideneacetonitrile (77 – 80) to (7E,9E)-
3-Hydroxy-α-Ionylideneacetaldehydes (73 – 76) with DIBAL-H.  A solution of 
hydroxynitriles 77+78 (86%) and 79+80 (14%) [2.3 g, 10 mmol] in CH2Cl2 (10 mL) 
was cooled down to -40°C under N2 and a 1M solution of DIBAL-H in CH2Cl2 (33 
mL, 33 mmol) was added dropwise in one hour. After the addition was completed, the 
reaction mixture was allowed to stir at -30°C for 1 h. The mixture was then treated 
with a very slow addition of a homogeneous mixture of 26 g of water absorbed on n-
silica (0.3 g of water/g of silica) at a rate that the temperature remained below -10°C 
[caution: the addition of silica/water results in rapid elevation of the temperature]. 
After the addition was completed, the reaction mixture was allowed to stir at 0°C for 
2 h. Na2SO4 (3 g) was added and the solids were filtered off and washed with CH2Cl2 
(20 mL). The organic layer was washed with water, dried over Na2SO4, and 
evaporated to dryness to give a pale yellow oil (2.7 g). Column chromatography 
(hexane:ethyl acetate, 95:5 to 80:20) of the product gave two fractions as 73+74 (1.2 
g, 4.9 mmol, 49%) and 75+76 (0.49 g,  2.1 mmol, 21%). 
trans-3-Hydroxy-α-ionylideneacetaldehydes (73+74): 1H NMR (400 MHz, 
CDCl3) δ 0.87 (s, 3H), 1.03 (s, 3H), 1.40 (dd, J = 13.3, 6.8, 1H), 1.62 (s, 3H), 1.85 (dd, 
J = 13.3, 5.8, 1H), 2.00 (d, J= 1.3, 1H), 2.26 (d, J = 1.0, 3H), 2.50 (d, J = 10, 1H), 
4.27 (s, 1H), 5.61 (s, 1H), 5.93 (d, J = 8.0, 1H), 6.02 (dd, J = 15.6, 10.0, 1H), 6.23 (d, 
J = 15.6, 1H), 10.12 (d, J = 8.0, 1H). 13C NMR (100 MHz, CDCl3) δ 13.3, 22.7, 24.4, 
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29.4, 34.1, 44.3, 55.0, 65.4, 125.3, 128.9, 133.6, 136.0, 136.3, 138.3, 153.9, 191.4. 
UV λmax = 280 nm (hexane). HRMS (EI+) calculated for C15H22O2 234.1620, found 
234.1706.  
cis-3-Hydroxy-α-ionylideneacetaldehydes (75+76): 1H NMR (400 MHz, CDCl3) 
δ 0.86 (s, 3H), 0.96 (s, 3H), 1.39 (dd, J = 12.3, 9.9, 1H), 1.63 (d, J = 0.8, 3H), 1.68 
(dd, J = 12.3, 6.4, 1H), 2.25 (d, J = 9.3, 1H), 2.25 (s, 3H), 4.26 (m, 1H), 5.55 (s, 1H), 
5.92 (d, J = 8.3, 1H), 6.11 (dd, J = 15.6, 9.3, 1H), 6.22 (d, J = 15.6, 1H), 10.11 (d, J = 
8.3, 1H). 13C NMR (100 MHz, CDCl3) δ 13.3, 22.5, 27.0, 29.2, 34.9, 40.8, 55.1, 66.4, 
125.6, 128.9, 135.0, 136.4, 139.2, 154.3, 191.5. UV λmax = 282 nm (hexane). MS 
(ESI+) calculated for C15H22O2 [M+H-H2O] + 217.1592, found 217.2000.  
 
One-Pot Reduction of (7E,9E)-3-Keto-α-Ionylideneacetonitrile (81) to 
Hydroxyaldehydes 73 – 76 with Potassium tri-sec-butylborohydride (K-
Selectride™) Followed by DIBAL-H. A solution of (7E,9E)-3-keto-α-
ionylideneacetonitrile (81) (1.2 g, 5.2 mmol) in TBME (10 mL) was cooled down to -
30°C under N2, A solution of K-Selectride™ (7.6 mL of 1 M in THF, 7.6 mmol) in 
TBME (5 mL) was added dropwise in 30 min and the mixture was stirred at this 
temperature and the course of the reaction was monitored by HPLC (Eluent A, 
Appendix I). After 2 h, 81 was shown by HPLC to have converted to a mixture of 
(7E,9E)-3-hydroxy-α-ionylideneacetonitriles 77+78 (86%) and (7E,9E)-3-hydroxy-α-
ionylideneacetonitriles 79+80 (14%). The reaction mixture was then treated with a 
1M solution of DIBAL-H in CH2Cl2 (13 mL, 13 mmol) dropwise in 30 minutes. After 
the addition was completed, the reaction mixture was allowed to stir at -20°C for 3 h. 
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The product was then treated with a very slow addition of a homogeneous mixture of 
20 g of water absorbed on n-silica (0.5 g of water/g of silica) at a rate that the 
temperature remained below -10°C [caution: the addition of silica/water results in 
rapid elevation of the temperature]. The reaction mixture was allowed to stir at 0°C 
for 2 h. Na2SO4 (3 g) was added and the solids were filtered off and washed with 
CH2Cl2 (20 mL). The organic layer was washed with water, dried over Na2SO4, and 
evaporated to dryness to give a pale yellow oil (1.9 g). Column chromatography 
(hexane:ethyl acetate, 95:5 to 80:20) of the product gave two fractions as 73+74 (0.94 
g, 4.0 mmol, 77%) and 75+76 (0.077 g,  0.33 mmol, 6%) that were shown by 1H-
NMR to be identical with previous characterized samples. 
 
Oxidative Degradation of (3R,3'R,6'R)-Lutein Diacetate to (3R,6R)-3-Hydroxy-
13-Apo-ε-Caroten-13-One (119) and (3R)-3-Hydroxy-β-Ionone (42).  
Preparation of (3R,3'R,6'R)-Lutein Diacetate. Naturally occurring (3R,3'R,6'R)-
lutein (1) was obtained from Kemin Health (Des Moines, Iowa) and converted to 
(3R,3'R,6'R)-lutein diacetate as follows. A solution of (3R,3'R,6'R)-lutein (1) (3.0 g, 
75% pure ≈ 2.3 g, 4.0 mmol) in 20 mL of THF was treated with pyridine (2.5 mL, 2.5 
g, 30 mmol) and acetic anhydride (2.5 mL, 2.7 g, 27 mmol) and the mixtue was 
heated at 45°C under N2 overnight. The product was partitioned between water (50 
mL) and hexane (50 mL). The organic layer was removed and washed sequentially 
with 50 mL of aqueous HCl (5%, v/v), 50 mL of saturated sodium bicarbonate 
solution, and water (50 mL). The organic layer was dried over Na2SO4 and evaporated 
to dryness to give a red solid which was purified by column chromatography on n-
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silica (hexane:acetone, from 90:10 to 70:30) to give lutein diacetate (2.3 g, 3.5 mmol; 
89%). 
Oxidative Degradation of (3R,3'R,6'R)-Lutein Diacetate. A solution of 
(3R,3'R,6'R)-lutein diacetate (1.0 g, 1.5 mmol) in ethyl acetate (30 mL) was cooled 
down in an ice-salt bath to 0°C under N2 and was treated with a 70% solution of 
TBHP in water (2.7 mL, 2.4 g 70% ≈ 1.7 g, 19 mmol). Household bleach containing 
5.25% NaOCl (8.8 g, 0.46 g NaOCl, 6.2 mmol) was then added over a period of 20 
min at 0°C. After the addition was completed, the reaction mixture was allowed to 
warm up to R.T. and stirred for 3 h. The organic layer was removed and the water 
layer was washed with EtOAc (2 X 100 mL). The combined organic layer was 
washed with water (2 X 150 mL), dried over Na2SO4, and evaporated to dryness. The 
residue was dissolved in dichloromethane (30 mL) and saponified with KOH/MeOH 
(30 mL, 10%, wt/v) at R.T. under N2. After 2 h, the product was washed with water (3 
X 100 mL), dried over Na2SO4, and evaporated to dryness. Purification by column 
chromatography on n-silica (hexane:acetone, from 95:5 to 70:30) followed by 
semipreparative HPLC (Eluent A) afforded two major products which were fully 
characterized from their UV-Vis, CD, 1H- and 13C-NMR, and mass spectra as 
(3R,6R)-3-hydroxy-13-apo-ε-caroten-13-one (119) and (3R)-3-hydroxy-β-ionone (3R-
42). 
(3R,6R)-3-Hydroxy-13-apo-ε-caroten-13-one (119): 1H NMR (400 MHz, CDCl3) 
 δ 0.84 (s, 3H), 0.99 (s, 3H), 1.37 (dd, J = 13.3, 6.8, 1H), 1.60 (s, 3H), 1.82 (dd, J = 
13.3, 6.0, 1H), 1.99 (s, 3H), 2.28 (s, 3H), 2.43 (d, J = 9.5, 1H), 4.24 (s, 1H), 5.56 (s, 
1H), 5.68 (dd, J = 15.6, 10.0, 1H), 6.16 (d, J = 15.3, 1H), 6.16 (m, 2H), 7.52 (dd, J = 
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11.8, 15.3, 1H). 13C NMR (100 MHz, CDCl3) δ 13.4, 22.7, 24.2, 27.6, 29.4, 34.0, 
44.4, 54.9, 65.6, 125.0, 127.7, 129.7, 133.6, 136.8, 136.9, 139.0, 144.4, 198.5. UV 
λmax = 322 nm (hexane). CD: 320 nm (10.6 mdeg). MS (ESI+) calculated for C18H26O2 
[M+Na]+ 297.1830, found 297.1720. 
(3R)-3-Hydroxy-β-ionone (3R-42): 1H NMR (400 MHz, CDCl3) δ 1.11 (s, 3H), 
1.12 (s, 3H), 1.25 (s, 1H), 1.49 (t, J = 12.0, 1H), 1.77 (s, 3H), 1.80 (dd, J = 2.0, 3.6, 
1H), 2.09 (dd, J = 9.5, 17.5, 1H), 2.30 (s, 3H), 2.43 (dd, J = 5.6, 17.5, 1H), 4.00 (m, 
1H), 6.11 (d, J = 16.5, 1H), 7.21 (d, J = 16.5, 1H). 13C NMR (100 MHz, CDCl3) 
δ 21.6, 27.3, 28.5, 30.0, 36.9, 42.7, 48.4, 64.5, 132.3, 135.6, 142.3, 198.6. UV λmax = 
290 nm (ethanol). MS (FAB+) calculated for C13H20O2 [M+H]+ 208.1541, found 
209.1312. CD: 310 nm (2.98 mdeg), 270 nm (-2.87 mdeg). 
 
Enzyme-Mediated Acylation of (7E,9E)-3-Hydroxy-α-Ionylidene-acetaldehydes 
73+74 with Lipase AK (pseudomonas fluorescens). To a solution of (7E,9E)-3-
hydroxy-α-ionylideneacetaldehydes 73+74 (2.4 g, 10.32 mmol) in 20 mL of pentane 
was added 1.5 g of lipase AK (pseudomonas fluorescens) and vinyl acetate (2.84 mL, 
2.65 g, 30.78 mmol). The mixture was refluxed (35-36°C) under N2 and the course of 
the enzymatic acylation was monitored by chiral HPLC (Eluent D, Appendix I). After 
48 h, the product was filtered through celite and the filtrate was evaporated to dryness 
to give a yellow oil (2.7 g). Column chromatography (hexane:ethyl acetate, 98:2 to 
85:15) of the product gave two major fractions.  
Without characterization, the first fraction was dissolved in CH2Cl2 (25 mL) and 
treated with KOH/MeOH (2.3 mL, 10% wt/v) for 2 h at 0°C. The product was washed 
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with water (3 X 50 mL), dried over Na2SO4, and evaporated to dryness. The product 
was fully characterized from its UV, CD, 1H- and 13C-NMR, and mass spectra as 
(3S,6S)-3-hydroxy-α-ionylideneacetaldehyde (74) (1.0 g, 4.3 mmol; 97%). The 
optical purity of 74 (93% ee) was established by chiral HPLC. 
The second fraction was fully characterized from its UV, CD, 1H- and 13C-NMR, 
and mass spectra as (3R,6R)-3-hydroxy-α-ionylideneacetaldehyde (73) (1.0 g, 4.4 
mmol, 43%). The optical purity of 73 (94% ee) was established by chiral HPLC. 
The absolute configuration of hydroxyaldehydes 73 and 74 was assigned by 
comparison of their 1H NMR and CD spectra with those of the standard C18-ketone 
119 prepared by oxidative degradation of (3R,3'R,6'R)-lutein (1). 
(3R,6R)-3-Hydroxy-α-ionylideneacetaldehyde (73): 1H NMR (400 MHz, CDCl3) 
δ 0.87 (s, 3H), 1.03 (s, 3H), 1.40 (dd, J = 13.3, 6.8, 1H), 1.62 (s, 3H), 1.85 (dd, J = 
13.3, 5.8, 1H), 2.0 (d, J = 1.3, 1H), 2.26 (d, J = 1, 3H), 2.50 (d, J = 10, 1H), 4.27 (s, 
1H), 5.61 (s, 1H), 5.93 (d, J = 8.0, 1H), 6.01 (dd, J = 15.6, 10, 1H), 6.23(d, J = 15.6, 
1H), 10.12 (d, J = 8.0, 1H). 13C NMR (100 MHz, CDCl3) δ 13.3, 22.7, 24.4, 29.4, 
34.1, 44.3, 55.0, 65.4, 125.3, 128.9, 136.0, 136.3, 138.3, 153.9, 191.4. UV λmax = 280 
nm (hexane). HRMS (EI+) calculated for C15H22O2 234.1620, found 234.1706. CD: 
281 nm (18 mdeg), 242 nm (-1.3 mdeg). 
(3S,6S)-3-Hydroxy-α-ionylideneacetaldehyde (74): 1H-NMR and 13C-NMR, UV, 
and   Mass spectra of 74 were identical with those of 73. CD: 281 nm (-13 mdeg), 242 




Enzyme-Mediated Acylation of (7E,9E)-3-Hydroxy-α-Ionylideneacetaldehydes 
75+76 with Lipase AK (pseudomonas fluorescens). To a solution of (7E,9E)-3-
hydroxy-α-ionylideneacetaldehydes 75+76 (0.84 g, 3.6 mmol) in 20 mL of pentane 
was added 0.58 g of lipase AK (pseudomonas fluorescens) and vinyl acetate (1.4 mL, 
1.3 g, 15 mmol). The mixture was refluxed (35-36°C) under N2 and the course of the 
enzymatic acylation was monitored by chiral HPLC (Eluent D, Appendix I). After 50 
h, the product was filtered through celite and the filtrate was evaporated to dryness to 
give a yellow oil (1.0 g). Column chromatography (hexane:ethyl acetate, 98:2 to 
85:15) of the product gave two major fractions. 
Without characterization, the first fraction was dissolved in CH2Cl2 (25 mL) and 
hydrolyzed with KOH/MeOH (0.80 mL, 10% wt/v) for 2 h at 0°C. After work up, the 
product was fully characterized from its UV, CD, 1H- and 13C-NMR, and mass spectra 
as (3S,6R)-3-hydroxy-α-ionylideneacetaldehyde (75) (0.27 g, 1.1 mmol; 99%). The 
optical purity of 75 (91% ee) was established by chiral HPLC. 
The second fraction was similarly characterized from its UV, CD, 1H- and 13C-
NMR, and mass spectra as (3R,6S)-3-hydroxy-α-ionylideneacetaldehyde (76) (0.31 g, 
1.3 mmol, 37%). The optical purity of 76 (92% ee) was established by chiral HPLC. 
The absolute configuration of hydroxyaldehydes 75 and 76 was assigned from 
comparison of their 1H NMR and CD spectra with those of C18-ketone 119. 
(3S,6R)-3-Hydroxy-α-ionylideneacetaldehyde (75): 1H NMR (400 MHz, CDCl3) 
δ 0.86 (s, 3H), 0.96 (s, 3H), 1.39 (dd, J = 12.3, 9.8, 1H), 1.63 (s, 3H), 1.68 (dd, J = 
12.3, 6.3, 1H), 2.25 (d, J = 9.3, 1H), 2.25 (s, 3H), 4.25 (m, 1H), 5.55 (s, 1H), 5.92 (d, 
J = 8.3, 1H), 6.11 (dd, J = 15.6, 9.3, 1H), 6.22 (d, J = 15.6, 1H), 10.11 (d, J = 8.3, 1H). 
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13C NMR (100 MHz, CDCl3) δ 13.2, 22.5, 27.0, 29.2, 34.9, 40.8, 55.1, 66.4, 125.6, 
128.9, 135.0, 136.4, 139.2, 154.3, 191.5. UV λmax = 282 nm (hexane). MS (ESI+) 
calculated for C15H22O2 [M+H-H2O]+ 217.1592, found 217.2010. CD: 280 nm (17.8 
mdeg). 
(3R,6S)-3-Hydroxy-α-ionylideneacetaldehyde (76): 1H-NMR and 13C-NMR, UV, 
and   Mass spectra were identical with those of 75. CD: 280 nm (-7 mdeg).  
 
Epimerization of (3R,6R)-3-Hydroxy-α-Ionylideneacetaldehydes (73) to 
(3S,6R)-3-Hydroxy-α-Ionylideneacetaldehydes (75). To a solution of optically pure 
hydroxyaldehyde 73 (3.2 mg, 0.014 mmol) in 1mL acetone and 0.5 mL H2O was 
added 0.12 mL of 0.1N HCl. The mixture was stirred at R.T. for 28 hours when 
HPLC (Eluent A, Appendix I) showed that an equilibrium had established between 73 
(32%) and hydroxyaldehyde 75 (68%). The product was washed with water (2 X 10 
mL), dried over Na2SO4, and evaporated to dryness. Purification by semipreparative 
HPLC (Eluent A) afforded two major products which were characterized by 1H-NMR 
and CD as 73 and 75. 
 
Epimerization of (3S,6R)-3-Hydroxy-α-Ionylideneacetaldehydes (75) to 
(3R,6R)-3-Hydroxy-α-Ionylideneacetaldehydes (75). To a solution of optically pure 
hydroxyaldehyde 73 (4.7 mg, 0.020 mmol) in 1mL acetone and 0.5 mL H2O was 
added 0.24 mL of 0.1 N HCl. The mixture was stirred at R.T. for 28 hours when 
HPLC (Eluent A, Appendix I) showed that the reaction had reached an equilibrium 
between hydroxyaldehyde 73 (31%) and hydroxyaldehyde 75 (69%). The product was 
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washed with water (2 X 10 mL), dried over Na2SO4, and evaporated to dryness. 
Purification by semipreparative HPLC (Eluent A) afforded two major products which 
were characterized by 1H-NMR and CD as 73 and 75. 
 
General Procedure for the Synthesis of C25-Hydroxyaldehydes 64 – 67. 
Synthesis of (3R,6R)-3-Hydroxy-12'-Apo-ε-Caroten-12'-Al (64). A solution of 
(3R,6R)-3-hydroxy-α-ionylideneacetaldehyde (73) (0.25 g, 1.1 mmol) in MeOH (3 
mL) was treated with a solution of the protected Wittig salt 72 (0.82 g, 1.7 mmol) in 
methanol (2 mL) at R.T. under N2. 1 mL of a 0.42 M solution of NaOMe (0.42 mmol) 
in MeOH (freshly prepared from Na in MeOH) was added and the mixture was stirred 
at R.T. for 4 h. The product was partitioned between water (50 mL) and CH2Cl2 (30 
mL), the organic layer was removed, and the water layer was extracted with CH2Cl2 
(20 mL). The combined organic layer was washed with water (2 X 30 mL), dried over 
Na2SO4, and evaporated to dryness to give a red solid (1.3 g). The red solids were 
dissolved in acetone (4 mL) and water (1 mL) and stirred with 75 µL of 0.3 N HCl for 
1 h at R.T. under N2. The product was extracted with CH2Cl2, and sequentially 
washed with saturated solution of NaHCO3 and water, dried over Na2SO4, and 
evaporated to dryness to give a red oil. Column chromatography (hexane:ethyl acetate, 
95:5 to 80:20) gave a red solid that was identified from its UV-visible, CD, 1H- and 
13C-NMR, and mass spectra as (3R,6R)-3-hydroxy-12'-apo-ε-caroten-12'-al (64) (0.33 
g, 0.91 mmol; 85%). 
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Following the above procedure, (3S,6S)-3-hydroxy-12'-apo-ε-caroten-12'-al (65, 
61%), (3S,6R)-3-hydroxy-12'-apo-ε-caroten-12'-al (66, 53%), and (3R,6S)-3-hydroxy-
12'-apo-ε-caroten-12'-al (67, 69%) were similarly prepared. 
(3R,6R)-3-Hydroxy-12'-apo-ε-caroten-12'-al (64): 1H NMR (400 MHz, CDCl3) 
δ 0.86 (s, 3H), 1.00 (s, 3H), 1.38 (dd, J = 13.3, 6.9, 1H), 1.63 (dd, J = 2.3, 1.6, 3H), 
1.85 (dd, J = 13.3, 5.9, 1H), 1.89 (d, J = 0.7, 3H), 1.94 (d, J = 0.9, 3H), 2.04 (s, 3H), 
2.43 (d, J = 9.9, 1H), 4.26 (s, 1H), 5.50 (dd, J = 15.4, 9.9, 1H), 5.56 (d, J = 1.4, 1H), 
6.16 (d, J = 15.4, 2H), 6.31 (d, J = 11.9, 1H), 6.38 (d, J = 15.0, 1H), 6.69 (dd, J = 14.4, 
11.5, 1H), 6.76 (dd, J = 15.0, 11.3, 1H), 6.97 (d, J = 11.5, 1H), 7.03 (dd, J = 11.9, 
14.4, 1H), 9.46 (s, 1H). 13C NMR (100 MHz, CDCl3) δ 9.6, 13.0, 13.2, 22.8, 24.2, 
29.5, 34.0, 44.6, 55.0, 65.9, 124.6, 127.4, 130.0, 130.3, 131.0, 136.7, 136.9, 137.0, 
137.5, 137.7, 141.6, 148.9, 194.5. UV/Vis λmax = 416 nm (ethanol). MS (ESI+) 
calculated for C25H34O2 [M+H]+ 367.2637, found 367.2091. CD: 292 nm (+5.82 
mdeg), 236 nm (+5.32 mdeg), 212 nm (+4.54 mdeg). 
(3S,6S)-3-Hydroxy-12'-apo-ε-caroten-12'-al (65): 1H NMR (400 MHz, CDCl3) 
δ 0.86 (s, 3H), 1.01 (s, 3H), 1.38 (dd, J = 13.3, 6.9, 1H), 1.63 (s, 3H), 1.85 (dd, J = 
13.3, 5.8, 1H), 1.89 (s, 3H), 1.94 (s, 3H), 2.04 (s, 3H), 2.43 (d, J = 9.9, 1H), 4.26 (s, 
1H), 5.51 (dd, J = 15.4, 9.9, 1H), 5.56 (s, 1H), 6.16 (d, J = 15.4, 2H), 6.31 (d, J = 11.9, 
1H), 6.38 (d, J = 15.0, 1H), 6.70 (dd, J = 14.4, 11.6, 1H), 6.77 (dd, J = 15.0, 11.3, 1H), 
6.97 (d, J = 11.7, 1H), 7.04 (dd, J = 14.4, 12.0, 1H), 9.46 (s, 1H). 13C NMR (100 MHz, 
CDCl3) δ 9.6, 13.0, 13.2, 22.8, 24.3, 29.5, 34.0, 44.6, 55.0, 65.9, 124.6, 127.4, 130.0, 
130.4, 131.0, 136.7, 137.0, 137.5, 137.7, 141.6, 148.9, 194.5. UV/Vis λmax = 416 nm 
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(ethanol). MS (ESI+) calculated for C25H34O2 [M+H]+ 367.2637, found 367.2235 
[M+H+]; CD: 292 nm (-4.32 mdeg), 238 nm (-4.86 mdeg), 210 nm (-4.72 mdeg).  
(3S,6R)-3-Hydroxy-12'-apo-ε-caroten-12'-al (66): 1H NMR (400 MHz, CDCl3) 
δ 0.86 (s, 3H), 0.95 (s, 3H), 1.40 (dd, J = 12.6, 9.8, 1H), 1.65 (s, 3H), 1.66 (m, 1H), 
1.89 (s, 3H), 1.94 (s, 3H), 2.04 (s, 3H), 2.18 (d, J = 9.4, 1H), 4.25 (m, 1H), 5.50 (s, 
1H), 5.61 (dd, J = 15.6, 9.4, 1H), 6.15 (d, J = 15.6, 1H), 6.16 (d, J = 10.8, 1H), 6.31 (d, 
J = 11.9, 1H), 6.37 (d, J = 15.2, 1H), 6.69 (dd, J = 14.8, 11.8, 1H), 6.76 (dd, J = 15.2, 
10.8, 1H), 6.97 (d, J = 11.8, 1H), 7.03 (dd, J = 14.8, 11., 1H), 9.46 (s, 1H). 13C NMR 
(100 MHz, CDCl3) δ 9.6, 13.0, 13.2, 14.1, 22.6, 27.0, 29.3, 34.8, 40.9, 55.0, 66.7, 
124.6, 127.4, 127.5, 130.4, 130.9, 131.0, 136.5, 136.6, 136.9, 137.1, 137.7, 137.8, 
141.6, 148.9, 194.5. UV/Vis λmax = 418 nm (ethanol). MS (ESI+) calculated for 
C25H34O2 [M-H]- 365.2480, found 365.2053. CD: 402 nm (+3.73 mdeg), 235 nm 
(+8.57 mdeg). 
(3R,6S)-3-Hydroxy-12'-apo-ε-caroten-12'-al (67): 1H NMR (400 MHz, CDCl3) 
δ 0.86 (s, 3H), 0.96 (s, 3H), 1.40 (dd, J = 12.8, 9.8, 1H), 1.64 (m, 1H), 1.65 (t, J = 1.6, 
3H), 1.89 (d, J = 0.8, 3H), 1.94 (d, J = 0.8, 3H), 2.04 (s, 3H), 2.18 (d, J = 9.3, 1H), 
4.25 (m, 1H), 5.50 (s, 1H), 5.61 (dd, J = 15.4, 9.3, 1H), 6.15 (d, J = 15.4, 1H), 6.16 (d, 
J = 11.0, 1H), 6.31 (d, J = 11.9, 1H), 6.38 (d, J = 15.0, 1H), 6.69 (dd, J = 14.4, 11.7, 
1H), 6.77 (dd, J = 15.0, 11.0, 1H), 6.97 (d, J = 11.7, 1H), 7.04 (dd, J = 14.4, 11.9, 1H), 
9.46 (s, 1H). 13C NMR (100 MHz, CDCl3) δ 9.6, 13.0, 13.2, 14.1, 22.6, 27.0, 29.3, 
34.8, 41.0, 55.0, 66.8, 124.6, 127.4, 127.5, 130.4, 130.9, 131.0, 136.5, 136.6, 136.9, 
137.1, 137.7, 137.8, 141.6, 148.9, 194.5. UV/Vis λmax = 416 nm (ethanol). MS (ESI+) 
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calculated for C25H34O2 [M-H]- 365.2480, found 365.1954 [M-H-]. CD: 406 nm (-4.32 
mdeg), 235 nm (-11.23 mdeg). 
 
General Procedure for the Synthesis of Luteins 1 – 4.  
Synthesis of (3R,3'R,6'R)-Lutein (1). A solution of (3R,6R)-3-hydroxy-12'-apo-ε-
caroten-12'-al (64) (0.26 g, 0.70 mmol) and (3R)-3-hydroxy-(β-ionylideneethyl)- 
triphenylphosphonium chloride [(3R)-16] (0.41 g, 0.79 mmol) in CH2Cl2 (5 mL) was 
cooled down to -5°C under N2. A solution of KOH (0.13 g, 2.3 mmol) in H2O (0.5 
mL) was added and the mixture was stirred for 0.5 h at -5°C and 3 h at R.T. 
Dichloromethane (20 mL) was added, and the product was washed with water (3 X 10 
mL). The organic layer was removed, dried over Na2SO4, and evaporated to dryness 
to give 1 g of a red oil. The crude product was thermally isomerized by refluxing in 
ethyl acetate for 4h under N2. After solvent evaporation, the product was purified by 
column chromatography (hexane:ethylacetate, from 90:10 to 50:50) to give a red solid 
that was crystallized from hexane:acetone = 4:1 and identified from its UV-visible, 
CD, 1H- and 13C-NMR, and mass spectra as (3R,3'R,6'R)-Lutein (1) (0.29 g, 0.52 
mmol; 74%). 
Following the above procedure, (3R,3'S,6'S)-lutein (2, 82%), (3R,3'S,6'R)-lutein or 
3'-epilutein (3, 85%), and (3R,3'R,6'S)-lutein (4, 80%) were similarly prepared. 
(3R,3'R,6'R)-Lutein (1): m.p. 132-134°C, 1H NMR (400 MHz, CDCl3) δ 0.86 (s, 
3H), 1.01 (s, 3H), 1.08 (s, 6H), 1.37 (dd, J = 13.1, 6.7, 1H), 1.49 (t, J = 12.3, 1H), 
1.63 (s, 3H), 1.74 (s, 3H), 1.78 (dd, J = 12.3, 2.8, 1H), 1.85 (dd, J = 13.1, 5.8, 1H), 
1.92 (s, 3H), 1.97 (s, 9H), 2.05 (d, J =  16.3, 9.7, 1H), 2.40 (dd, J = 16.3, 6.7, 1H), 
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2.41 (d, J = 9.9, 1H), 4.01 (m, 1H), 4.26 (s, 1H), 5.44 (dd, J = 15.5, 9.9, 1H), 5.55 (s, 
1H), 6.12 (m, 2H), 6.17 (m, 3H), 6.26 (m, 2H), 6.37 (m, 2H), 6.63 (m, 4H). 13C NMR 
(100 MHz, CDCl3) δ 12.8, 13.1, 21.6, 22.9, 24.3, 28.7, 29.5, 30.3, 34.0, 37.1, 42.6, 
44.6, 48.4, 54.9, 65.1, 65.9, 124.5, 124.8, 124.9, 125.6, 126.2, 128.7, 130.0, 130.1, 
130.8, 131.3, 132.6, 135.1, 135.7, 136.5, 137.6, 137.7, 138.0, 138.5. UV/Vis λmax = 
444 nm (ethanol). HRMS (ESI+) calculated for C40H56O2 568.8714, found 568.5973. 
CD: 284 nm (-1.26 mdeg), 246 nm (+2.67 mdeg), 212 nm (+3.75 mdeg). 
(3R,3'S,6'S)-Lutein (2): m.p. 128-130°C,1H NMR (400 MHz, CDCl3) δ 0.86 (s, 
3H), 1.01 (s, 3H), 1.08 (s, 6H), 1.37 (dd, J = 13.2, 6.9, 1H), 1.49 (t, J = 11.8, 1H), 
1.63 (s, 3H), 1.74 (s, 3H), 1.78 (dd, J = 11.8, 2.8, 1H), 1.85 (dd, J = 13.2, 5.8, 1H), 
1.92 (s, 3H), 1.98 (s, 9H), 2.05  (dd, J = 16.4, 9.7, 1H), 2.40 (dd, J = 16.4, 6.8, 1H), 
2.41 (d, J = 9.9, 1H), 4.01 (m, 1H), 4.26 (s, 1H), 5.44 (dd, J = 15.5, 9.9, 1H), 5.56 (s, 
1H), 6.13 (m, 2H), 6.17 (m, 3H), 6.27 (m, 2H), 6.37 (m, 2H), 6.64 (m, 4H). 13C NMR 
(100 MHz, CDCl3) δ 12.7, 12.8, 13.1, 21.6, 22.9, 24.3, 28.7, 29.5, 30.2, 34.0, 37.1, 
42.5, 44.6, 48.4, 54.9, 65.1, 65.9, 124.5, 124.8, 124.9, 125.6, 126.2, 128.7, 130.0, 
130.1, 130.8, 131.3, 132.6, 135.1, 135.7, 136.4, 136.5, 137.6, 137.7, 138.0, 138.5. 
UV/Vis λmax = 446 nm (ethanol). HRMS (ESI+) calculated for C40H56O2 568.8714, 
found 568.6036. CD: 272 nm (-6.19 mdeg), 238 nm (+0.41 mdeg), 214 nm (-4.73 
mdeg).   
(3R,3'S,6'R)-Lutein (3): m.p. 125-127°C, 1H NMR (400 MHz, CDCl3) δ 0.86 (s, 
3H), 0.95 (s, 3H), 1.08 (s, 6H), 1.42 (dd, J = 11.8, 3.5, 1H), 1.49 (t, J = 11.9, 1H), 1.65 
(s, 3H), 1.75 (s, 3H), 1.78 (m, 1H), 1.85 (dd, J = 12.7, 7.0, 1H), 1.98 (s, 9H), 2.06 (dd, 
J = 16.0, 10.9, 1H), 2.17 (d, J = 9.4, 1H), 2.40 (dd, J = 16.0, 5.0, 1H), 4.01 (m, 1H), 
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4.24, (m, 1H), 5.49 (s, 1H), 5.54 (dd, J = 15.4, 9.4, 1H), 6.14 (m, 3H), 6.26 (d, 2H), 
6.36 (m, 2H), 6.63 (m, 4H). 13C NMR (100 MHz, CDCl3) δ 12.8, 13.1, 21.6, 22.6, 
27.0, 28.7, 29.3, 30.3, 34.8, 37.1, 41.0, 42.5, 48.4, 55.0, 65.1, 66.8, 124.4, 124.8, 
124.9, 125.6, 126.2, 128.5, 129.8, 130.1, 130.8, 131.3, 132.5, 132.6, 135.3, 
135.7,136.5, 136.7, 137.5, 137.6, 137.7, 138.0, 138.5. UV/Vis λmax = 446 nm 
(ethanol). HRMS (ESI+) calculated for C40H56O2 [M+H]+ 568.8714, found 568.4256. 
CD: 333 nm (+1.79 mdeg), 280 nm (-2.71 mdeg), 242 nm (+4.92 mdeg). 
(3R,3'R,6'S)-Lutein (4): m.p. 123-125°C, 1H NMR (400 MHz, CDCl3) δ 0.86 (s, 
3H), 0.95 (s, 3H), 1.08 (s, 6H), 1.41 (m, 1H), 1.49 (t, J = 11.9, 1H) 1.65 (s, 3H), 1.75 
(s, 3H), 1.80 (m, 1H), 1.92 (m, 1H), 1.98 (s, 9H), 2.05 (dd, J = 16.6, 9.0, 1H), 2.17 (d, 
J = 9.4, 1H), 2.40 (dd, J = 16.6, 5.5, 1H), 4.01 (m, 1H), 4.24, (m, 1H), 5.50 (s, 1H), 
5.54 (dd, J = 15.4, 9.4, 1H), 6.16 (m, 5H), 6.26 (d, 2H), 6.36 (m, 2H), 6.63 (m, 4H). 
13C NMR (100 MHz, CDCl3) δ 12.8, 13.1, 21.6, 22.6, 27.0, 28.7, 29.3, 30.3, 34.8, 
37.1, 41.0, 42.5, 48.4, 55.0, 65.1, 66.8, 124.4, 124.8, 125.6, 126.2, 129.8, 130.1, 
130.8, 131.3, 132.5, 132.6, 135.3, 135.7,136.5, 136.7, 137.5, 137.6, 137.7, 138.5. 
UV/Vis λmax = 446 nm (ethanol). HRMS (ESI+) calculated for C40H56O2 [M+H]+ 
568.8714, found 568.3536. CD: 328 nm (-2.08 mdeg), 266 nm (-5.03 mdeg), 238 nm 
(-5.78 mdeg). 
 
Preparation of (±)-α-Ionone Ketal (125). Freshly distilled (±)-α-ionone (23 g, 
0.11 mol) was transferred into a 250 mL three necked flask with 10 mL hexane and 
was treated with ethylene glycol (18 mL, 0.32 mol) and trimethylorthoformate (14 
mL, 0.13 mol). p-Toluenesulfonic acid (0.29 g, 1.5 mmol) was added and the mixture 
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was stirred at R.T. under nitrogen overnight. The progress of the reaction was 
monitored by NMR. The product was partitioned between water and hexane, and the 
organic layer was washed water (3 X 300 mL), dried over Na2SO4, and evaporated to 
dryness to yield a 29.7 g pale yellow oil. The product was identified by NMR as (±)-
α-Ionone Ketal (125) and was used in the next step without purification. 1H NMR 
(400MHz, CDCl3) δ 0.81 (s, 3H), 0.88 (s, 3H), 1.17 (m, 1H), 1.41 (dd, J = 13.2, 7.9, 
1H), 1.47 (s, 3H), 1.57 (m, 3H),  1.99 (m, 2H), 2.11 (d, J = 9.7, 1H), 3.86 (m, 2H), 
3.96 (m, 2H), 5.38 (d, J = 15.4, 1H), 5.40 (s, 1H), 5.61 (dd, J = 15.4, 9.7, 1H). These 
NMR data were in agreement with the published data.96 
 
Oxidation of (±)-α-Ionone Ketal (125) to (±)-3-Keto-α-Ionone Ketal (124). (±)-
α-Ionone ketal (125) (29.7 g, 12.6 mmol) from preceding experiment was transferred 
into a 1 L three-necked flask using acetonitrile (105 mL, 82.5 g, 2.00 mol). K2CO3 
(1.8 g, 13 mmol) was added and the mixture was cooled down in an ice-salt bath to 
0°C under N2. A 70% solution of TBHP in water (108 mL, 97.2 g 70% ≈ 68.0 g, 0.755 
mol) was added dropwise to the mixture under N2 at 0°C in 30 min. Household bleach 
containing 5.25% NaOCl (356 g, 18.7 g NaOCl, 0.251 mol) was then added over a 
period of 8 h at -5 to 0°C. After the addition was completed, the reaction mixture was 
stirred at 0°C for an additional hour. The product was treated with 2g NaHCO3 at 0°C 
and then extracted with hexane (2 X 150 mL). The combined organic layer was 
washed with water (3 X 150 mL), dried over Na2SO4, and evaporated to dryness to 
give 30.3 g of pale yellow oil. The crude product was purified by column 
chromatography (hexane: ethyl acetate, from 98:2 to 85:15) to yield (±)-3-keto-α-
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ionone ketal (124) (19.0 g, 91.0 mmol, 83%) as a pale yellow oil. 1H NMR (400 MHz, 
CDCl3) δ 0.94 (s, 3H), 1.01 (s, 3H), 1.45 (s, 3H), 1.87 (m, 3H), 2.07 (d, J = 16.6, 1H), 
2.32 (d, J = 16.6, 1H), 2.53 (d, J = 9.3, 1H), 3.83 (m, 2H), 3.96 (m, 2H), 5.55 (d, J = 
15.4, 1H), 5.70 (dd, J = 15.4, 9.3, 1H), 5.89 (d, J = 0.7, 1H). 13C NMR (100 MHz, 
CDCl3) δ 23.3, 25.0, 27.0, 27.8, 36.0, 47.5, 54.9, 64.4, 106.9, 125.9, 127.6, 134.9, 
161.3, 198.9. MS (FAB+) calculated for C15H22O3 [M+H]+ 251.1647, found 251.1650. 
 
Reduction of (±)-3-Keto-α-Ionone Ketal (124) with NaBH4 (Table 4, Entry 1). 
To a solution of (±)-3-keto-α-ionone ketal (124) (16 g, 66 mmol) in 100 mL ethanol 
was added NaBH4 (3.8 g, 99 mmol) at 10°C. The mixture was kept at 10°C and 
allowed to warm up to room temperature, stirred for 4 h, and the product was 
partitioned between water (400 mL) and ethyl acetate (150 mL). The organic layer 
was removed and the aqueous layer was extracted with 100 mL of ethyl acetate. The 
combined organic layer was washed with brine and water, dried over Na2SO4, and 
evaporated to dryness. The crude product (10 g) was deprotected in the following step 
without purification.  
General Procedure for Deprotection of (±)-3-hydroxy-α-ionone ketal. The 
deprotection of (±)-3-hydroxy-α-ionone ketal to (±)-3-hydroxy-α-ionone (120 – 123) 
was carried out according to the following general procedure in all subsequent 
reduction reactions.  
The crude product (10 g) was transferred into a 500 mL round bottom flask with 
100 mL acetone and 20 mL water and the mixture was kept under nitrogen. The 
solution was treated with 16.5 mL of 0.3N HCl with dropwise addition in 10 minutes 
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and stirred at R.T. for 3 h. The course of the reaction was monitored by NMR. The 
crude (±)-3-hydroxy-α-ionone (120 – 123) was partitioned between 300 mL water and 
150 mL ethyl acetate. The organic layer was washed with saturated NaHCO3, dried 
over Na2SO4, and evaporated to dryness to obtain 13.1 g of a yellow oil. After work 
up, two fractions were obtained that were separated by column chromatography 
(hexane: acetone, from 95:5 to 85:15) and identified as trans-3-hydroxy-α-ionone 
(120+121) (4.0 g, 19 mmol, 30%) and cis-3-hydroxy-α-ionone (122+123) (3.9 g, 19 
mmol, 28%) in diastereomeric ratio of 1:1 (1.6 g, 7.7 mmol; 77%). 
120+121: 1H NMR (400 MHz, CDCl3) δ 0.89 (s, 3H), 1.03 (s, 3H), 1.41 (dd, J = 
13.5, 6.4, 1H), 1.53 (s, 1H), 1.62 (m, 3H), 1.84 (dd, J = 13.5, 5.9, 1H), 2.26 (s, 3H), 
2.50 (d, J = 10.2, 1H), 4.27 (m, 1H), 5.63 (m, 1H), 6.10 (d, J = 15.6, 1H), 6.54 (dd, J 
= 15.6, 10.2, 1H). 13C NMR (100 MHz, CDCl3) δ 22.6, 24.6, 27.2, 29.3, 33.8, 43.8, 
54.3, 65.4, 125.8, 133.6, 135.4, 135.2, 147.1, 198.1. UV λmax = 226 nm (hexane). 
HRMS (EI) m/z calculated for C13H18O2 206.1307, found 206.1331. 
122+123: 1H NMR (400 MHz, CDCl3) δ 0.87 (s, 3H), 0.96 (s, 3H), 1.39 (dd, J = 
12.9, 9.8, 1H), 1.61 (t, J = 1.5, 3H), 1.68 (dd, J = 12.9, 6.5, 1H), 1.92 (s, 1H), 2.25 (s, 
3H), 2.26 (d, J = 9.6, 1H), 4.24 (m, 1H), 5.58 (s, 1H), 6.06 (d, J = 15.9, 1H), 6.63 (dd, 
J = 15.9, 9.6, 1H). 13C NMR (100 MHz, CDCl3) δ 22.3, 26.9, 29.0, 34.9, 40.6, 54.2, 
66.3, 126.4, 132.6, 134.0, 135.2, 147.8, 198.5. UV λmax = 226 nm (hexane). MS was 
identical to that of 120+121. 
 
Reduction of (±)-3-Keto-α-Ionone Ketal (124) with NaBH4/dl-Tartaric Acid. A 
solution of dl-tartaric acid (1.8 g, 12 mmol) in ethanol (10 mL) was cooled down to 
 136
0°C under N2 and solid NaBH4 (0.46 g, 12 mol) was added slowly in small portions. 
An extothermic reaction began with evolution of H2. The mixture was stirred at R.T. 
for 20 minutes and was then cooled down to -15°C. (±)-3-Keto-α-ionone ketal (124) 
(2.5 g, 10 mmol) in 8 mL ethanol was added and the mixture was stirred at -15°C for 
10 minutes. This was followed by the addition of solid NaBH4 (0.23 g, 6.1 mmol) to 
the suspension at -15°C. The mixture was allowed to warm up to R.T. and the course 
of the reaction was followed by HPLC (Eluent A). The product was worked up by 
pouring the reaction mixture into crushed ice and extraction with ethyl acetate (50 
mL). The organic layer was washed with water (2 X 100 mL), dried over Na2SO4, and 
evaporated to dryness to give 2.4 g of a colorless oil identified as ketal 120 – 123. The 
oil was dissolved in acetone (25 mL) and water (14 mL) and treated with 1.8 mL of 
0.3N HCl to deprotect the ketal as described in the general deprotection procedure. 
After work up and purification by chromatography, 1.6 g of a colorless oil was 
obtained that was identified as trans-3-hydroxy-α-ionone (120+121) and cis-3-
hydroxy-α-ionone (122+123) in diastereomeric ratio of 1:1 (1.6 g, 7.7 mmol; 77%). 
 
Reduction of (±)-3-Keto-α-Ionone Ketal (124) with NaBH4/Cerium Chloride. A 
solution of (±)-3-keto-α-ionone ketal (124) (0.32 g, 1.3 mmol) in methanol (20 mL) 
was cooled down to -15°C under N2 and was treated with solid CeCl3 (0.73 g, 2.0 
mmol). NaBH4 (80 mg, 2.1 mmol) was added at -15°C and stirred at this temperature 
for 2 h. The course of the reaction was followed by HPLC (eluent A). The product 
was poured into a solution of NH4Cl (10%) and extracted with ethyl acetate (25 mL). 
The organic layer was washed with water (2 X 80 mL), dried over Na2SO4, and 
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evaporated to dryness to give 0.2 g of ketal 120 – 123 as a colorless oil. The oil was 
dissolved in acetone (2 mL) and water (4 mL) and treated with 0.15 mL of 0.3N HCl 
to deprotect the ketal as described in the general procedure. After work up, the crude 
product was purified by chromatography to afford 120 – 123 (0.10 g, 0.51 mmol; 40%) 
which was shown by HPLC (eluent A) and NMR to consist of a mixture of trans-3-
hydroxy-α-ionone (120+ 121) (34%) and cis-3-hydroxy-α-ionone (122+ 123) (66%). 
 
Reduction of (±)-3-Keto-α-Ionone Ketal (124) with 9-BBN. A solution of (±)-3-
keto-α-ionone ketal (124) (0.2 g, 0.8 mmol) in TBME (6 mL) was cooled down to -
35°C under N2 and a 2M solution of 9-BBN in THF (4 mL, 2 mmol) was added. The 
mixture was stirred at -40°C for 45 min. The reaction was quenched by addition of 
water (1 mL) and the mixture was allowed to warm up to R.T. 3N NaOH (1.5 mL) 
followed by 30% H2O2 (1.5 mL) were added and the mixture was stirred for 15 min at 
R.T. The product was washed with water, dried over Na2SO4 and evaporated to 
dryness to yield ketal 120 – 123 as a colorless oil. The oil was dissolved in acetone (5 
mL) and water (1.5 mL) and treated with 0.2 mL of 0.3N HCl to deprotect the ketal as 
described in the general procedure. After work up with ethyl acetate, the crude 
product was shown by HPLC (eluent A) to consist of a mixture of 3-keto-α-ionone 
(124) (80%), (3,6)-trans-3-hydroxy-α-ionone (8.4%), and (3,6)-cis-3-hydroxy-α-
ionone (11.6%). 
 
Reduction of (±)-3-Keto-α-Ionone Ketal (124) with Sodium Bis(2-
Methoxyethoxy)aluminum Hydride (Red-Al™).  A solution of (±)-3-keto-α-ionone 
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ketal (124) (13.3 g, 53.0 mmol) in TBME (30 mL) was cooled down to -20°C under 
N2 and a solution of Red-Al™ in toluene (25.0 mL of 65 wt%, 16.8 g, 83.0 mmol) 
was added dropwise in 40 minutes. The mixture was allowed to warm up to 0°C and 
stirred for 1 h at this temperature. The reaction was quenched by addition of water (10 
mL) at -10°C and stirring for 10 minutes. The product was filtered through celite 
using acetone. The filtrate was concentrated under reduced pressure and the residue 
was partitioned between TBME (120 mL) and water (300 mL). The organic layer was 
removed and sequentially washed with brine and water. After drying over Na2SO4 and 
solvent evaporation, the crude product was dissolved in acetone (50 mL) and water 
(20 mL) and stirred with 5 mL of 0.3 N HCl at R.T. for 2 h to deprotect the ketal 
120 – 123. After work-up 10.8 g of a yellow oil was obtained. The oil was purified by 
column chromatography (hexane: ethyl acetate from 90:10 to 70:30) to yield (±)-3-
hydroxy-α-ionone (124) (6.27 g, 30 mmol, 57%) as a pale yellow oil which was 
shown by HPLC (Eluent A) and 1H NMR to consist of a 1:1 mixture of (3,6)-trans- 
and (3,6)-cis-3-hydroxy-α-ionone. 
 
Reduction of (±)-3-Keto-α-Ionone Ketal (124) with Diisobutylaluminum 
Hydride (DIBAL-H). A solution of (±)-3-keto-α-ionone ketal (124) (0.98 g, 3.9 
mmol) in CH2Cl2 (7 mL) was cooled down to -30°C under N2 and a solution of 
DIBAL-H (7 mL of 1M in CH2Cl2, 7 mmol) was added with a syringe in 5 min. The 
mixture was stirred at -30°C to -20°C for 1 h. The reaction was quenched by adding 
water (20 mL) at -10°C followed by 1 g of silica gel. The mixture was allowed to 
warm up to R.T. and stirred for 1 h. The mixture was filtered through celite and 
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CH2Cl2 was removed under reduced pressure. The residue was dissolved in 10 mL 
acetone and 5 mL water and was stirred with 0.3N HCl (0.4 mL) at R.T. for 30 min. 
After work up with ethyl acetate and column chromatography purification, 
hydroxyionone 120 – 123 (0.73 g, 3.5 mmol, 90%) was shown by HPLC (eluent A) 
and 1H NMR to consist of a mixture of (3,6)-trans-3-hydroxy-α-ionone (34%) and 
(3,6)-cis-3-hydroxy-α-ionone (66%). 
 
Reduction of (±)-3-Keto-α-Ionone Ketal (124) with Sodium Tri-sec-
Butylborohydride (N-Selectride™). A solution of (±)-3-keto-α-ionone ketal (124) 
(50 mg, 0.20 mmol) in TBME (5 mL) was cooled down to -20°C under N2 and a 1M 
solution of N-Selectride™ in THF (0.52 mL, 0.52 mmol) diluted with TBME (1 mL) 
was added by a gas-tight syringe. The mixture was stirred at this temperature for 0.5 h 
and the product was worked up and deprotected as described in the general procedure 
to give 120 – 123 (33.3 mg, 0.16 mmol; 80%). This was shown by HPLC (Eluent A) 
and NMR to consist of a mixture of (3,6)-trans-3-hydroxy-α-ionone (41%) and (3,6)-
cis-3-hydroxy-α-ionone (59%). 
 
Reduction of (±)-3-Keto-α-Ionone Ketal (124) with Potassium Tri-sec-
Butylborohydride (K-Selectride™). A solution of (±)-3-keto-α-ionone ketal (124) 
(0.445 g, 1.78 mmol) in TBME (5 mL) was cooled down to -30°C under N2 and a 1M 
solution of K-Selectride™ in THF (2.5 mL, 2.5 mmol) was added with an air-tight 
syringe in 15 min. The mixture was stirred at -30°C for 1 h and was then treated with 
1.5 mL of 3 N NaOH followed by 1.5 mL of 30% H2O2. After stirring at R.T. for 30 
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min, the product was extracted with TBME (10 mL) and washed twice with water, 
dried over Na2SO4, and evaporated to dryness to give ketal 120 – 123 as a pale yellow 
oil. After deprotection with 0.3N HCl and purification by chromatography, the 
product was shown by HPLC (Eluent A) and 1H NMR to consist of a mixture of (3,6)-
trans-3-hydroxy-α-ionone (55%) and (3,6)-cis-3-hydroxy-α-ionone (45%) (0.315 g, 
1.51 mmol, 85%). 
 
Base-Catalyzed Isomerization of 3-Hydroxy-α-Ionone (120 – 123) to (±)-3-
Hydroxy-β-Ionone (42). A solution of 3-hydroxy-α-ionone (120 – 123) (1.93g, 9.27 
mmol) in THF (7 mL) was treated with 0.5 mL of a solution of KOH in methanol 
(10% wt./vol) under N2. The mixture was heated to 50°C for 1 h and the product was 
partitioned between water and ethyl acetate. The organic layer was washed with water 
(2 X 100 mL), dried with Na2SO4, and evaporated to dryness to give 1.8 g of a yellow 
oil. The product was purified by column chromatography (hexane: ethyl acetate, from 
98:2 to 90:10) to give a yellow oil which was identified as (±)-3-hydroxy-β-ionone 
(42) (1.26 g, 6.03 mmol; 65%). The spectroscopic data of 42 were identical with those 
of a standard sample of this ionone obtained by oxidative degradation of lutein 
described earlier. 
 
Enzyme-Mediated Acylation of (±)-3-Hydroxy-β-Ionone (42) with Lipase PS 
(pseudomonas cepacia). To a solution of (±)-3-hydroxy-β-ionone (42) (3.3 g, 16 
mmol) in 25 mL of ethyl acetate was added 5.0 g of immobilized lipase PS 
(pseudomonas cepacia) and vinyl acetate (1.0 mL, 0.93 g, 10 mmol). The mixture was 
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stirred at R.T. under N2 and the course of the enzymatic acylation was monitored by 
chiral HPLC (Eluent B, hexane:isobutanol = 9/1). After 20 h the enzyme was filtered 
through celite and the filtrate was evaporated to dryness to give a yellow oil (4.0 g). 
Column chromatography (hexane: ethyl acetate, 98:2 to 80:20 of the product gave two 
major fractions. 
The first fraction was identified from its 1H NMR and UV spectrum as (3R)-3-
acetoxy-β-ionone (129) (2.0 g, 8.0 mmol).  
(3R)-3-Acetoxy-β-ionone (129): 1H NMR (400 MHz, CDCl3) δ 1.08 (s, 3H), 1.12 
(s, 3H), 1.23 (s, 1H), 1.57 (t, J = 12.2, 1H), 1.74 (s, 3H), 1.77 (dd, J = 12.2, 3.5, 1H), 
2.02 (s, 3H), 2.12 (dd, J = 17.1, 9.3, 1H), 2.27 (s, 3H), 2.47 (dd, J = 17.1, 6.0, 1H), 
5.02 (m, 1H), 6.09 (d, J = 16.4, 1H), 7.17 (d, J = 16.4, 1H). 13C NMR (100 MHz, 
CDCl3) δ 21.3, 27.3, 28.3, 29.7, 36.3, 38.6, 43.9, 67.6, 131.3, 132.5, 135.6, 141.8, 
170.6, 198.3. UV λmax = 288 nm (ethanol). HRMS (EI) m/z calculated for C15H22O3 
250.1569, found 250.1576. CD: 306 nm (-3.01 mdeg), 271 nm (+2.24 mdeg). 
This fraction was dissolved in CH2Cl2 (30 mL) and stirred with KOH/MeOH 
(5.5 mL, 10% wt/v) for 2 hours at 0°C. The product was treated with 23 mL of 0.3N 
HCl to bring the pH to 5. The organic layer was sequentially washed with a saturated 
solution of NaHCO3 (100 mL) and water (100 mL), and dried over Na2SO4. After 
solvent evaporation, 1.6 g of a yellow oil (7.7 mmol) was obtained which was 
identified by chiral HPLC (Eluent B, Appendix I) as (3R)-3-hydroxy-β-ionone (3R-42) 
(96% ee). A small sample of this ionone was fully characterized from its UV, CD, 1H- 
and 13C-NMR, and mass spectra. 
The second fraction (1.7 g, 8.2 mmol) was identified by chiral HPLC (Eluent B) 
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as (3S)-3-hydroxy-β-ionone (3S-42) (96% ee). Similarly, this hydroxyionones was 
fully characterized from its UV, CD: 311 nm (3.20 mdeg), 273 nm (-3.59 mdeg), 1H- 
and 13C- NMR, and mass spectra. 
The absolute configuration of hydroxyionones (3R)-42 and (3S)-42 was 
determined by comparison of their CD spectra with that of (3R)-3-hydroxy-β-ionone 
which was prepared by oxidative cleavage of naturally occurring (3R,3'R,6'R)-lutein. 
 
Preparation of (3R)-3-Hydroxy-(β-Ionylideneethyl)triphenylphosphonium 
Chloride (16) From (3R)-3-Hydroxy-β-Ionone [(3R)-42] via (3R)-3-Hydroxy-
Vinyl-β-Ionol [(3R)-43]. A solution of (3R)-3-hydroxy-β-ionone [(3R)-42] (0.85 g, 
4.1 mmol) in toluene (15 mL) was cooled down to -20°C under argon. A 1M solution 
of vinyl magnesium bromide (10 mL, 10 mmol) was added dropwise in 30 min and 
the mixture was stirred at this temperature for 1 h. The reaction was quenched with 
addition of 10 mL saturated ammonium chloride solution at -20°C and stirred at R.T. 
for 10 min. The product was partitioned between water (100 mL) and ethyl acetate 
(50 mL). The organic layer was washed with water (100 mL), dried over Na2SO4, and 
evaporated to dryness. The crude product (0.78 g), (3R)-3-hydroxy-vinyl-β-ionol 
[(3R)-43], was dissolved in 5 mL MeOH and directly used without purification in the 
next step for the preparation of the Wittig salt (3R)-16. 
Triphenylphosphine hydrochloride was prepared fresh by adding 0.44 mL of 
concentrated HCl to triphenylphosphine (1.3 g, 4.9 mmol) in 5 mL methanol at 0°C. 
The salt was stirred at R.T. for 20 min and was treated with a solution of crude (3R)-
3-hydroxy-vinyl-β-ionol [(3R)-43] (0.78 g) in MeOH (5 mL) by dropwise addition in 
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5 min at 0°C. The reaction was kept at 0°C for 1 h and was allowed to stir to R.T. 
overnight. The product was partitioned between hexane (50 mL) and methanol:water 
= 1:1 (50 mL). The aqueous layer was washed with hexane (3 X 50 mL) to remove 
the excess triphenylphosphine and the aqueous layer was extracted with CH2Cl2 (3 X 
50 mL). The combined CH2Cl2 layer was washed with water (100 mL), dried over 
Na2SO4, and evaporated to dryness to give 1.4 g crude product that was crystallized 
from 1,2-dichloroethane (11 mL) and ethyl acetate (25 mL) at -20°C. The crystals 
were washed with ethyl acetate and hexane and dried under high vacuum to give (3R)-
3-hydroxy-(β-ionylideneethyl)triphenyl-phosphonium chloride [(3R)-16] (1.27 g, 2.46 
mmol; 60%) as a grayish powder. 1H NMR (400 MHz, CDCl3) δ 0.95 (s, 3H), 0.97 (s, 
3H), 1.34 (d, J = 4.2, 3H), 1.42 (t, J = 12.1, 1H), 1.60 (s, 3H), 1.73 (dd, J = 12.1, 3.47, 
1H), 1.99 (dd, J = 16.8, 9.5, 1H), 2.16 (s, 1H), 2.32 (dd, J = 16.8, 4.9, 1H), 3.94 (m, 
1H), 4.95 (m, 1H), 5.34 (dd, J = 14.3, 6.9, 1H), 5.90 (s, 2H), 7.66 (m, 6H), 7.77 (m, 
3H), 7.87 (m, 6H). 13C NMR (100 MHz, CDCl3) δ 12.7, 21.4, 24.4, 24.9, 28.5, 30.1, 
36.8, 42.3, 48.0, 64.6, 113.3, 113.4, 117.9, 118.7, 126.8, 127.6, 127.7, 130.1, 130.3, 
133.8, 133.9, 134.8, 134.9, 136.2, 136.3, 136.8, 143.5, 143.6. UV λmax =  268 nm 
(ethanol). CD: 279 nm (-4.07 mdeg). The NMR and CD were identical with standard 
sample of (3R)-16 obtained from the DSM Nutritional Products (Basel, Switzerland).  
 
Preparation of (3S)-3-Hydroxy-(β-Ionylideneethyl)triphenylphosphonium 
Chloride [(3S)-16] From (3S)-3-Hydroxy-β-Ionone [(3S)-42] via (3S)-3-Hydroxy-
Vinyl-β-Ionol [(3R)-43]. Employing the same procedure described above, (3S)-3-
hydroxy-β-ionone (3S)-42 (0.85 g, 4.1 mmol) was transformed into (3S)-3-hydroxy-
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(β-ionylideneethyl)triphenyl-phosphonium chloride [(3S)-16] (1.2 g, 2.3 mmol, 55%). 
The 1H and 13C-NMR spectra of (3S)-16 were identical with those of (3R)-16. UV 
λmax =  268 nm (ethanol). CD: 281 nm (+6.43 mdeg). 
 
Synthesis of (3R,3'R)-Zeaxanthin (5). A mixture of (3R)-3-hydroxy-(β-
ionylideneethyl)triphenylphosphonium chloride [(3R)-16] (0.30 g, 0.58 mmol), C10-
dialdehyde 17 (45 mg, 0.28 mmol), 1,2-epoxybutane (0.5 mL) in ethanol (5 mL) was 
refluxed under N2 and the course of the reaction was monitored by HPLC (eluent A, 
Appendix I). After 22 h, HPLC showed the completion of the reaction. The product 
was filtered and the solids were washed with ethanol. Crystallization from CH2Cl2 
and hexane gave a red solid that was identified from its NMR, CD, UV-Vis, and MS 
spectra as (3R,3'R)-zeaxanthin (5) (68 mg, 0.12 mmol, 43%). The product was shown 
by chiral HPLC (Eluent L, Appendix I) to have an enantiomeric excess (ee) of 98%. 
1H NMR (400 MHz, CDCl3) δ 1.08 (s, 12H), 1.38 (s, 2H), 1.49 (t, J = 12.0, 2H), 1.75 
(s, 6H), 1.78 (dd, J = 12.1, 3.5,  2H), 1.98 (s, 12H), 2.06 (dd, J = 16.9, 9.7, 2H), 2.40 
(dd, J = 16.9, 5.4, 2H), 4.01 (m, 2H), 6.08-6.20 (m, 6H), 6.26 (d, J = 7.6, 2H), 6.37 (d, 
J = 15.0, 2H), 6.60-6.70 (m, 4H). 13C NMR (100 MHz, CDCl3) δ 12.7, 19.3, 21.6, 
28.7, 30.3, 37.1, 42.5, 48.5, 65.1, 124.9, 125.5, 126.2, 130.1, 131.3, 132.7, 135.6, 
136.6, 137.6, 137.9, 138.5. UV/Vis λmax = 450 nm (ethanol). HRMS (ESI) m/z 
calculated for C40H56O2 568.4280, found 568.4277. CD: 342 nm (+1.80 mdeg), 284 




Synthesis of (3S,3'S)-Zeaxanthin (6). A mixture of (3S)-3-hydroxy-(β-
ionylideneethyl)triphenylphosphonium chloride [(3S)-16] (0.30 g, 0.58 mmol), C10-
dialdehyde 17 (45 mg, 0.28 mmol), 1,2-epoxybutane (0.5 mL) in ethanol (5 mL) was 
refluxed under N2 and the course of the reaction was monitored by HPLC (eluent A). 
After 22 h, HPLC showed the completion of the reaction. The product was filtered 
and the solids were washed with ethanol. Crystallization from CH2Cl2 and hexane 
gave a red solid that was identified from its NMR, CD, UV-Vis, and MS spectra as 
(3S,3'S)-zeaxanthin (6) (63 mg, 0.11 mmol, 39%); according to chiral HPLC (Eluent 
L, Appendix I) this product  was obtained in 98% ee. The 1H- and 13C-NMR were 
identical with 5. UV/Vis λmax = 450 nm (ethanol). HRMS (ESI) calculated for 
C40H56O2 568.4280, found 568.4279 CD: 342 nm (-1.88 mdeg), 284 nm (+8.48 mdeg), 
246 nm (-5.38 mdeg), 222 nm (+5.87 mdeg).  
 
Synthesis of (3R)-β-Cryptoxanthin (134). A mixture of β-apo-12'-carotenal (134) 
(0.16 g, 0.45 mmol), (3R)-3-hydroxy-(β-ionylideneethyl)triphenylphosphonium 
chloride [(3R)-16] (0.27 g, 0.52 mmol), and 1,2-epoxybutane (0.39 mL) in ethanol (5 
mL) was refluxed under N2. After 6 h, the product was filtered and the solids were 
washed with ethanol. Crystallization from CH2Cl2 and hexane gave a red solid that 
was identified as (3R)-β-cryptoxanthin (135) (0.18 g, 0.32 mmol; 70%), m.p. 134-
136°C. The product was shown by chiral HPLC (Eluent M, Appendix I) to have an 
optical purity of 98% (ee). 
135: 1H NMR (400 MHz, CDCl3) δ 1.04 (s, 6H), 1.08 (s, 6H), 1.47 (m, 2H), 1.61-
1.65 (m, 2H), 1.72(s, 3H), 1.75 (s, 3H), 1.78 (dd, J = 12.1, 3.5, 2H), 1.98 (s, 12H), 
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2.02 (t, J = 6.2, 1H), 2.07 (d, J = 9.8, 1H), 2.40 (dd, J = 16.8, 5.3, 1H), 4.01 (m, 1H), 
6.08-6.21 (m, 6H), 6.26 (d, J = 6.3, 2H), 6.37 (dd, J = 14.9, 3.6, 2H), 6.60-6.70 (m, 
4H). 13C NMR (100 MHz, CDCl3) δ 12.8, 19.3, 21.6, 21.8, 28.7, 29.0, 30.3, 33.1, 
34.3, 37.1, 39.7, 42.6, 48.5, 65.1, 124.9, 125.1, 125.5, 126.2, 126.7, 129.4, 129.9, 
130.1, 130.8, 131.3, 132.4, 132.7, 135.6, 136.1, 136.4, 136.6, 137.2, 137.6, 137.8, 
137.9, 138.5. UV/Vis λmax = 450 nm (ethanol). MS (FAB+) calculated for C40H55O 
[M+H]+ 552.4330, found 552.4000. CD: 342 nm (+0.88 mdeg), 286 nm (-4.13 mdeg), 
248 nm (+2.65 mdeg), 222 nm (-2.80 mdeg). 
 
Synthesis of (3S)-β-Cryptoxanthin (136). β-Apo-12'-carotenal (134) (0.16 g, 0.45 
mmol) was allowed to react with (3S)-3-hydroxy-(β-ionylideneethyl)- 
triphenylphosphonium chloride [(3S)-16] (0.27 g, 0.52 mmol) in the presence of 1,2-
epoxybutane (0.39 mL) under reflux in ethanol (5 mL). After 6 h, the product was 
worked up and crystallized as described in the previous experiment to afford (3S)-β-
cryptoxanthin (136) (0.18 g, 0.32 mmol; 70%). This was shown by chiral HPLC 
(Eluent M) to have an optical purity of 98% (ee). The 1H-, 13C-NMR, UV/Vis, and 
MS were identical to those of 135. CD: 342 nm (-1.08 mdeg), 284 nm (+4.12 mdeg), 
248 nm (-2.78 mdeg), 224 nm (+2.85 mdeg). 
 
Synthesis of C20-3-Hydroxynitriles (93+94) from 3-Hydroxy-α-Ionylidene-
acetaldehydes (73+74). To a solution of 3-methyl-4-oxobut-2-enenitrile (31 mg, 
0.090 mmol) in 3 mL TBME was added butyl lithium (1.6 M in hexane, 0.96 mL, 1.5 
mmol) at 0°C under N2. The ice bath was removed and the reaction mixture was 
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stirred for 0.5 h at R.T. The mixture was cooled down to 0°C and a recemic mixture of 
hydroxyaldehydes 73+74 (0.20 g, 0.86 mmol) in 5 mL TBME was added dropwise at 
0oC. After stirring for 1 h at R.T., the product was worked up by adding saturated 
NH4Cl (10 mL) and EtOAc (15 mL). The EtOAc layer was dried over Na2SO4 and 
evaporated to dryness. After purification by column chromatography (hexane: ethyl 
acetate from 95:5 to 85:15), a small portion of the product (0.20 g, 0.69 mmol, 83%) 
was further purified by semipreparative HPLC (Eluent N, Appendix I) to yield (±)-3-
hydroxy-α-ionylideneacetaldehydes (93+94). 
93+94: 1H NMR (400MHz, CDCl3) δ 0.86 (s, 3H), 1.01 (s, 3H), 1.38 (dd, J = 13.3, 
6.8,  1H), 1.63 (s, 3H), 1.84 (dd, J = 13.3, 6.0, 1H), 1.96 (d, J = 0.8, 3H), 2.22 (d, J = 
1.2, 3H), 2.43 (d, J = 9.9, 1H), 4.26 (br, 1H), 5.20 (s, 1H), 5.57 (s, 1H), 5.6 (dd, J = 
15.3, 9.7,  1H), 6.11 (d, J = 11.3, 1H), 6.16 (d, J = 15.3, 1H), 6.30 (d, J = 15.1, 1H), 
6.92 (dd, J = 15.1, 11.1, 1H). 13C NMR (100 MHz, CDCl3) δ 13.3, 16.6, 22.8, 24.3, 
29.5, 34.0, 44.5, 54.9, 65.8, 96.8, 118.1, 124.8, 128.8, 131.7, 131.9, 132.3, 137.0, 
137.4, 140.3, 156.9. UV λmax = 338 nm (hexane); HRMS (ESI+) calculated for 
C20H27NO [M+Li]+ 304.2252, found 304.2250. 
 
Reduction of (±)-C20-3-Hydroxynitrile (93+94) to (±)-3-Hydroxy-α-Retinal 
(89+90). A solution of (±)-C20-3-hydroxynitriles (93+94) (0.15 g, 0.50 mmol) in 5 mL 
CH2Cl2 was cooled down to -40°C under N2 and a 1M solution of DIBAL-H in 
CH2Cl2 (1.5 mL, 1.5 mmol) was added dropwise in one hour. After the addition was 
completed, the reaction mixture was allowed to stir at -30°C for 1 h. The mixture was 
very slowly treated with a homogeneous mixture of 3 g of water absorbed on n-silica 
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(0.3 g of water/g of silica) at a rate that the temperature remained below -10°C 
[caution: the addition of silica/water results in rapid elevation of the temperature]. 
After the addition was completed, the reaction mixture was allowed to stir at 0°C for 
1 h. Na2SO4 (3 g) was added and the solids were filtered off and washed with CH2Cl2 
(20 mL). The organic layer was washed with water, dried over Na2SO4, and 
evaporated to dryness to give a yellow oil. Column chromatography (hexane:ethyl 
acetate, 98:2 to 88:12) of the product gave 89+90 (94 mg, 0.31 mmol; 62%).  
89+90: 1H NMR (400MHz, CDCl3) δ 0.86 (s, 3H), 1.01 (s, 3H), 1.39 (dd, J = 13.1, 
6.8,  1H), 1.63 (s, 3H), 1.85 (dd, J = 13.1, 5.9, 1H), 1.98 (s, 3H), 2.33 (d, J = 1.0, 3H), 
2.44 (d, J = 10.2, 1H), 4.27 (br, 1H), 5.58 (s, 1H), 5.61 (dd, J = 15.4, 10.2,  1H), 5.98 
(d, J = 8.2, 1H), 6.17 (d, J = 15.4, 1H), 6.18 (d, J = 11.0, 1H), 6.38 (d, J = 15.1, 1H), 
7.11 (dd, J = 15.1, 11.0, 1H), 10.11 (d, J = 8.2, 1H). 13C NMR (100 MHz, CDCl3) δ 
13.1, 13.3, 22.8, 24.3, 29.5, 34.0, 44.5, 55.0, 65.8, 124.8, 129.2, 129.4, 131.9, 132.2, 
134.9, 137.1, 137.4, 140.2, 154.6, 184.5, 191.1. UV λmax = 360 nm nm (hexane). 
HRMS (ESI+) calculated for C20H28O2 [M+H]+ 301.2167, found 301.1907. 
 
Preparation of (±)-Vinyl-α-Ionol (116). A solution of vinylmagnesium bromide 
(1M, 0.1 mol) in THF (100 mL) was added dropwise to a solution of (±)-α-ionone (18 
g, 94 mmol) in THF (20 mL) at –20oC under N2. The reaction mixture was stirred for 
1 h at 0oC and 30 minutes at R.T., and subsequently was cooled down to –20oC and 
treated with 70 mL of saturated ammonium chloride solution. The product was 
extracted with TBME (2 X 100 mL), dried over Na2SO4, and evaporated to dryness to 
give a colorless oil. The crude product was purified by fractional distillation (b.p. = 
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94oC at 0.5mm/Hg) to yield (±)-vinyl-α-ionol (116) (17.7 g, 80.4 mmol; 86%): Rf = 
0.58 (hexane/acetone, 9/1); the NMR data was consistent with that of literature.96  
 
Bleach Oxidation of (±)-Vinyl-α-Ionol (116) to (±)-3-Keto-Vinyl-α-Ionol (115). 
(±)-Vinyl-α-ionol (116) (3.0 g, 14 mmol) was transferred into a 1 L three-necked flask 
using ethyl acetate (13.4 mL, 12.0 g, 136 mmol). K2CO3 (0.19 g, 1.4 mmol) was 
added and the mixture was cooled down in an ice-salt bath to 0°C under N2. A 70% 
solution of TBHP in water (11.7 mL, 10.5 g, 70% ≈ 7.40 g, 81.7 mmol) was added 
dropwise to the mixture under N2 at 0°C in 10 mins. Household bleach containing 
5.25% NaOCl (38.6 g, 2.03 g NaOCl, 27.2 mmol) was then added over a period of 7 h 
at -5 to 0°C. After the addition was completed, the reaction mixture was stirred at 0°C 
for additional 10 h. The product was extracted with hexane (200 mL) and the organic 
layer was separated. The water layer was washed with hexane (2 X 100 mL) and the 
combined organic layer was washed with water (3 X 200 mL), dried over Na2SO4, 
and evaporated to give 2.9 g of a yellow oil. The crude product was purified by 
column chromatography (hexane:acetone, from 98:2 to 90:10) to yield a mixture of 3-
keto-vinyl-α-ionol (115) (2.51 g, 10.7 mmol; 79%) as a colorless oil. The 1H NMR 
data of 115 was consistent with that of literature.96 
 
Rh2(cap)4 Catalyzed Oxidation of (±)-Vinyl-α-Ionol (116) to (±)-3-Keto-Vinyl-
α-Ionol (115). To a solution of (±)-vinyl-α-ionol (116) (1.0 g, 4.5 mmol) in 10 mL of 
CH2Cl2 was added K2CO3 (0.30 g, 2.3 mmol) and Rh2(cap)4 (2 mg, 0.005 mmol); this 
was followed by the addition of tert-butylhydroperoxide (6.3 M in decane, 3.6 mL, 23 
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mmol). The reaction mixture was stirred at 0oC for 2 hours and then at R.T. for 22 h. 
The product was filtered through celite and the filtrate was washed with water (2 X 30 
mL), dried over Na2SO4, and evaporated to dryness to give a colorless oil. Purification 
by column chromatography (hexane/acetone, 95/5) afforded 0.6 g (60%) of (±)-3-
keto-vinyl-α-ionol (115): Rf = 0.47 (hexane/acetone, 8/2); 1H NMR data of 115 was 
consistent with that of literature.90 
 
Pd(II)-Mediated Oxidation of (±)-Vinyl-α-Ionol (116) to (±)-3-Keto-Vinyl-α-
Ionol (115). To a solution of (±)-vinyl-α-ionol 116 (30.0 g, 136 mmol) in 50 mL of 
hexane was added K2CO3 (4.85 g, 35.1 mmol) and Pd/C (10% on activated carbon, 
3.75 g, 3.52 mmol). The mixture was cooled down to 0oC in an ice bath and tert-
butylhydroperoxide (70% in water, 65.3 mL, 681 mmol) was added dropwise under 
N2. The reaction mixture was stirred at 0oC for 2 hours and at R.T. for 20 h and then 
filtered through celite. The filtrate was washed with water (3 X 100 mL) and the 
organic layer was dried over Na2SO4 and evaporated to dryness to give a colorless oil. 
Purification by column chromatography (hexane/acetone, 95/5) afforded 14.2 g 
(44.5%) of (±)-3-keto-vinyl-α-ionol (115). The structure of this product was 
confirmed from its 1H NMR spectrum. 
 
Preparation of (E)-Ethyl-3-Formyl-2-Butenoate (113). To a flask containing 
sodium hydride (5.6 g, 0.14 mol) and 30 mL of TBME was added triethyl 
phosphonoacetate (22 g, 0.10 mol) in 30 mL TBME at 0°C. The reaction mixture was 
stirred for 1 h at R.T. and was then treated with pyruvaldehyde dimethylacetal (14 g, 
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0.12 mmol) in 30 mL TBME at 10°C. The mixture was stirred for 24 hours at R.T. and 
the product was washed with water. The aqueous layer was washed with TBME (3 X 
30 mL) and the combined organic layer was washed with water (2 X 30 mL), dried 
over Na2SO4, and evaporated to dryness. The crude product (17g) was dissolved in 
CH2Cl2 (30 mL) and then subjected to cis-trans isomerization by treatment with 30 
mL HCl (3N) at R.T. for 4 hours. The all-trans product was then purified by column 
chromatography (hexane/acetone, 98/2) to yield 113 as a colorless liquid (9.0 g, 76 
mmol; 64%, E/Z = 49/1).  
(E)-Ethyl-3-formyl-2-butenoate (113): 1H NMR (400MHz, CDCl3): δ 1.26 (t, J = 
7.0, 3H), 2.07 (d, J = 1.5, 3H), 4.24 (q, J = 14.3, 7.0, 2H), 6.46 (dd, J = 3.02, 1.5, 1H), 
9.47 (s, 1H). 13C NMR (100 MHz, CDCl3) δ 14.0, 60.9, 104.9, 135.4, 165.3, 194.3. 
(Z)-Ethyl-3-formyl-2-butenoate (113): 1H NMR (400MHz, CDCl3): δ 1.24 (t, J = 
5.3, 3H), 1.90 (d, J = 1.8, 3H), 4.13 (q, J = 7.0, 2H), 5.98 (s, 1H), 10.6 (s, 1H). 13C 
NMR (100 MHz, CDCl3) δ 10.5, 53.1, 104.0, 118.2, 150.2, 203.8. 
 
Synthesis of (±)-3-Keto-α-Retinoic Acid Ethyl Esters (17) from (±)-3-Keto-
Vinyl-α-Ionol (115). To a solution of (±)-3-keto-vinyl-α-ionol (115) (2.74 g, 11.7 
mmol) in 15 mL of ethanol was added triphenylphosphine hydrobromide (4.0 g, 12 
mmol). The mixture was stirred at R.T. for 2 hours and then partitioned between water 
(50 mL) and hexane (50 mL). The organic layer was removed and the aqueous layer 
was washed with hexane (2 X 30 mL). The water layer was then extracted with 
CH2Cl2 (2 X 30 mL) and the combined organic layer was washed with water (2 X 50 
mL), dried over Na2SO4, and evaporated to dryness. The residue was transferred into a 
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three-neck flask equipped with an addition funnel and a low temperature thermometer. 
A solution of (E)-ethyl-3-formyl-2-butenoate (113) (1.58 g, 11.1 mmol) in ethanol 
(20mL) was added and the mixture was cooled to –20°C. A freshly prepared solution 
of NaOEt (from 0.30 g of Na, 13 mmol) in EtOH (10 mL) was added dropwise to the 
reaction mixture and the course of the reaction was monitored by normal phase HPLC 
(Eluent O, Appendix I). After stirring at –10°C for 4 h, the product was partitioned 
between hexane (30 mL) and water (30 mL). The organic layer was removed and the 
aqueous layer was extracted with hexane (2×30 mL). The combined organic layer was 
washed with brine (25 mL) and water (25 mL), dried over Na2SO4, and evaporated to 
dryness to give 5.9 g of a yellow oil. This was shown by HPLC (Eluent O, Appendix I) 
to consist of three major fractions. The crude product was quickly passed through a 
silica gel column using hexane/acetone (98/2) to yield a mixture of (E/Z)-(±)-3-keto-
α-retinoic acid ethyl esters (112) (2.6 g, 65%). A small portion of this product was 
subjected to semipreparative HPLC (Eluent O, Appendix I) to separate three fractions 
that in the order of chromatographic elution were identified as: (11Z)-3-keto-α-
retinoic acid ethyl ester (11Z-112), (all-E)-3-keto-α-retinoic acid ethyl ester (all-E-
112), and (9Z)-3-keto-α-retinoic acid ethyl ester (9Z-112) (11Z: all-E: 9Z = 1.6:4.2:1). 
(11Z)-3-Keto-α-retinoic acid ethyl ester (11Z-112): 1H NMR (400MHz, CDCl3) δ 
0.97 (s, 3H), 1.05 (s, 3H), 1.28 (t, J = 7.3, 3H), 1.90 (s, 3H), 1.91 (d, J = 1.3, 3H), 
2.10 (d, J = 16.9, 1H), 2.33 (d, J = 1.3, 3H), 2.37 (d, J = 16.9, 1H), 2.61 (d, J  = 9.4, 
1H), 4.19 (q, J = 14.2, 7.3, 2H), 5.62 (dd, J = 15.4, 9.4, 1H), 5.84 (s, 1H), 5.91 (s, 1H), 
5.95 (d, J = 10.7, 1H), 6.25 (d, J = 15.4, 1H), 6.50 (dd, J = 12.3, 10.7, 1H), 6.52 (m, 
2H). 13C NMR (100 MHz, CDCl3) δ 12.6, 14.3, 19.2, 23.6, 27.4, 27.9, 36.5, 47.6, 56.4, 
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59.8, 119.6, 125.7, 126.9, 127.4, 128.2, 132.6, 138.1, 138.4, 153.0, 162.0, 166.8, 
199.1. UV λmax = 330 nm (hexane). MS (DEI+) m/z calculated for C32H30O3 342.4718, 
found 342.2002.  
(all-E)-3-Keto-α-retinoic acid ethyl ester (all-E-112): 1H NMR (400MHz, CDCl3) 
δ 0.96 (s, 3H), 1.04 (s, 3H), 1.28 (t, J = 7.0, 3H), 1.89 (d, J = 1.26, 3H), 1.93 (d, J = 
1.0, 3H), 2.09 (d, J = 17.8, 1H), 2.33 (d, J = 1.25, 3H), 2.35 (d, J = 17.8., 1H), 2.61 (d, 
J  = 9.2, 1H), 4.15 (q, J = 7.0, 14.3, 2H), 5.64 (dd, J = 15.5, 9.2, 1H), 5.78 (s, 1H), 
5.91 (m, 1H), 6.16 (d, J = 11.4, 1H), 6.22 (d, J = 15.5, 1H), 6.30 (d, J = 15.1, 1H), 
6.93 (dd, J = 15.1, 11.4, 1H). 13C NMR (100 MHz, CDCl3) δ 13.1, 13.7, 14.3, 23.6, 
26.5, 27.3, 27.9, 36.5, 47.5, 56.3, 59.6, 119.3, 125.7, 127.5, 130.2, 130.7, 136.3, 137.7, 
138.0, 152.2, 161.8, 167.0, 199.1. UV λmax = 336 nm (hexane). MS was same as that 
of (9Z)-112.  
(9Z)-3-Keto-α-retinoic acid ethyl ester (9Z-112): 1H NMR (400MHz, CDCl3) δ 
0.99 (s, 3H), 1.08 (s, 3H), 1.30 (t, J = 7.0, 3H), 1.94 (d, J = 1.3, 3H), 1.94 (s, 3H), 
2.14 (d, J = 17.1, 1H), 2.37 (d, J = 1.1, 3H), 2.39 (d, J = 17.1, 1H), 2.69 (d, J  = 9.8, 
1H), 4.18 (q, J = 14.3, 7.0, 2H), 5.64 (dd, J = 15.3, 9.8, 1H), 5.8 (s, 1H), 5.93 (m, 1H), 
6.08 (d, J = 11.4, 1H), 6.25 (d, J = 15.0, 1H), 6.77 (d, J = 15.3, 1H), 7.04 (dd, J = 15.0, 
11.4, 1H). 13C NMR (100 MHz, CDCl3) δ 13.9, 14.3, 21.1, 23.7, 27.4, 27.9, 36.5, 47.7, 
56.8, 59.7, 119.3, 125.7, 128.9, 129.2, 129.5, 130.2, 135.6, 136.5, 152.2, 161.8, 167.0, 
199.0. UV λmax = 332 nm (hexane). MS was same as that of (9Z)-112. 
 
Z/E-Isomerization of (±)-3-Keto-α-Retinoic Acid Ethyl Ester (112) with 
Pd(OAc)2. To the mixture of (±)-3-keto-α-retinoic acid ethyl esters  (112) (11Z:all-
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E:9Z = 1.6:4.2:1) (1.1 g, 3.2 mmol) was added 5 mg of Pd(OAc)2 in 30 mL hexane. 
The mixture was refluxed for 24 h and the progress of isomerization was monitored 
by normal phase HPLC (System 3). The product was filtered through celite and the 
solvent was evaporated to dryness. The residue was examined by HPLC (Eluent O, 
Appendix I) and was shown to consist of (all-E)-3-keto-α-retinoic acid ethyl ester 
[(all-E)-112, 84%] and (9Z)-3-keto-α-retinoic acid ethyl ester [(9Z)-112,16%]. 
 
Reduction of 3-Keto-α-Retinoic Acid Ethyl Ester (112) to 3-Hydroxy-α-
Retinoic Acid Ethyl Esters (108 – 111) with Sodium bis(2-
Methoxyethoxy)aluminum Hydride (Red-Al™). A solution of (all-E)-(±)-3-keto-α-
retinoic acid ethyl ester [(all-E)-112] (0.31 g, 0.90 mmol) purified by semipreparative 
HPLC (Eluent O, Appendix I) in toluene (10 mL) was cooled down to -10°C under 
nitrogen and a solution of Red-Al (1.0 mL of 1M in toluene, 1.0 mmol) was added. 
The course of the reaction was monitored by HPLC (Eluent O, Appendix I). The 
mixture was stirred at -10°C for 2 h and the reaction was quenched by adding water (5 
mL). The product was diluted with TBME (5 mL) and washed sequentially with brine 
and water. The organic layer was dried over Na2SO4 and evaporated to afford 3-
hydroxy-α-retinoic acid ethyl esters (108 – 111) in nearly quantitative yield (0.29 g, 
0.85 mmol, 95%). Two pairs of diastereomeric hydroxyesters were separated by 
semipreparative HPLC and identified as a mixture of 108+109 (50%) and 110+111 
(50%). 
(3,6-trans)-3-Hydroxy-α-retinoic acid ethyl ester (108+109): 1H NMR (400 
MHz, CDCl3) δ 0.86 (s, 3H), 1.00 (s, 3H), 1.29 (t, J = 7.0, 2H), 1.39 (dd, J = 13.1, 6.8, 
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1H), 1.48 (br, 1H), 1.62 (s, 3H), 1.84 (dd, J = 13.1, 5.8, 1H), 1.94 (s, 3H), 2.34 (d, J = 
1.3, 1H), 2.42 (d, J = 10.0, 1H), 4.15 (q, J = 7.0, 2H), 4.25 (br, 1H), 5.54 (dd, J = 
15.5, 10.0, 1H), 5.56 (m, 1H), 5.78 (s, 1H), 6.13 (d, J = 11.3, 1H), 6.15 (d, J = 15.5, 
1H), 6.29 (d, J = 15.0, 1H), 6.95 (dd, J = 15.0, 11.3, 1H). 13C NMR (100 MHz, 
CDCl3) δ 12.7, 13.2, 13.8, 14.3, 22.8, 24.2, 29.4, 34.2, 44.5, 54.9, 59.7, 65.8, 118.8, 
124.7, 129.5, 130.6, 130.8, 135.5, 137.2, 137.5, 138.5, 138.6, 152.5, 167.1. UV λmax = 
338 nm (hexane). MS (ESI+) calculated for C22H32O3 [M+H-H2O] + 327.2324, found 
327.2001. 
(3,6-cis)-3-Hydroxy-α-retinoic acid ethyl ester (110+111): 1H NMR (400 MHz, 
CDCl3)  δ 0.85 (s, 3H), 0.95 (s, 3H), 1.27 (q, J = 5.3, 2H), 1.29 (t, J = 5.3, 3H), 1.39 
(dd, J = 12.6, 9.8, 1H), 1.59 (m, 1H), 1.63 (m, 3H), 1.93 (s, 3H), 2.17 (d, J = 9.4, 1H), 
2.34 (d, J = 1.01, 3H), 4.17 (q, J = 7.3, 2H), 4.23 (s, 1H), 5.46 (s, 1H), 5.64 (dd, J =  
15.5, 9.4, 1H), 5.77 (s, 1H), 6.13 (d, J = 11.6, 1H), 6.14 (d, J = 15.5, 2H), 6.28 (d, J = 
15.1, 1H), 6.95 (dd, J = 15.7, 11.6, 1H). 13C NMR (100 MHz, CDCl3) δ 13.2, 13.8, 
14.3, 22.6, 27.0, 29.2, 34.7, 40.9, 55.0, 60.0, 66.7, 118.8, 124.7, 129.5, 130.7, 131.8, 
135.5, 136.2, 137.6, 138.7, 152.5, 166.8. UV λmax = 334 nm. MS (ESI+) calculated for 
C22H32O3 [M+H-H2O] + 327.2324, found 327.3113. 
 
Synthesis of C20-3-Hydroxy-Retinals 89 – 92 from 3-Hydroxy-α-Retinoic Acid 
Ethyl Esters (108 – 111). To a flask containing 3-hydroxy-α-retinoic acid ethyl esters 
(108 – 111) (0.25 g, 0.73 mmol) in 15 mL THF was added LiAlH4 (1 M in THF, 1.5 
mL, 1.5 mmol) at -25°C. The mixture was allowed to warm up to -10°C and stirred 
for 2 hour. The reaction was monitored by HPLC (Eluent O, Appendix I) and the 
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product was worked up by adding saturated NH4Cl (20 mL) and extracted with 30 mL 
EtOAc. The EtOAc layer was then dried over Na2SO4 and evaporated to dryness to 
obtain the crude product (0.3 g) as a pale yellow oil. Without purification, this diol 
was dissolved in 5 mL of CH2Cl2 and treated with MnO2 (65 mg, 0.75 mmol) at R.T. 
After stirring for 2 h, HPLC showed the completion of the reaction. The MnO2 was 
filtered off and the filtrate was evaporated to dryness. The crude product was then 
purified by column chromatography (hexane:ethyl acetate, 98:2 to 88:12) to afford 
89 – 92 in 61% yield (0.13 g, 0.44 mmol). A small sample of this mixture was then 
subjected to semipreparative HPLC (Eluent N, Appendix I) to yield two fractions. The 
first fraction was identified from its 1H and 13C-NMR spectra as a racemic mixture of 
89 and 90 prepared earlier. The second fraction was identified from its proton NMR 
as a racemic mixture of 91 and 92. 
91+92: 1H NMR (400 MHz, CDCl3)  δ 0.87 (s, 3H), 0.96 (s, 3H), 1.40 (dd, J = 13.6, 
9.8, 2H), 1.65 (t, J = 1.75, 3H), 1.68 (dd, J = 6.5, 1H), 1.97 (d, J = 1.0, 1H), 2.20 (d, J 
= 9.3, 1H), 2.33 (d, J = 1.0, 1H), 4.26 (m, 1H), 5.52 (s, 1H), 5.71 (dd, J = 15.4, 9.4, 
1H), 5.98 (d, J =  8.0, 1H), 6.17 (d, J = 15.3, 1H), 6.18 (d, J = 11.5, 1H), 6.37 (d, J = 
15.1, 1H), 7.11 (dd, J = 15.1, 11.5, 1H). 
 
General Procedure for Base-Catalyzed Isomerization of 3-Hydroxy-α-
Ionylideneacetonitriles (77 – 80) with KOH (Table 8, Entry 1-4).  
Base-Catalyzed Isomerization of 3-Hydroxy-α-Ionylideneacetonitriles (77 – 80) 
(Table 8, Entry 3). A solution of 3-hydroxy-α-ionylideneacetonitriles (77 – 80) (71 
mg, 0.31 mmol) in 15 mL ethylene glycol mono ether was treated with 0.3 mL of a 
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solution of KOH (5.3 mmol) in the same alcohol (5% wt./vol) under N2. The mixture 
was heated at 120°C overnight and the product was partitioned between water and 
EtOAc. The organic layer was washed with water (2 X 100 mL), dried with Na2SO4, 
and evaporated to dryness to give 1.8 g of a yellow oil. The product was shown by 
HPLC (Eluent A, Appendix I) to consist of 35% of unreacted starting material 77 – 80 
(77+78 : 79+80 = 1.0 : 3.0) and 65% of a racemic mixture of 3-hydroxy-β-
ionylideneacetonitriles (102+103). This isomerization was also carried out under 
similar conditions in three other solvents (ethanol, propanol, and ethylene glycol) and 
the results are summarized in Table 8 in the results and discussion section of this 
dissertation. 1H NMR (400 MHz, CDCl3)  δ 1.07 (d, J = 2.3, 6H), 1.48 (t, J = 12.1, 
1H), 1.66 (s, 1H), 1.71 (s, 3H), 1.78 (dd, J = 12.1, 3.6, 1H), 2.06 (dd, J = 17.2, 9.5, 
1H), 2.20 (d, J = 1.0, 3H), 2.40 (dd, J = 17.2, 5.7, 1H), 4.00 (m, 1H), 5.18 (d, J = 0.8, 
1H), 6.13 (d, J =  16.1, 1H), 6.50 (dd, J = 16.1, 0.8, 1H). 13C NMR (100 MHz, CDCl3) 
δ 16.5, 21.5, 28.6, 30.1, 37.0, 42.4, 48.1, 64.6, 96.9, 117.8, 129.2, 133.4, 134.7, 136.4, 
156.9. UV λmax = 298 nm (hexane). MS (ESI+) calculated for C15H21NO [M+H]+ 
232.1701, found 232.1861. 
 
Base-Catalyzed Isomerization of 3-Hydroxy-α-Ionylideneacetonitriles (77 – 80) 
with KF-alumina (Table 8, Entry 5 and 6). A solution of 3-hydroxy-α-
ionylideneacetonitriles (77 – 80) (71 mg, 0.31 mmol) in 5 mL DMF was treated with 
KF-Al2O3 (40% by wt, 90 mg ≈ 36 mg, 0.62 mmol) under N2. The mixture was heated 
to 120°C for 29 hours and the product was partitioned between water and EtOAc. The 
organic layer was washed with water (2 X 100 mL), dried with Na2SO4, and 
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evaporated to dryness to give a yellow oil. The product was shown by HPLC (Eluent 
A, Appendix I) to consist of 36% of unreacted starting material 77 – 80 (77+78 : 
79+80 = 1.0 : 4.4) and 64% of a racemic mixture of 3-hydroxy-β-
ionylideneacetonitriles (102+103). This isomerization was also carried out under 
similar conditions in ethylene glycol (Table 8, Entry 6) and the results are summarized 
in Table 8 in the results and discussion section of this dissertation. 
 
Synthesis of 3-Hydroxy-Retinol (98) from (3R)-16. A solution of (3R)-3-
hydroxy-(β-ionylideneethyl)triphenylphosphonium chloride [(3R)-16] (1.7 g, 3.3 
mmol) and (E)-3-formyl-2-butenyl acetate (0.50 g, 4.3 mmol) in CH2Cl2 (10 mL) was 
cooled down to -20°C under N2. A solution of NaOMe (0.10 g of Na, 4.3 mmol) in 
3mL of MeOH was added in 20 minutes and the mixture was stirred at -10°C for 3.5 h. 
Dichloromethane (20 mL) was added, and the product was washed with water (3 X 10 
mL). The organic layer was removed, dried over Na2SO4, and evaporated to dryness 
to give 2.3 g of a yellow oil. The crude product was purified by column 
chromatography (hexane:ethylacetate, from 95:5 to 88:12) to give 88 (0.80 g, 2.6 
mmol, 80%) as a pale yellow oil. 1H NMR (400 MHz, CDCl3)  δ 1.07 (s, 6H), 1.34 (s, 
1H), 1.48 (t, J = 12.1, 1H), 1.74 (s, 3H), 1.77 (dd, J = 12.1, 5.9, 1H), 1.97 (s, 3H), 
2.04 (dd, J = 16.9, 9.5, 1H), 2.34 (s, 3H), 2.39 (dd, J = 16.9, 5.9), 4.01 (m, 1H), 4.33 
(d, J = 7.0, 2H), 6.10 (d, J = 11.0, 1H), 6.20 (d, J = 16.0, 2H), 6.33 (dd, J =15.0, 11.0), 
6.51 (d, J = 15.0, 1H). 13C NMR (100 MHz, CDCl3) δ 12.8, 21.6, 28.8, 30.3, 37.2, 
42.7, 48.7, 65.2, 64.0, 125.0, 125.7, 126.3, 130.2, 131.4, 132.6, 135.7, 136.5, 137.9. 
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APPENDIX I a 
HPLC Columns HPLC Eluents Compounds separated, 
monitoring wavelength (nm) 
Silica-based nitrile bonded 
(Analytical & Semipreparative) 
A 75% Hexane, 25% CH2Cl2, 0.6% MeOH 83/84, 260 nm; 81/82, 260 nm; 
77 – 80, 260 nm; 73 – 76, 280 nm; 
64 – 67, 412 nm; 120 – 123, 224 
nm; (3R)-42/(3S)-42, 286 nm. 
Silica-based nitrile bonded 
(Semipreparative) 
B 99.9% Hexane, 0.1% Isopropyl alcohol 83/84, 260 nm 
Chiral column  C 95% Hexane, 5% Isopropyl alcohol, 0.75% CH3CN 77 – 80, 260 nm 
Chiral column  D 98% CH3CN, 2% Isopropyl alcohol 73 – 76, 280 nm, 64 – 67, 412 nm 
Silica-based nitrile bonded 
(Semipreparative) 
E 75% Hexane, 25% CH2Cl2, 0.35% MeOH 119, 324 nm, (3R)-42, 286 nm 
C18-Reversed phase (Analytical) F 85% CH3CN, 2.5% Hexane, 2.5% CH2Cl2, 10% MeOH 1 – 4, 446 nm 
Chiral column  G 95% Hexane, 5% tert-Amyl alcohol 1/2, 446 nm 
Chiral column  H 90% Hexane, 10% 2-Pentanol 3/4, 446 nm 
Chiral column  I 97% Hexane, 3% Isopropyl alcohol, 0.1% CH3CN 120 – 123, 224 nm 
Chiral column  J 90% Hexane, 10% Isobutyl alcohol (3R)-42/(3S)-42, 286 nm 
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APPENDIX I (Continued) 
HPLC Columns HPLC Eluents Compounds separated, 
monitoring wavelength (nm) 
C18-Reversed phase (Analytical) K 75% CH3CN, 20% H2O, 5% Formic acid  (3R)-16, (3S)-16, 286 nm 
Chiral column L Pump A: 95% Hexane, 5% Isopropyl alcohol 








5 – 7, 450 nm 
Chiral column  M 97.5% Hexane, 2.5% Isopropyl alcohol 135/136, 450 nm 
Silica-based nitrile bonded 
(Semipreparative) 
N 75% Hexane, 25% CH2Cl2, 0.1% MeOH 89 – 92, 360 nm 
Silica-based nitrile bonded 
(Analytical & Semipreparative) 
O 90% Hexane, 10% CH2Cl2, 0.2% MeOH 112, 336 nm; 108 – 111, 338nm 
a Details of the HPLC systems, columns, and flow rates are described in the experimental section. 
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